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Abstract
Since the initial discovery of the association between C4 protein 
deficiency and autoimmune disease, much effort has been devoted to 
the characterisation of C4 protein and its molecular composition 
(Dawkins et al., 1983). From the outset, researchers have found the 
C4 protein difficult to work with as it is unstable and degrades 
rapidly. However, with the advent of molecular techniques, studies of 
the C4 gene have accelerated, uncovering a very complicated and 
large duplicated gene region.
This thesis reviews the literature on complement component C4, and 
reports on three interrelated research areas involving protein and 
DNA analysis of complement C4. Contributions to the molecular 
characterisation of the C4 complement gene region and population 
genetics are discussed in relation to current knowledge, and direction 
for further research is provided.
This study set out to establish whether indigenous people of PNG and 
Aboriginal Australians have shared a common gene pool. By 
analysing the distribution of polymorphic C4 alleles these studies 
found the Aboriginal Australian and PNG populations to be distinctly 
different. Analysis of the distribution of C4 alleles in the two ethnic 
groups indicated that the two Aboriginal populations showed 
significant similarities but the three geographically distinct PNG 
populations were significantly different. Studies here suggested these 
ethnic populations are more reliably distinguished from each other 
by differences in the frequencies of the most frequently occurring 
C4 alleles, than by the incidence of rare alleles.
The high frequency of C4 null alleles in northern located Darwin 
Aboriginal's reported by Ranford et al. (1987), is not an isolated 
incident as this study also found the highest frequencies of C4 null 
alleles in northern located Aboriginal Australian's compared to any 
ethnic group studied. This could be associated with the high 
occurrence of the autoimmune disease Systemic Lupus 
Erythematosus (SLE) in Aboriginal Australians, and strong
Vsusceptibility of Aboriginal Australians to this disease (Anstey et al., 
1993).
Accurate identification of C4 alleles including C4 null alleles is 
essential both for investigating gene-linked disease associations, as 
well as for advancing future population genetics studies. Studies here 
demonstrate that C4 protein allotyping does not accurately identify 
the C4 genotype of an individual. This was highlighted by the lack of 
Hardy-Weinberg equilibrium with respect to C4 allele frequencies of 
the East Cape York Aboriginal population as well as the identification 
of a number of alleles by molecular analysis which could not be 
identified by protein typing. The difficulties associated with 
determining C4 allotypes by C4 protein gel electrophoresis include 
instability of the C4 protein, high degree of technical expertise for 
interpretation of allotypes, and limitations of this technique in 
distinguishing overlapping alleles.
It was established in these studies that the polymorphic C4d  region 
of C4 genes may be used by molecular means to identify and type 
C4 alleles. With the advent of molecular biological techniques such 
as protein and DNA sequencing, and RFLP analysis of the C4 gene 
region, information required for development of a molecular-based 
typing protocol has become available. Some of the previously 
described C4A and C4B alleles have been found to have unique 
combinations of polymorphic amino acid residues distributed within 
a short stretch of DNA, otherwise known as the C4d region. This 
region of the gene is highly polymorphic encoding amino acid 
residues known to be involved in immune-complex binding, and also 
encodes antigenic determinants. Therefore the C4d region was 
considered an ideal candidate for the development of a molecular- 
based allotyping protocol. The molecular-based C4 typing technique 
developed here is based on PCR-RFLP analysis of the C4d region. 
Protein and DNA sequence information, C4 protein allotyping data, 
and computer analysis which estimates the predicted isoelectric 
value of a protein were used to develop this protocol. Application of 
the molecular C4 typing protocol enabled the identification of C4 
alleles which co-migrate by C4 protein gel electrophoresis as well as 
a number of rare and novel C4 alleles.
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The molecular basis of C4 null alleles has been extensively studied 
in Caucasians, however, very little is known about the genetic basis 
of C4 null alleles in other ethnic populations. C4 null alleles from 
Aboriginal Australians were investigated here in order to identify 
the genetic basis of these alleles compared to those in Caucasians. 
Many Caucasian C4 null alleles result from large deletions. However, 
this study found that the C4B null allele in Aboriginal Australians 
results from either duplication of C4A genes on a single haplotype, 
or possession of a hybrid C4A/C4B type of novel allele, which was 
denoted as C4A *CAN1. These findings have considerable 
significance in relation to the high frequency of C4 null alleles found 
in Aboriginal Australian populations. Many of these "null alleles" may 
indeed be functional alleles which have been misinterpreted by C 4 
protein typing. The molecular basis of C4A null alleles remains 
unresolved, however, this study indicates that the defect is likely to 
be due to post-transcriptional processing of the allele.
This thesis describes a detailed investigation into the molecular basis 
of C4 alleles including rare and null alleles. This information 
together with the vast amount of molecular data available on C 4 
enabled the development of a molecular-based C4 typing protocol. 
This protocol is considered to be a more reliable and accurate typing 
method than the traditional protein typing method, and can be easily 
adopted in any laboratory for routine allotyping.
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1Chapter 1
General Introduction
1.1 Introduction
Complement component C4 protein, as part of the complement 
pathway, has an important role in immune response. Deficiencies in 
C4 protein are implicated in the pathogenesis of some autoimmune 
diseases (Dawkins et aL, 1983; Atkinson, 1988; Robb et al., 1988). 
Knowledge of the molecular basis of C4 is necessary to advance 
studies in the role of C4 complement, diagnosis and treatment of 
associated diseases, and in population genetics. Although much is 
known of the molecular basis of C4, including its genomic structure, 
knowledge of the molecular basis of individual C4A and C4B null 
alleles is incomplete, especially for non-Caucasoid populations. In this 
context, the high frequency of C4 deficiency alleles reported in 
Aboriginal Australian populations (Ranford et al., 1987) is of 
particular interest, due to a possible correlation with high prevalence 
and marked severity of the autoimmune disease, systemic lupus 
erythematosus (SLE) in these populations (Anstey et al., 1993).
C4 allotyping is a notoriously unreliable technique, available to only 
a limited number of specialised laboratories. An accurate definition 
of the various alleles associated with the C4 gene region is essential 
for reproducible results, and so a more reliable and accurate C 4 
allotyping method was a major part of studies for this thesis. Studies 
here are concerned principally with defining the molecular basis of 
C4 null alleles and other alleles in Aboriginal Australians, and the 
development of a molecular-based C4 allotyping protocol.
This chapter reviews the role of complement in human immune 
response, the association of C4 protein deficiencies with autoimmune 
diseases, the molecular structure and organisation of the C4 gene 
region, and the molecular basis of C4 null alleles in 
Caucasians. The main aims of each of three major areas of research 
undertaken are summarised at the conclusion of this review.
21.2 The role of complement in the human immune response
Complement consists of a complex series of 30 plasma and membrane 
proteins which are now grouped into families according to their 
degree of homology and functional activity (Kinoshita, 1991). These 
families consist of proteins of the activation pathways, terminal 
pathway, regulatory proteins, and complement receptors. A large 
number of biological activities important in the inflammatory 
response and in host resistance to infection are programmed at 
various points in the complement cascade. During an immune 
response, the ability of antibody to inactivate foreign antigen 
depends upon the co-operation of complement. The complement 
cascade is responsible for solubilisation of immune complexes, viral 
neutralisation, stimulation of the inflammatory response (a localised 
protective defense), opsonisation (promotes recognition by phagocyte 
complement receptors), and lysis of foreign cells from tissues and 
blood. These processes are achieved through the sequential activation 
of complement proteins and by complement protein interaction with 
antibodies and/or cells that express complement receptors. Clearance 
of immune complexes prevents their interaction with the 
endothelium and reduces local inflammation and tissue damage from 
the activation of complement.
The complement system targets microorganisms and other antigens 
for binding to complement receptor-bearing cells, attracts phagocytic 
cells to the area of complement activation, and destroys target 
membrane. These processes are initiated by the formation of the C 3 
convertase enzyme which activates C3 to C3b. C3 complement 
protein products are then responsible for activation of other 
complement proteins which lead to formation of the membrane 
attack complex (MAC), and finally cell lysis. There are two pathways 
to complement activation- either the 'classical pathway' which is 
triggered by antibody/antigen complexes, or the second, known as 
the 'alternative pathway', which has its own intrinsic ability to 
recognise foreign organisms. A summary of these pathways is shown 
in Figure 1.1.
3Figure 1.1 Classical and alternative complement activation 
pathways. Ag: antigen, Ab: antibody, MAC: membrane attack 
complex, B: factor B, D: factor D, the remaining proteins are other 
complement pathway proteins
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41.2.1 Classical and alternative complement pathways
The classical pathway involves Cl,  C4, C2 and C3 proteins, and is 
activated by antigen/antibody complexes containing IgM and IgG 
(aggregated immunoglobulins). Cl  consists of three sub-components, 
Clq,  Cl r  and Cls.  Activation of this pathway is specific, and 
requires the interaction of Cl q  with the Fc portion of antibodies 
(aggregated IgG or IgM), which are bound to antigen. This interaction 
leads to conversion by limited sequential proteolysis of Cl r  and C l s  
to their activated enzymatic forms, C l r ~ and C l s ~. Clq  can also 
interact directly with surface components of certain bacteria and 
viruses (Tomlinson, 1993). Cls~  activates complement component 
C4, cleaving 10 KDa (C4a released) from the amino terminal of the 
alpha chain of C4 and leaving C4b which binds covalently to the 
Ag:Ab:C7 complex. In the presence of magnesium ions, C2 binds to 
C4b and is cleaved by Cls  to C2b (released) and C2a~ which has a 
proteolytic catalytic site (Figure 1.1). The resulting product is 
'C4b2a',  which is a C3 convertase enzyme.
The alternative complement pathway operates by continuously 
generating small amounts of activation products derived from C3.
This pathway can function in the absence of antibodies, and is 
spontaneous. There are two possible mechanisms which could 
activate the alternative pathway. Firstly, initiation may be due to 
hydrolysis of the intramolecular thioester bond of C3,  causing a 
conformational change in C3 resulting in a C3b- like structure which 
is often called C3(H20) (Pangburn and Müller-Eberhard, 1984). The 
other mechanism involves the thioester bond of C3 which is directly 
attached by a surface-containing hydroxyl group resulting in 
covalent binding. C3b bound to host cells is deactivated by host 
regulatory mechanisms, whereas C3b bound to foreign substances 
such as bacteria, (where there is usually no regulatory mechanism), 
results in the formation of a surface-bound C3 convertase. Once C3b 
is established, whether it be surface bound or in fluid phase, the C 3 
convertase enzyme is formed by an interaction with Factor B and 
Factor D. Factor B is activated by antigens particularly those carrying 
complex polysaccharides on their surface, such as bacteria, as well as 
large insoluble immune
5complexes and IgA-carrying immune complexes. Factor D cleaves 
Factor B forming 'Ba' which is released, and 'Bb' which binds to C3b . 
creating the alternative-pathway C3 convertase 'C3bBb'  (Figure 
1.1). A catalytic site on Bb in the fluid phase of C J(H 20)B b 
convertase, splits multiple molecules of C3 to C3b, some of which 
bind covalently to amino or hydroxyl groups on surrounding 
surfaces. An amplification loop is generated, as those C3 convertase 
complexes which are surface bound in turn produce more C3b  
(Pangburn and Müller-Eberhard, 1984). As a result, once activation 
occurs, the generation of C3b is accelerated. The invading organism 
becomes coated with C3b which acts as a tag for complement 
receptors on phagocytic cells, and terminal components of the 
complement system (Ross and Medof, 1985).
C3 convertases of the classical and alternative pathways are 
homologous, as are C4 and C3, C4b and C3b, C2 and B, and C2a 
and Bb (Campbell el al., 1988). Phylogenetic evidence, (reviewed by 
Farries and Atkinson, 1991), suggests that complement probably 
arose as an independent immune mechanism like the 'alternative 
pathway' which can act independently, and provides a natural 
immunity against invading microorganisms. The 'classical pathway' 
most probably evolved along with the antibody response, enabling 
the host to cope with rapidly evolving pathogens, and respond to 
poor stimulators, to memorise, and to prevent recurrent infections.
1.2.2 Terminal pathways
Once the C3 convertase enzyme has been formed it cleaves C3, 
creating C3a and C3b through the proteolytic site on 'C2a' or 'Bb'. 
C3a, an anaphylotoxin, is released into the circulation, and C3b 
binds to the C4b2a or C3bBb complex forming the C5 convertase 
C4b2a3b or C3bBb3b.  These latter enzymes in turn, cleave 
complement component C5 to C5a and C5b. C5b induces the 
association of the later-acting components C6, C7, C8, and C9 with 
itself, producing a large protein complex known as the membrane- 
attack complex 'C5b-9b'. This complex contains one molecule of 
C5b, C6, C l  and C8, and multiple molecules of C9 (up to 18). C9
6has been shown to greatly enhance the activity of the membrane 
attack complex (Müller-Eberhard, 1986). The membrane-attack 
complex is extremely hydrophobic, and inserts into the lipid bilayer 
of bacterial and animal cells causing lysis. The precise model for the 
membrane-attack complex ('MAC' pore), is unknown, although 
various models have been proposed, (for review refer to Esser, 1991; 
Bhakdi and Tranum-Jensen, 1991). The terminal pathway in host 
defence is important, as individuals deficient in one of the 
components C5 to C9 suffer from infection by Gram-negative 
bacteria of the genus Neisseria (Ross and Densen, 1984), reflecting 
the breakdown in the immune response at this stage.
1.2.3 Inflammatory response
Activation of the complement cascade at the site of injury results in 
the production of pro-inflammatory mediators C5a , C4a, and C3a. 
These proteins cause a spasmogenic response in smooth muscle, 
vasoactive amine release, and an increase in vascular permeability. 
C5a is also a potent chemoattractant, and effects cellular responses 
from phagocytes, such as, stimulation of cytokine synthesis, oxidative 
metabolism, and release of eicosanoids and degradative enzymes 
(Morgan, 1990; Frank and Fries, 1991).
In addition to these complement effector systems described above, 
the host has developed a means of controlling the complement 
cascade and protecting its cells against complement attack. These 
include complement-regulatory proteins and complement-cellular 
receptors.
1.2.4 Regulatory proteins
Host cell membranes contain proteins with down-regulatory 
properties such as the membrane cofactor protein (MCP), decay- 
accelerating factor (DAF), and complement receptor CR1. These act on 
C3b bound to host cells by promoting the cleavage of their 
components by serine protease I and its cofactors. The C3b 
inactivator is a potent inhibitor of the alternative pathway. It acts 
enzymatically to destroy C3b which is surface-bound and in fluid
7phase. Properdin stabilises the C3 convertase formed by the 
alternative pathway, and Factors I and H regulate the amplification 
of C3 convertase by this pathway. In the classical pathway, Cl  is 
controlled by Cl  esterase inhibitor, and C4 is inactivated by C 4 
binding protein and Factor 1 which cleaves C4b to C4c and C4d.
For future protection, the host-cell membranes contain inhibitors of 
the terminal pathways which regulate formation of the membrane- 
attack complex (MAC); they are, homologous restriction factor 
(HRF)/CS-binding protein (C£bp), and CD59. Some regulatory 
proteins have a number of functions. Factor H and CR1 for example, 
apart from their functions mentioned above, are involved in host cell 
protection (Kinoshita, 1991). Membrane-bound complement 
inhibitors are most important for protecting host cells. This is 
evidenced by individuals containing blood cells which have an 
increased susceptibility to complement (Kinoshita, 1991), and 
suffering from the disorder paroxysmal nocturnal haemoglobinuria 
(PNH) (Rosse, 1989; Rotoli and Luzzatto, 1989).
1.2.5 Complement receptors
Phagocytosis of most encapsulated microorganisms requires antibody 
and/or complement, which jointly promote binding and ingestion. 
Complement-dependent phagocytosis, mediated by the alternative 
pathway, depends on the interaction between deposited complement 
components and phagocyte receptors, such as CR1, CR3 and C5a 
(Ahearn and Fearon, 1989; reviewed by Krych et al., 1992). C5a  
induces margination and chemotaxis of neutrophils (Hugh, 1984), and 
is responsible for attracting other phagocytic cells to the area of 
complement activity. It renders these cells fully active in 
phagocytosis by up-regulating surface expression of CR1 and CR3  
(Fearon and Collins., 1983; Arnaout et al., 1984). C3b and C4b 
immune complexes can bind to a receptor, CR1 , which is found in 
large numbers on erythrocytes. The erythrocyte/immune complex is 
transported to the liver and spleen where the immune complex is 
transferred to a mononuclear phagocyte, and the erythrocyte returns 
to circulation (Schifferli et al,  1980). Clearance of immune 
complexes prevents their interaction with the endothelium and 
reduces local inflammation and tissue damage from the activation of
8complement. Clq  has also been shown to enhance phagocytosis of 
both IgG and complement-C3b coated organisms (Bobak et al., 1987 
and 1988).
1.2.6 Additional roles of complement
It is well established that complement's principal role is host defence 
by eliminating foreign material. Current research however, has 
suggested complement also plays a role in the induction and 
modulation of the adaptive immune response which leads to 
antibody production. Two factors have suggested this additional role 
of complement. Firstly, animals depleted of C3 by treatment with 
cobra venom factor (CVF), as well as humans and animals genetically 
deficient in early complement components, have an impaired 
antibody response (Bottger and Bitter-Suermann. 1987; Heyman, 
1990b). Secondly, CR2 transduces a growth signal in B cells (Cooper 
et al., 1988; Ahearn and Fearon., 1989; Matsumoto et al., 1991), and 
a monoclonal antibody that recognises the ligand-binding site of 
mouse CR2, inhibits the primary antibody response in vivo (Heyman 
et al., 1990a; Kinoshita, 1991). Additional evidence which also 
support the theory of complement's involvement with adaptive 
immunity include the following: (1) Antigen-presenting cells and B 
cells which have complement receptors 1, 2 and 3; (2) Binding of 
immune complexes to follicular dendritic cells in the germinal centers 
of lymph nodes (important for generation of memory B cells), and 
also; (3) Depletion of C3 in experimental animals which impairs 
antigen localisation to germinal centres (reviewed by Morgan and 
Walport, 1991).
1.3 C4 deficiency and systemic lupus erythematosus (SLE)
SLE is an autoimmune connective tissue disease, the aetiology of 
which is unknown. This disease is complex having many clinical 
manifestations ranging from a mild cutaneous disorder to a more 
severe, life-threatening disorder which can affect multiple organs.
The disease can also have both active stages and periods of 
remission. The extreme diversity of symptoms seen in SLE, many of 
which are non-specific, make the diagnosis of this disease very
9difficult, especially when other connective tissue diseases have the 
same or similar features (Garfield, 1989). Due to the complexity of 
this disease an attempt has been made to develop criteria for the 
diagnosis of SLE to ensure some uniformity with regard to its cause, 
and to exclude other autoimmune connective tissue disorders (Tan 
et a l 1982). Since 1951 when activation of complement in SLE was 
first recognised, (Vaughan et al., 1951), there has been a major 
interest in the field of complement research and its association with 
this disease.
Deficiency of classical pathway proteins, especially Clq, C4 and C2, 
are associated with an increased susceptibility to SLE (Morgan and 
Walport, 1991a). The mechanism underlying the association of SLE 
with complement deficiency has not been established, but is thought 
to be related to the physiological inactivity of these proteins in 
removing immune complexes from circulation and tissues (Schifferli 
et al., 1986). Accumulation of immune complexes in tissues causes 
inflammation and the release of autoantigens, which in turn 
stimulate the production of autoantibodies, and therefore more 
immune complexes (Lachmann and Walport, 1987).
The strong association between complement deficiency and SLE 
suggests partial complement deficiency may also cause increased 
disease susceptibilty. Research by Atkinson (1988), supported this 
hypothesis, finding homozygous C4A deficiency in 10-15%, and 
heterozygous C4A deficiency in 50-80% of Caucasian patients with 
SLE. Other studies found strong linkage disequilibrium between C4A 
null and HLA-DR 3 alleles in association with SLE (Fielder et al., 
1983), and so confusing the relative contribution of each disease 
susceptibility gene. Some studies have found that in Caucasians with 
SLE, the B8 and DR 3 alleles associated with C4A null alleles 
represent the most important HLA-linked genetic risk factor for SLE 
(Howard et al., 1986; Dunckley et al., 1987). These act in a dose 
response manner, and synergistically increase disease risk when 
found in combination with another independent risk factor, DR 2 
which is associated with C2 deficiency.
10
An attempt was made to resolve this problem by analysing the HLA 
association with SLE amongst different racial groups (reviewed by Ng 
and Walport, 1988). This analysis was used to determine which SLE 
candidate genes were maintained amongst different HLA haplotypes 
in each racial group. Unlike HLA-DR and DQ associations in SLE, the 
C4A null allele association with SLE was maintained across racial 
barriers. One group of researchers found a significant association 
between C4A null alleles and SLE in black and white Americans 
(Reveille et al., 1985). This association was stronger and often 
independent of HLA-R8 and/or DR 3's association with SLE. Others 
found that complete or partial C4A deficiency is a genetic 
determinant of SLE common to three ethnically distinct populations, 
namely Caucasoid, Chinese and Japanese (Dunckley et al., 1987). 
Reveille et al. (1985), detected a C4 null allele dosage effect in 
relation to disease predisposition. They found an increased frequency 
of C4 null alleles in individuals with SLE (60 %), compared with 
healthy relatives (50 %), and spouses (24 %). As a result of these 
studies it can be said that C4 null alleles show a strong association 
with SLE which is common in a number of ethnic groups.
Most studies have indicated that C4A rather than C4B null alleles 
are associated with SLE. Fielder et al. (1983), found 15 % of SLE 
patients, compared to none of the control patients were homozygous 
for C4A null alleles. Other studies of SLE groups from Australia,
China, Japan and the United States found 10-15 % of white SLE 
patients were completely deficient in C4A compared with less than 
2 % of control subjects (Howard et al., 1986). It is generally believed 
that the stronger association of C4A rather than C4B null alleles 
with SLE may be a reflection of C4A proteins ability to 
preferentially form amide linkages with amino groups such as those 
formed between C4 and immune complexes. Therefore, C4A protein 
deficiency is thought to lead to accumulation immune complexes 
within the body which is a feature of SLE. C4B protein on the other 
hand, more efficiently forms ester linkages with hydroxyl groups 
such as those found on the surface of encapsulated microorganisms.
It has been shown that C4A protein is about twice as efficient as 
C4B protein in functionally restoring C4 deficient human serum 
ability to inhibit precipitation of immune complexes (Carroll et al.,
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1989). As a result of the functional preferences of C4A and C4B 
proteins, C4A rather than C4B null alleles are more likely to be the 
strong susceptibility factor in SLE.
As a result of the association between complement deficiency and 
SLE, measuring complement activation is important for detecting and 
monitoring this disease state. The degree of complement activation is 
thought to reflect the intensity of the inflammatory response (Porcel 
et al., 1993), which in turn indicates the stage of disease activity. 
Assessing complement activation has mainly been carried out on 
patients with 'SLE' (reviewed by Porcel et al., 1993). This type of 
testing relies on measuring intact C3 and C4 protein levels in 
serum, or by determination of complement haemolytic function 
assays. These techniques measure complement activation indirectly, 
and are relatively insensitive (reviewed by Porcel et al., 1993).
New approaches for measuring complement activation are currently 
being developed. These depend on the detection of complement 
activation fragments, neo-antigens or complexes which directly result 
from complement activation. These methods are now being 
implemented in the clinical immunology laboratory for routine 
testing (Porcel et al., 1993).
1.4 C4 deficiency and other disease states
The majority of C4 deficiency biological research has concentrated 
on the association with the autoimmune disease SLE as described 
above (Dawkins et al., 1983; Fielder et al., 1983; Howard et al.,
1984; Kemp et al., 1987). However, investigations of candidate genes 
for other diseases have found C4 deficiency to be associated with 
Myasthenia Gravis (Dawkins et al., 1983), Insulin Dependent 
Diabetes Mellitus (Dawkins et al., 1983; Hauptmann, 1980;
Deschamps et al., 1988; Jenhani et al., 1992; Segurado et al., 1991), 
juvenile dermatomyositis (Robb et al., 1988), as well as chronic 
hepatitis and sub-acute sclerosis panencephalitis (Atkinson, 1988). 
The transient selective C4 deficiency in infancy results in 
erythema multiforme with outbreaks of bacterial and viral infection
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(Mayumi et al., 1992). C4B null alleles have been found in 
association with Brazilian Paracoccidioidomycosis (a thermo- 
dimorphic fungal infection) (Messias et al., 1991). C4B deficiency is 
considered a genetic marker for IgA Nepropathy (Welch et al., 1987 
and 1989). In addition, C4A and C4B protein deficiency have been 
found to be associated with rapid onset of AIDS after infection by 
HIV-1 in Caucasians (Hentges et al., 1992).
The HLA class III gene region has complement genes C2, C4, and 
factor B which are collectively referred to as complotypes. Specific 
complotypes are associated with various disease states (Dawkins et 
al., 1983). These complotypes include both functional and 
dysfunctional C4 alleles. Examples of complotypes as part of HLA- 
extended haplotypes include HLA-A 1, Cw 7, B 8, Bf S, C2 C, C4A QO, 
C4B 1, DR 3, associated with Myasthenia Gravis, SLE, and IDDM;
HLA- B 18, Bf Fl, C2 C, C4A 3, C4B QO, DR 3, associated with IDDM; 
and HLA- B 14, C4A 2, C4B 2, DR 1, associated with late onset of 21- 
hydroxylase deficiency (Dawkins et al., 1983).
Disease association studies have confirmed the importance of the 
function of the C4 protein in the immune response. From an 
aetiological perspective, the molecular basis of C4 deficiency plays 
an important role in understanding association of the C4 null allele 
with different diseases. The majority of C4 disease association 
studies have been based on serological typing of C4 allotypes and 
thus do not indicate the molecular basis of this protein deficiency.
1.5 C4 protein and origin of its synthesis
In humans, the liver is the major producer of C4 messenger. It has 
been shown that after liver transplantation, patients take on 
expression of the donor's C4 and factor B allotypes (Koskimies et 
al., 1991). C4 genes have a transcript for a protein of about 200,000 
Mr, consisting of three peptide chains, namely alpha (a) (95,000 Mr), 
beta (ß) (75,000 Mr), and gamma (y) (30,000 Mr), (Carroll, 1983). C4 
protein is synthesised in the liver as a single peptide chain (pro-C4), 
which undergoes proteolytic cleavage on secretion into plasma to 
produce ß, a , and y chains in this order (Goldberger et al., 1980).
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C4 transcripts have also been found in the kidney, thyroid, brain, 
and breast carcinoma (Feucht et al., 1989; Witte et al., 1990).
Andoh et al. (1993), found C4 synthesis in the intestinal epithelial 
cell line 'Caco-2-^'. In murine studies, C4 is expressed in a variety of 
tissues including mammary gland, lung, spleen, and kidney (Saunders 
and Edidin, 1974; Cox and Robins, 1988; Passwell et al., 1988). In 
vitro studies have shown that macrophages are capable of 
synthesising C4 (Whaley, 1980; Alpert et al., 1983).
In the last few years a number of studies have concentrated on 
determining which cells are responsible for C4 protein synthesis in 
human kidneys, and if there is an association between C4 protein 
synthesis and immune-complex-mediated lesions in this organ (Witte 
et al., 1991; Zhou et al., 1993). Witte et al. (1991), found C4 is 
expressed at high levels in both normal and diseased kidneys, and 
in situ hybridisation analysis found the renal tubular epithelial cells 
are the source of these transcripts. Also, this study indicated that C4 
expression is unlikely to contribute to glomerulonephritis, and in fact 
may serve as a local protective function for the epithelial lining. In 
addition, this group identified C4 expression in hepatocytes, thyroid 
follicular epithelial cells, and ductal epithelial cells of the 
submandibular salivary gland, indicating that some components of 
complement may have a physiological role in epithelial cell function. 
Zhou et al. (1993), found C4 transcripts in human glomerular 
epithelial cells. These cells form part of a charge and size-selective 
filtration barrier between the blood and urinary spaces (Adler et al., 
1983; Couser, 1990). The function of this cell barrier was found to be 
disrupted in various types of complement-mediated injury. For 
example, it was shown to be the primary target of complement- 
mediated attack in glomerulonephritis (Couser and Abrass, 1988).
The above studies have narrowed down the region in which cells 
transcribe C4 protein. However, there is some controversy over the 
functional and pathophysiological significance of C4 protein 
synthesis in the kidney and therefore requires further study.
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1.6 Detection of C4 protein
Protein gel electrophoresis followed by immunofixation is the most 
common technique used for the identification of C4 protein 
allotypes. C4 protein allotyping identifies the phenotype of a C4 
allele, and is denoted as for example C4A 3, whereas C4 alleles 
identified by analysis of DNA represents the allotype determined by 
DNA sequencing of a C4 allele and is therefore denoted as C4A *3 in 
this thesis. Other methods for characterising C4 allotypes have been 
summarized by Mauff et al. (1990a-d), Rittner and Stradmann- 
Bellinghausen, (1990), and Kaufmann et al. (1990). These papers 
reported on a collaborative study of 136 individual's serum samples 
to define common and rare C4 alleles to be used as standard 
reference variants. Also, duplicated, deleted and non-deleted C4 null 
alleles, and hybrid C4 alleles were investigated. A series of different 
typing criteria including gel electrophoresis and immunofixation, 
haemolytic activity, reactivity with monoclonal antibodies and 
Rodgers/Chido reagents, a-, and ß-chain types, and C4/CYP21 Taq I 
RFLP's, were collectively used for the above studies. Each of these 
techniques is limited by the amount of information it can provide 
with respect to an individual's C4 allotype. Collectively, however, 
these techniques are quite informative but are unsuitable for routine 
diagnostic typing as each technique requires specific skills and are 
time consuming.
C4 a-chain typing and immunoblotting with C4A- and C4B- 
specific monoclonal antibodies is used for classification of a number 
of expressed gene products and haplotypes aberrant with respect to 
their Rodgers and Chido determinants (Rittner and Stradmann- 
Bellinghausen, 1990). However, this technique is not able to detect 
every type of C4 allele including heterozygous null alleles at each 
C4 gene locus. More recently an enzyme-linked immunoassay (EIA), 
has been developed for C4 allotyping (Moulds et al., 1990). This 
assay uses heat-aggregated human IgG (Fc portion of antibody) to 
activate Cl  and capture C4. C4 bound to Ab:C7 complex molecules 
are detected with horseradish peroxidase-conjugated monoclonal 
antibodies, and are specific for C4d (C4A/C4B cross-reactive),
C4A(Rgl), and C4B(Chi). This technique is useful in that it provides
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an indication of the level of C4 protein in an individual. However, 
the normal level of C4 in an individual is not uniform and difficult to 
determine, and as stated above, monoclonal antibodies for Chido and 
Rodgers antigenic determinants do not detect all C4 alleles including 
C4 null alleles. A C4-specific haemolytic activity assay was 
designed to estimate the function of C4 in an in vitro system, 
thereby reflecting as close as possible the in vivo situation 
(Kaufmann et al., 1990). This assay was based on C4 dependent 
lysis of sensitised sheep erythrocytes, which involves activation of 
the whole complement cascade and thereby reflecting most of the in 
vivo interactions of C4. However, estimation of the number of C4 
null alleles depends on different activity levels by comparisons 
between the C4A and C4B isotypes. This does not provide a clear 
indication of the presence of C4 null alleles as some C4 null 
allotypes have been shown to result from duplicated C4 genes on 
the one haplotype. They therefore have functional C4 alleles at both 
C4 gene loci. Also, this assay does not indicate which C4 alleles are 
present. A Rodgers and Chido C4 antigenic determinant typing 
system has been developed which is based on haemagglutination 
inhibition (Giles, 1990). Although this technique is probably the best 
technique for accurate detection of rare C4 allotypes, the success of 
this typing technique depends on the correct combinations of 
antigenic determinants in haplotypes and in genotypes, and therefore 
relies heavily on family studies. Also, in the presence of other C4 
allotypes it is not always possible to detect reversed antigenicity. An 
alternative to haemolytic overlays is immunoblotting with 
monoclonal antibodies (Doxiadis and Grosse-Wilde, 1990). This 
technique is very useful as it identifies C4B and C4A isotypes which 
tend to migrate by gel electrophoresis into the opposite anode and 
cathode ends, respectively. However, this technique does not enable 
double C4 null allele heterozygotes to be identified.
C4 protein gel electrophoresis followed by immunofixation has 
remained the most informative C4 typing protocol and is the method 
of choice by standard reference C4 typing laboratories around the 
world. Serological analysis by electrophoresis and immunofixation 
involves the resolution of C4 alleles according to their unique size 
and charge. Treatment of the resulting protein gel with antisera
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specific for C4A and C4B gene products results in visualisation of 
three bands for each C4 gene (shown in Chapter 3), which represent
pro-C4(ß-a+y), C4S (secreted form of C4), and C4P (predominant 
plasma form of C4) (Chan et al., 1984). Exactly which band is 
represented by which C4 form is unknown. Another team of 
researchers found that C4 digestion with pancreatic 
carboxypepiidase B converts the two cathode located bands for each 
C4 protein into the most anodally located band which is intensified 
after digestion, and thus enables the allotypes to be more easily 
interpreted (Sim and Cross, 1986). As the C4 alleles are highly 
polymorphic, another modification of C4 protein gel electrophoresis 
has been developed to standardise the relative migration distances 
for each allele by measuring each C4 protein migration using laser 
densitometry (Mauff et al., 1990a).
Gel electrophoresis and immunofixation of C4 proteins does not 
reveal the number of C4 genes present on a particular haplotype, 
nor can it easily identify overlapping or closely migrating alleles. A 
molecular-based technique which could utilise genomic sequence 
features which are unique for each C4 allele, involving the use of 
only one protocol, and which could be easily implemented in a 
standard laboratory, would permit C4 molecular allotyping for 
routine diagnostic studies.
1.7 C4 protein as a polymorphic marker for population studies
As with the HLA class I and II alleles, a number of population and 
evolutionary studies have been performed by analysing the HLA 
class III complement component C4A and C4B polymorphic alleles. 
Serological typing of the C4 alleles has been performed on a number 
of populations including, Tunisians (Ayed and Gorgi, 1990), 
Caucasians, Arabs, African Blacks, German Caucasians (Schendel et 
al., 1984), Finnish (Partanen et al., 1986b; 1987), Aboriginal 
Australians from Darwin and Alice Springs (Ranford et al., 1987), 
Melanesians, Micronesians, Japanese, Chinese, Koreans, Thai, Indians 
and white Australians (Ranford et al., 1986; Ranford, 1989).
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Only five of the C4A alleles, 'A 2', 'A 3', ’A 4', A 6\ and A Q0\ and 
three C4B alleles, 'B 1\ 'B 2', and B QO', are commonly found with 
frequencies above 10 % in any population, and distribution of these 
alleles appears to define various racial groups (Ranford, 1989). 
Mutation is more common at the C4B locus creating more allelic 
variants than at the C4A locus, and in some cases these C4B alleles 
may be used as markers for specific populations. For example, the 'B 
5' allele was detected in all Asian groups and may be regarded as a 
marker for this population (Ranford, 1989).
Analysis of the molecular basis of alleles in isolated populations can 
indicate genetic mechanisms responsible for allelic diversity. Recent 
studies by Gao et al. (1992b) of Aboriginal Australian populations 
using molecular genetic typing techniques of the polymorphic HLA 
class II gene region, have identified class II allotypes which are 
commonly detected in Aboriginal Australian populations, and have 
provided some insight into how these alleles have evolved.
1.8 Complement C4 genetics
To understand the basis of complement C4 protein association with 
autoimmune disease, a sound knowledge of this proteins' genetic 
structure and regulation is necessary.
1.8.1 Gene localisation
Complement component C4 is situated in the HLA region on the 
short arm of chromosome 6. The HLA region has three classes of 
genes. Class I and class II gene products are highly polymorphic cell- 
surface glycoproteins involved in the discrimination of self from non­
self by the immune system (Steinmetz and Hood, 1983; Kaufman et 
al., 1984). The class III gene region is about 1,000 kb and contains 
many duplicated genes, all of which have different functions. Genes 
in this region which have been localised and characterised include 
the tumor necrosis factors 'a ' and 'ß' (Spies et al., 1986; Carroll et 
al., 1987a; Dunham et al., 1987), heat shock proteins HSP70 
(Sargent et al., 1989), complement proteins including factor B, C 2, 
C4A and C4B (Carroll et al., 1984a), and the adrenal steroid 21-
18
hydroxylase genes CYP21A and CYP21B (Higashi et al., 1986;
White et al., 1986). These genes lie along chromosome 6 in the order
C2, Bf, C4A, CYP21A, C4B, and CYP21B. C2 and Bf  genes are
separated by less than 2 Kb, and are approximately 30 Kb away from
the C4 genes (Carroll et al., 1984a and 1984b). CYP21B is
important for the synthesis of steroids in the adrenal gland, whereas
CYP21A (highly homologous to CYP21B), is a dysfunctional
pseudogene.
1.8.2 Structure of the C4 gene locus and surrounding gene region
There are two C4 genes, namely C4A and C4B, which are 
approximately 12 kb apart (Carroll et al., 1985a; Yu et al., 1990), 
and are transcribed in the same 5' to 3' direction (Figure 1.2). C4A is 
usually at locus I, and C4B at locus II in the C4 gene region.
However, there have been exceptions reported (Awdeh and Alper, 
1980; Carroll et al., 1984b; Yu and Campbell, 1987). Each C4 gene is 
accompanied by a 21-hydroxylase gene situated approximately 3 kb 
downstream from the 3' end of each C4 gene (Carroll et al., 1985a; 
White et al., 1985). The orientation and position of these genes was 
determined by pulsed field gel electrophoresis (PFGE) (Dunham et 
al., 1987). The C4B gene lies approximately 350 kb from the DRA  
locus, and is centromeric to the C4A gene, which lies approximately 
600 kb from the HLA-f? gene locus.
Recent chromosome and gene mapping studies have explored the 
gene region immediately surrounding the C4 and CYP21 gene loci 
for other genes which may be associated with autoimmune disease. A 
pair of genes with tenascin-like sequences, XA and X B , were 
reported overlapping the CYP21A and CYP21B genes, respectively 
(Morel et al., 1989; Gitelman et al., 1992). When the promoter 
regions of the C4A and C4B genes were identified, a 
polyadenylation (poly(A)} signal, 'AATAAA', was found 631 bp 
upstream of the transcriptional initiation sites of each C4 gene 
(Alper, 1991). Each of these poly(A) sites is followed by a stretch of 
GT-rich sequence which is characteristic of the 3' end of mammalian 
genes (Proudfoot, 1991).
Figure 1.2 C4 gene region structure and polymorphic amino acid 
residues situated in each region of the pro-C4 protein molecule
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Shen et al. (1994), has recently identified two novel genes RP 1 and 
RP2,  located immediately upstream (611 bp), of the C4A and C4B  
genes, respectively. Molecular analysis suggests that the RP gene 
may encode a nuclear protein (Shen et al., 1994). This gene was 
found to undergo duplication and deletion together with 
neighbouring genes X, C4 , and CYP21,  which has triggered a special 
interest in the investigation of RP structure, genetics and function. 
Cumulative data suggest that the four tandemly arranged genes RP,  
C4, CYP21, and gene X, together form a modular structure, namely 
'RCCX' (Shen et al., 1994). The number of RCCX modules varies in 
each individual from one to three. The bimodular structure is the 
most common. However, it has been reported that single RCCX 
modular structures have a frequency of 10-30 % (Shen et al., 1994). 
Single modular RCCX structures consist of RP1, gene XB,  and various 
types of C4 and CYP21 gene loci (Shen et al., 1994).
1.8.3 Exon and intron structure of C4
The exon and intron structure, and DNA sequence of a long (23 kb) 
C4A gene was reported by Yu (1991), who in addition provides a 
thorough overview of previous studies concerning the molecular 
organisation of the C4 gene locus. Yu (1991), found that the C4A 
gene spans 41 exons which encode a transcript for a precursor 
protein of 1744 amino acid residues (Figure 1.2). The intron size was 
found to vary from 82 bp to 7 kb (intron #9). The exon size varied 
between 51 bp to 232 bp. Analysis of intron sequences within the 
C4d region (polymorphic region of the a-chain), found these 
sequences to be highly conserved (Yu et al., 1986). The coding 
sequences of the proteolytic cleavage sites for the ß -a  and a -y  chain 
junctions are located in the middle of exons 16 and 33, respectively.
The ß-chain consists of 656 amino acid residues, and is encoded by 
nucleotide bases in exons 1 to 16. Exon 1 encodes the leader 
sequence and the first three residues of the N terminus of the pro- 
C4 molecule. This fragment is unusual as some C4 genes encode a 
large intron (intron 9) of about 7 kb. This intron will be discussed in 
section 1.8.4 of this chapter.
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The oc-chain contains amino acid residues #661 to #1428, and is 
encoded by nucleotides in exons 16 to 33. The anaphylatoxin C4a is 
encoded by part of exon 16 and the whole exon 17, together, forming 
77 amino acids. The two factor 1 cleavage sites in C4 are encoded by 
exons 23 and 30. These two cleavages generate the polymorphic C4d  
fragment, where thioester residues, isotypic residues, Rg/Ch antigenic 
determinants, and many of the allelic polymorphic residues are 
located. Exon 33 encodes the proteolytic cleavage site which forms 
the a -  and y- chains.
The y-chain contains exons 33 to 41, and the nucleotides encode 291 
amino acid residues. No specific function has yet been described for 
the y-chain. This section of the gene is thought to be rather rigid as it 
possesses five intra-chain and two inter-chain disulfide linkages 
(Janatova, 1986; Seya et al., 1986).
1.8.4 C4 gene size variation
An interesting feature of the C4 gene locus, is the size variation of 
C4A and C4B genes. In general, the C4 gene located at locus I 
(usually C4A), is approximately 23 kb in length, whereas the gene at 
the second C4 gene locus (usually C4B), is either 23 kb or 16 kb in 
size (Prentice et al., 1986; Schneider et al., 1986; Palsdottir et al., 
1987a) (Figure 1.2). C4 gene size variation results from the presence 
or absence of a 6-7 kb intron (separating exon 9 and 10), in the ß- 
chain, which is approximately 2.5 kb from the 5' end of the C4 gene.
It has been estimated that approximately half of the C4 genes at 
locus II are of the long 23 kb form (Schneider et al., 1986). The 
presence of the large 6-7 kb intron does not affect expression of the 
C4 gene harbouring it (Palsdottir et al., 1987b).
1.8.5 Molecular basis of C4A and C4B
Comparison of protein sequences derived from genomic DNA, cDNA, 
and partial protein sequencing data found 20 polymorphic residues, 
(reviewed by Yu, 1991). These polymorphic amino acid residues 
account for C4A/C4B isotypic differences, and Rg/Ch antigenic
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determinants and some allelic differences. The distribution of these 
polymorphic residues between a, ß, and y C4 chains are shown in 
Figure 1.2. Those residues located in the C4d region of the a-chain 
are found in four discrete regions (Belt et al., 1984). The C4d region 
is a degradation fragment (Mr of about 40,000), from the middle of 
the a-chain (Reid, 1981). These polymorphic amino acid residues 
include residues #1054, #1090, #1101, #1102, #1105, #1106, #1157, 
#1182, #1188, and #1191, #1267, #1281, #1286, and #1287. 
Polymorphic nucleotides encoding amino acid residues #1101, #1102, 
#1105, and #1106 are known as the isotypic or class-specific 
nucleotides, and are either C4A or C4B nucleotides. Nucleotides 
encoding amino acid residues #1054, #1157, #1188, and #1191 are 
usually common to either C4A or C4B alleles, and are the Chido and 
Rodgers antigenic determinants. Six other polymorphic residues 
including three from the ß-chain, two from the a-chain, and one from 
the y-chain have been reported. These residues are thought to be C 4 
allelic differences.
Apart from nucleotide base differences, the two isotypes of C4 may 
also be distinguished by their slight differences in molecular weight. 
The a-chain of C4A has a slightly higher molecular weight than that 
of C4B (96 kD as opposed to 94 kD), as determined by 
polyacrylamide gel electrophoresis in the presence of sodium dodecyl 
sulphate (Roos, 1982). The difference in molecular weight between 
these alleles is due to a specific amino acid residue difference ('Lys' 
or 'Pro'), for residue #1101 of the C4 precursor molecule (Rittner 
and Stradmann-Bellinghausen, 1990).
1.8.6 Functional differences between C4A and C4B isotypes
The isotypic amino acid residues situated in the C4d region are 
thought to be located on the surface of the C4 protein (Yu et al.,
1988), where they are readily accessible for antigen/antibody 
interaction (Novotny et al., 1987). Each of the C4 isotypes differs 
markedly in haemolytic activity, covalent binding reactivity, and the 
expression of antigenic determinants, which can be detected using 
anti-Chido (detects C4B) and anti-Rodgers (detects C4A), 
alloantisera. In general, the C4A isotype has lower activity than the
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C4B isotype in the classical haemolytic assay (Awdeh and Alper, 
1980). This in turn is related to the ability of the C4B isotypic amino 
acid residues to preferentially bind covalently with acceptor 
hydroxyl groups that predominate amongst the carbohydrates of red 
cell surfaces (Isenman and Young., 1984). In contrast, C4A isotypic 
amino acid residues bind preferentially to amino groups such as 
those found in immune complexes (Law et al., 1984). It has been 
demonstrated that three to four times as much C4A binds to 
immunoglobulin as C4B (Kishore et al., 1988). This difference in 
haemolytic strength has been shown to result from polymorphism of 
residue #1106 (Carroll et al., 1989). Even though each C4 isotype 
has slightly different binding affinities, both C4A and C4B isotypes 
are capable of binding amino and hydroxyl groups, and therefore 
both isotypes are not required for survival. The importance of their 
preferential binding affinities has yet to be elucidated.
Peake et al. (1989), studied differences in the metabolism of C4A 
and C4B isotypes in healthy control subjects as well as in patients 
with active immunological diseases, such as SLE and rheumatoid 
arthritis. These studies investigated the significance of functional 
differences between these isotypes in vitro. Peake et al. (1989) has 
found that the C4B 1 protein is catabolised more rapidly than C4A 
3 in patients with pathological complement activation compared to 
healthy controls. However, the molecular basis for this finding is 
unresolved.
1.8.7 Chido and Rodgers antigenic determinants
To test the antigenicity of C4, plasma containing this protein is 
examined for its ability to inhibit agglutination in an antiglobulin 
test. This type of serological test was originally developed by Grubb 
(1956), and was first applied to C4 antigenic determinant testing by 
Middleton and Crookston (1972). The Chido (Ch) antigenic 
determinants were originally identified by Harris et al. (1967), and 
Middleton and Crookston, (1972). Rodgers (Rg) antigenic 
determinants were defined by Longster and Giles (1976), who also 
found that some plasma samples exhibited partial inhibition in 
antigen testing, suggesting anti-Rg and anti-Ch are polyspecific and
24
that there may be more than one antigenic determinant for Rodgers 
and Chido. Giles (1985), proposed a model of multiple Ch and Rg 
antigenic determinants, which led to the development of 
standardised polyspecific anti-Rg and anti-Ch alloantisera. This in 
turn has allowed serological characterisation of many rare C 4 
allotypes and the subdivision of common allotypes. C4A proteins 
generally have Rodgers type 1 and 2 antigenic determinants (blood 
group antigens), and C4B proteins usually have Chido types 1, 2, 3,
4, 5 and 6 antigenic determinants.
These antigens were mapped to the HLA gene region by serological 
studies (Longster and Giles, 1976), and later were found to be part of 
the C4d region of C4A and C4B genes (Tilley et al., 1978). A 
characteristic antigenic site for a protein is thought to span about six 
amino acid residues (Kabat, 1970, Schechter, 1971), and these may 
be continuous (sequential), or discontinuous (conformational) in 
nature (Benjamin et al., 1984; Van Regenmortel, 1987). The 
proposed locations for Rodgers and Chido antigenic determinants in 
the C4 amino acid sequence proposed by Yu et al. (1988), 
correspond to these characteristics of antigen/antibody binding areas 
within a protein. C4A isotypic residues #1101 -# 1106 and residue 
'Gin' encoded by nucleotide bases for residue #1157, are involved in 
the formation of the discontinuous Rg2 epitope. C4B isotypic 
residues on the other hand are related to the continuous Ch4, and 
discontinuous Ch2 epitopes, with residue 'Gly' encoded by nucleotides 
for residue #1154. Residues 'Val'-'Asp'-'Leu'-'Leu' encoded by 
nucleotides for residues #1188 to #1191 of a C4A allele are thought 
to be related to the formation of the Rgl epitope. The C4B residues 
'Ala'-'Asp'-'Leu’-'Arg' encoded by nucleotides for residues #1188 to 
#1191 are thought to be related to the continuous Chi and 
discontinuous Ch3 epitopes, the latter having residue 'Ser' encoded 
by nucleotides for residue #1157 (Yu et al., 1988; Giles et a l 1988).
1.8.8 C4 polymorphism and method of detection
Researchers investigating C4 antigenic determinants were the first 
to establish the molecular basis for much of the polymorphism of C4 
proteins. The C4A 1 and C4B 5 alleles have C4A and C4B isotypic
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properties respectively. However, these alleles were found to express 
the reversed antigenic determinants, where C4A 1 had C4B and 
C4B 5 had C4A antigenic determinants (Roos et al., 1984a and b). 
Detailed serological analysis of 'B 5' led to the discovery of three 
additional specificities of anti-Ch and their corresponding antigen 
determinants on C4 , which were designated Ch4, 5 and 6 (Giles,
1987).
Researchers investigating Chido and Rodgers antigenic determinants, 
found it difficult to assign specific Rg/Ch determinants to each C4 
allele in individuals with heterogeneous C4A and/or C4B alleles.
Family studies were therefore necessary (Yu et al., 1988).
Serological observations by Roos et al. (1984a) and Giles (1987), 
enabled a number of conclusions to be drawn concerning the 
relationship between Chido/Rodgers antigenic determinants and 
C4A/C4B isotypes (summarized by Yu et al., 1988). However, a 
degree of uncertainty was still associated with correlating Ch/Rg 
antigenic determinant types with specific C4A and C4B alleles.
The more commonly used method for detecting C4 polymorphism is 
C4 protein gel electrophoresis followed by immunofixation. This 
technique does not rely on family analysis. Originally this method 
could only detect 'fast' and 'slow' types of C4 alleles. However, with 
the advent of neuraminidase treatment of serum samples prior to 
electrophoresis (Awdeh and Alper, 1980), extensive polymorphism at 
both the C4A and C4B loci has been detected. A total of 35, C4 
alleles (13 C4A and 22 C4B), including the less common variants, 
have been assigned (Mauff et al., 1983).
In parallel with advances in C4 protein gel electrophoresis, progress 
was made in the structural studies of C4 including determination of 
the C4d region amino acid sequence (Campbell et al., 1981; Harrison 
et al., 1981; Chakravarti et al., 1983; Heilman et al., 1984). This 
was followed by cDNA and genomic sequencing (Carroll et al., 1983; 
Carroll et al., 1984a,b; Belt et al., 1984, 1985). The estimate of 35,
C4 alleles probably represents a minimum. This is because the most 
common alleles, 'A 3' and 'B V, {which have gene frequencies of 
approximately 60 % to 70 % (Schendel et al., 1984)}, have been
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subdivided on the basis of serological determinants (Giles, 1984a), 
DNA restriction fragment length polymorphism (RFLP) (Palsdottir et 
al., 1987a), and nucleotide sequencing (Belt et al., 1985).
1.9 C4 analysis in other animals - purpose and findings
Apart from humans, organisation and structure of C4 genes in the 
C4 gene region has been studied in a variety of other mammals such 
as those shown in Tables 1.1, 1.2 and 1.3. The molecular basis for 
evolution of the C4 gene region has also been studied. The C4 gene 
region has been used as a model for eukaryotic gene regulation and 
multigene family studies.
Many studies concerning organisation of the C4 gene region, 
structure of C4 genes, and most importantly C4 gene regulation 
studies, have centered on murine C4 genes. A summary of C4 
research findings in mice is shown in Table 1.1. Many other 
mammals have also been used for analysis of the C4 gene region for 
both gene organisation and evolutionary studies (Table 1.2).
Guinea-pigs have been used to investigate the molecular basis for C 4 
protein deficiency (review by Colten, 1982; Whitehead et al., 1983). 
Whitehead et al. (1983), used a human cDNA clone encompassing 
the human C4 y-chain for hybridisation analysis of normal and C4- 
deficient guinea-pig-liver mRNA. A 5 kb transcript was found in 
normal C4 productive liver. However, in C4-deficient liver a 7 kb 
transcript was detected, indicating the presence of C4 precursor 
RNA. This analysis suggested that the basis of C4 deficiency in 
guinea-pig is a post-transcriptional defect in the processing of C 4 
precursor RNA to mature C4 mRNA. Whitehead's study has shown 
the usefulness of human cDNA probes in the investigation of the 
molecular basis of C4 deficiency. Evolutionary studies of the C4 
gene region have focussed on the analysis of primates, and results of 
these findings are shown in Table 1.3. In addition to evolutionary 
studies, the analysis of C4 in primates has been aimed at identifying 
ancestral haplotypes which are common to both humans and other 
primates. These haplotypes may represent genes which have a
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Table 1.2 C4 studies of mammals
mammal C4 gene locus protein binding activity
dog (1 and 2), cat (3) 
guinea-pig (4) 
Syrian-hamster  (5) 
several species of whale (6)
s in g le C4B
mice (7), pig (8), horse (9) 
rat (10), goat (11) 
cattle (12), sheep (13) 
primate (14), human (15)
duplica ted C4A and C4B
References for C4 gene locus studies for each mammal include; (1) Kay and Dawkins 
(1984a); (2) Doxiadis et al. (1985); (3) DeKroon et al. (1986); (4) Bitter-Suermann et al. 
(1977); (5) Levi-Strauss et al. (1985); (6) Spilliaert et al. (1990); (7) Roos et al. (1978) 
(8) Kirszenbaum et al. (1985); (9) Kay et al. (1987a); (10) Tosi et al. (1985)
(11) Cameron et al. (1990); (12) Groth et al. (1987); (13) Groth et al. (1988)
(14) Kawaguchi et al. (1992a); (15) Yu (1991). Dodds and Law (1990), investigated 
the C4 isotypic binding activity for the majority of mammals described above.
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selective advantage for the elimination of infectious agents, and may 
be able to withstand harsh environmental conditions.
Recent studies of the C4 gene region in sheep and cattle (ungulates) 
(Table 1.2), have concentrated on the residues encoded by 
nucleotides at the C4A/C4B isotype gene region with an aim to 
gaining some insight into the possible evolutionary route of the C4A 
and C4B genes in comparison with that of the primates (Ren et al., 
1993). Comparing the nucleotide sequences of the C4A and C4B 
isotype region between these species enabled Ren et al. (1993) to 
propose an evolutionary model for this region of the genome. This is 
described in the following section.
1.10 Evolution of the C4 gene region
1.10.1 Multiple copies of a C4 module
The C4 and CYP21 genes are part of a modular structure which 
includes other closely linked genes (see Chapter 1. section 1.8.2).
Some species carry multiple copies of this module which appears to 
have undergone continuous expansion and contraction (Kawaguchi 
et al., 1991). The original C4 gene may have been a C4B- like gene, 
as this sene has been detected in all mammals. The C4A gene may 
have arisen independently after speciation in some mammals such as 
mice, primates, and ungulates, as sequences in both C4A and C4B 
genes from these mammals are quite different from each other (Ren 
et al., 1993). Alternatively, duplication of the C4 gene region may 
have occurred only once in the history of placental mammals, and as 
a result of continuous homogenisation (concerted evolution) in each 
species, these genes became quite different between the species 
(Kawaguchi et al., 1991).
Two copies of the C4 module appear to be standard in humans. 
However, haplotypes with one, three, or four modules are quite 
common. In Caucasians, for example, haplotypes with one or three 
modules occur at frequencies of 16 % and 18 %, respectively 
(Teisberg et al., 1988). This modular polymorphism is thought to 
arise by unequal cross-over between misaligned modules (Raum et
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al., 1984; Carroll et at., 1985a and b; Donohoue et at., 1986a;
Rodrigues et at., 1987). This cross-over theory has been supported 
by pedigree analysis of one family (Sinnott et at., 1990). Orginally it 
was thought unequal cross-over only occurred between the 
boundaries of C4 and CYP21 genes (White et at., 1984). However, it 
has more recently been shown that cross-overs can occur between 
individual exons of these genes (Donohoue et at., 1989). Analysis of 
many haplotypes has shown that no matter how the C4 modules 
rearrange, they retain their modular organisation.
If originally there was a single copy of the C4 module, it is difficult 
to explain how the second copy arose. It has been suggested that 
possibly the original cross-over between chromatids, possessing the 
C4 alleles, occurred between homologous sequences flanking the C4 
module (Kawaguchi et at., 1991). This exchange would result in one 
chromosome where the gene has been deleted, and another where 
gene duplication has occurred (Figure 1.3). Alternatively, it is 
possible that the duplication arose as a result of insertion of movable 
repetitive elements epitomized by Alu repeats. Frequent occurrence 
of recombination leading to changes in gene copy numbers has been 
reported to be associated with the insertion of Alu elements in 
several genetic systems (Ottolenghi and Giglioni, 1982; Lehrman et 
at., 1985; Rouyer et at., 1987; Miura et at., 1989). As neither Alu, 
nor any other repetitive element has been found in the vicinity of 
the C4 and CYP21 genes in any species, it has been assumed that 
the original duplication arose via the first described mechanism of 
duplication and deletion (Kawaguchi et al., 1991).
A study by Gitelman et al. (1992), located the duplication 
boundaries between CYP21A and C4B by sequencing this region 
known as the XA locus. This analysis indicated that the duplication 
occurred by non-homologous recombination. These boundaries 
aresubstantially different to those in the mouse genome, suggesting 
similar gene duplications have occurred independently in ancestors 
of rodents and primates after mammalian speciation. Those 
proponents of the C4 module duplication arising prior to speciation 
of mammals, believe that even though mice C4 genes form one
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Figure 1.3 Model for deletion and duplication within the 
C4 gene region
C4A CYP21A C4B CYP21B
C4A CYP21A C4B CYP21B
C4B CYP21B
C4A C4A C4B
CYP21A CYP21A CYP21B
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phylogenetic group, and humans another, it does not prove the two 
groups originated by independent duplications (Kawaguchi et al., 
1991). These researchers believe unequal cross-over would have 
homogenised the genes to look more alike within each of the two 
orders than between them.
1.10.2 C4A and C4B isotypic residues and C4 gene size variation
The C4A and C4B isotypic residues appear to have diverged before 
that of the orangutan and the African-ape lineages more than 12 
million years ago, whilst the remaining C4d region of the C4 gene 
appeared to diverge separately in each of the four species after their 
formation (Kawaguchi et al., 1991). Some hypothesise that most of 
the C4d region (apart from the isotypic residues) have homogenised. 
Analysis of the presence or absence of a 7 kb intron in humans and 
other primates indicates that the original C4 gene was of the short 
type, and that the insertion must have occurred before the 
divergence of the orangutan and the African-ape lineages, but after 
the original duplication in one of the two C4 genes (Kawaguchi et 
a l ., 1991). Also, the transfer of the insert from one copy (C4A or 
C4B ), to its duplicate must have occurred by unequal cross-over 
(Kawaguchi et al., 1991).
1.10.3 Evolution of C4 polymorphism
The origin of, and genetic mechanisms responsible for the extensive 
polymorphism detected in HLA class I, II and III loci, are of 
considerable interest in evolutionary studies. Discovery of the 
remarkable patchwork pattern of allelic sequence diversity at the 
human class II loci (Bodmer et al., 1991; Gyllensten et al., 1991), 
and the example of gene conversion in the bml2 mouse mutation 
(McIntyre and Seidman, 1984; Mengle-Gaw et al., 1984), suggested 
recombination events may have been important for the generation of 
polymorphism, (reviewed by Erlich and Gyllensten, 1991).
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An important factor which has played a major role in the evolution of 
polymorphism in the C4 gene region is the mechanism of genetic 
exchange between chromatids. Many of these studies have 
investigated the CYP21 genes, as the dysfunctional types appear to 
have arisen from genetic exchange between the CYP21P and CYP21 
genes. Two explanations have been put forward for the apparent 
transfer of sequence between these two genes, namely, gene 
conversion (Donohoue et al., 1986b; Matteson et al., 1987; Higashi 
et al., 1988; Miller et al., 1988), and unequal cross-over (Raum et 
al., 1984; Carroll et ai, 1985a, and b; Donohoue et al., 1986a;
Rodrigues et al., 1987).
1.10.3.1 Gene conversion mechanism
Gene conversion can be defined as a recombination event over a 
short region between alleles or loci where the flanking markers 
remain in the parental configuration, a pattern which is 
indistinguishable from a double cross-over event. The donor gene 
remains unchanged. The length of DNA sequence exchanged is 
uncertain and may range from a hundred bases to kilo bases 
(Kourilsky, 1986).
Gene conversion has gained some attention over the years as 
molecular studies have shown many instances of non-reciprocal 
recombination in bacteria, fungi, yeast and mammals (reviewed by 
Kobayashi, 1992). Evidence of this type of genetic exchange is 
commonly found in repeated genes, and is thought to have played an 
important role in the evolution of these gene regions. This 
mechanism appears to have specific functions in different organisms. 
For example, yeast cells alter their mating type by non-reciprocal 
recombination. This mechanism creates diversity of immunoglobulin 
genes in chickens, and is thought to lead to antigenic variation, and to 
be responsible for the movement of introns between homologous 
genes.
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The mechanism of gene conversion was most probably observed as 
early as 1926 in studies of fungi, when Brunswick noticed that 
recombination may not always be reciprocal. In 1930, Winkler 
hypothesised that those cases of non-Mendelian segregation were a 
result of recombination where a physiological process of one allele 
influences its counterpart on the homologous chromosome, and 
physiologically converts it to its own kind. This hypothesis was not 
recognised by the scientific community at that time, although was 
resurrected in 1949 by Lindgren as a synonym for non-reciprocal 
genetic recombination. The hypothesis has been retained in this form 
by fungal geneticists.
The current genetic theory, from studies of yeast and fungi, states 
that non-reciprocal recombination (gene conversion), is the result of 
DNA repair following intragenic cross-over (Holliday, 1964). The 
theory postulates that cross-over between either the gene itself or its 
RNA transcript (Kourilsky, 1986), leads to the formation of DNA 
heteroduplexes (molecules containing one strand from one chromatid 
and the other from the homologous chromatid). An alternative theory 
put forward is that a block of donor strand DNA is accidently copied 
into the cognate position of the recipient strand during DNA synthesis 
(Kourilsky, 1986). As the point of synthesis migrates along the gene 
and reaches nucleotides which are different between the two alleles, 
the non-complementary nucleotides remain unpaired. DNA synthesis 
proof-reading enzymes then recognise the unpaired nucleotides, 
excise one of the nucleotides, and replace it with a complementary 
nucleotide, and thereby convert one of the alleles to the other 
(Kawaguchi et a l 1991).
One of the major problems which confounds the understanding of 
gene conversion is the process of heteroduplex formation, and 
whether heteroduplex formation actually occurs. A study of monkey 
cells detected heteroduplex formation in vitro and their fate was 
observed in vivo. This study found that blocks rather than single 
nucleotides were exchanged, resulting in patchworks of the parental 
sequences. A technique was designed to detect heteroduplex 
formation in yeast during meiotic recombination, by using a 
denaturing gel procedure (Lichten et al., 1990). Recent studies of
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this mechanism were based on detection of heteroduplex formation 
by identifying stem-loop or hairpin configuration of nucleotide base 
sequence using yeast as a model system (Nag and Petes, 1993). Until 
recently, the majority of studies on the molecular basis of this 
mechanism have involved lower eukaryotes, as all of the products of 
a single meiosis can be recovered and analysed, whereas this has not 
been possible in mammals.
1.10.3.2 Gene conversion in mammals
Slightom et al. (1980), were the first to suggest that a gene 
conversion-like mechanism occurs in mammalian genes. The study of 
this mechanism in mammals is difficult, as geneticists must study 
products of many cell generations, often, many generations removed 
from the initial meiosis which created the recombinant. In addition, 
low probability recombination or mutation events are most likely to 
have occurred after a number of generations. Therefore, instead of 
being the product of gene conversion, the recombinant sequence 
could be the result of two independent, sequential reciprocal cross­
over events. Also, under most circumstances, it is virtually 
impossible to differentiate between the products of gene conversion 
and those of double cross-over. If the occurrence of the recombinant 
sequence is associated with deletion or duplication of chromatin, then 
it is more likely to be the outcome of unequal cross-over than gene 
conversion (Collier et al., 1989).
1.10.3.3 Gene conversion and the C4/CYP21 module
Early studies of the CYP21 gene region in congenital adrenal 
hyperplasia (CAH) patients by RFLP analysis, found 30 % suffered 
from this disease due to a deleted CYP21 gene (Schneider et al.,
1986; Werkmeister et al., 1986; Jospe et al., 1987; Rumsby et al.,
1986; White et al., 1988). These deletions were thought to result 
from unequal cross-over. Short-range restriction mapping (Donohoue 
et al., 1986a; Jospe et al., 1987; Matteson et al., 1987; Rumsby et 
al., 1986; White et al., 1988), based on the use of specific 
oligonucleotide probes (Higashi et al., 1988), and sequencing (Harada 
et al., 1987; Higashi et al., 1988), of the CYP21-C4 gene region,
37
provided evidence of inter-locus transfer of sequences between 
alleles in this region. Since this time there have been over 200 
reported cases of apparent gene conversion events between CYP21P  
and CYP21 (Collier et al., 1993). Some investigators (Matteson et al., 
1987; Miller, 1988), argue that the apparent deletions were in fact 
genes which had evolved by gene conversion. However, pulsed-field 
gel electrophoresis (PFGE) studies have authenticated deletions of 
this gene region by demonstrating that portions of chromatin are 
missing in some of the CAH patients (Collier et al., 1989), and 
therefore more likely to result from unequal cross-over.
1.10.4 Gene duplication and evolution of the C4 gene region
Bimodular C4/CYP21 haplotypes are common in humans, 
chimpanzee, gorilla, mouse, rat, pig and the macaque (Mevag et al., 
1983). Monomodular haplotypes are common in Syrian hamster, dog, 
cat, guinea-pig and several species of whale, whilst trimodular 
haplotypes have been reported in humans and the orangutan. The 
presence of multi-modular haplotypes provides the potential for 
unequal cross-over, and therefore instability of the C4/CYP21 gene 
region (Kawaguchi et al., 1991). The fact that these multimodular 
species have not reverted back to a single module suggests there is a 
selective advantage in having more than one module. There does not 
appear to be an advantage of having multiple copies of CYP21,  as all 
but one CYP21 allele are dysfunctional when multiple copies of this 
allele are present on a haplotype (Kawaguchi et al., 1991). This 
observation also suggests that multiple copies of CYP21 may 
produce an undesirable condition (Kawaguchi et al., 1991). We are 
still learning about other genes in the C4 gene region, and therefore 
uncertain of the contribution that these genes make on the stability 
of this region. Much attention has been given therefore to the 
duplicated C4 genes. It appears there may be a selective advantage 
to having more than one C4 module, as complete deficiency is very 
rare, and most C4 deficient patients develop SLE and other 
autoimmune diseases. This is presumably because of decreased level 
of circulating C4 protein which is required to clear immune 
complexes from the circulation.
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Partial C4 deficiency occurs frequently within a population. 
Approximately 10 % of Caucasians have only two C4 genes 
expressed, 13 % - 24 % have three genes expressed, and 69 % - 76% 
have four genes expressed in a diploid genome of four C4 genes 
(Kawaguchi et al., 1991). In the Caucasian population, the frequency 
of homozygous C4A deficient individuals is 2.5% -3.5 %, and 
homozygous C4B deficient individuals is 1 % - 2 % as determined by 
C4 protein gel electrophoresis (Hauptmann et al., 1986). The effects 
of partial C4 deficiency are far less drastic than those of complete 
C4 deficiency. However, studies have found an association between 
partial C4 deficiency and susceptibility to development of a range of 
diseases, such as, SLE, IDDM, and Graves disease (Dawkins et al.,
1983). These studies showed that individuals with more than one 
copy of C4 in their genome have less chance of contracting these 
types of diseases, thereby suggesting a selective advantage of 
possessing multiple copies of this gene. It is also possible that other 
recently identified genes in this gene region may convey a selective 
advantage by possessing multiple copies. In these cases where a 
single C4 module has been detected in a species by C4 protein 
analysis, it is possible that more than one C4 module is present 
because there has not been confirmation by cloning. However, in the 
mouse, where a bimodular arrangement of C4 genes has been 
detected, only one of these genes is functional (Ferreira et al., 1978).
It is possible that species with a monomodular arrangement of C 4 
genes may have a C4 gene which has been re-modelled, thus 
enabling the product of this gene to carry out functions executed by 
both C4A and C4B type genes (Kawaguchi et al., 1991).
Researchers who have studied the evolution of the C4/CYP21 gene 
region have suggested it may be under two opposing selective 
pressures, one which selects for the presence of two C4 genes, and 
the other which selects for a single CYP21 gene (Kawaguchi et al., 
1991). This differential selection may be responsible for the presence 
of monomodular haplotypes in some species and bimodular 
haplotypes in others. Kawaguchi et al. (1991), suggest that if this 
arrangement between C4 and CYP21 genes is undesirable, this may 
explain why all but one copy of CYP21 is dysfunctional in a multi- 
modular haplotype.
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1.11 Molecular analysis of C4 null alleles
A major factor preventing the development of a molecular-based 
technique for C4 allotyping is the accurate characterisation of C4 A 
and C4B null alleles. Four types of C4 null alleles have been 
reported and include: (1) Deletion of a C4 gene locus which usually 
occurs together with a CYP21 gene (Carroll et al., 1985b and c; 
Schneider et al., 1986); (2) C4A mutation as a result of a small 
insertion (2 bp) leading to a stop codon and truncated mRNA product 
(Barba et al., 1993); (3) Two C4A or C4B alleles on the same 
haplotype which are associated with a C4B or C4A null allele {for 
example C4A 2,3 B QO (isoexpression), or C4A 3,3 BQO 
(homoexpression)}, (Raum et al., 1984; Rittner et al., 1984; Uring- 
Lambert et al., 1984; Yu and Campbell, 1987); and (4) Uring- 
Lambert et al. (1989), and Barba et al. (1993) have reported a non- 
deleted type of C4 null allele, the molecular basis of which is yet to 
be established.
1.11.1 C4 deletions
Only large deletions of 28 kb to 30 kb including a C4 gene locus and 
usually a neighbouring CYP21 gene have been detected. Deletion of 
the entire C4 gene region has not been reported. It has been 
suggested that the large intron (7kb), (absent in short forms of C4B ), 
may affect the site of recombination of C4B and CYP21B in an 
unequal cross-over event leading to C4 gene locus deletions (Yu et 
al., 1986). Studies of haplotypes with a deleted C4A gene have 
found that the remaining C4B genes were almost always the short 
form of C4 gene (Carroll and Alper, 1987b).
The types of C4 deletions detected thus far include CYP21A/C4B, 
C4B/CYP21B, and C4A/CYP21A leaving a long 23kb C4B gene, and 
C4A/CYP21A leaving a short 16kb C4B gene on the chromatid 
(Schneider et al., 1986). These large deleted types of C4 null alleles 
can be detected by RFLP analysis using restriction enzyme Taq I, or 
restriction enzymes Bgl II, Kpn I, Bam HI, and Hind III (Carroll 
et al., 1985b).
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1.11.2 C4A gene mutation resulting from a small insertion
Recent studies by Barba et al. (1993), detected an intact 23 kb C4A 
type of gene which is dysfunctional due to a small 2 bp insertion in 
exon 29. This mutation was found to lead to a termination codon 
during transcription in 10 of 12 individuals with non-deleted types 
of C4A null alleles. For one of the two remaining C4A non-deleted 
null allele individuals, evidence was obtained for gene conversion to 
the C4B isotype. The basis for the other type of C4A null allele was 
unresolved.
1.11.3 Isoexpression, homoexpression and hybrid C4 null alleles
There are two types of non-deleted C4 haplotypes, associated with 
C4 null alleles, which have been identified (Partanen and Campbell, 
1989). One type has C4 genes with the same C4A or C4B 
polymorphisms and antigenic determinants otherwise known as 
isoexpression and homoexpression, for example, C4A null alleles 
with Rodgers antigenic determinants, and C4A isotypic 
polymorphisms. The second type has C4 genes with mixed C4A and 
C4B polymorphisms and antigenic determinants, also described as 
C4A/C4B hybrid types of alleles, for example, C4A null alleles with 
Chido antigenic determinants and C4A isotypic polymorphisms. The 
reason for non-expression of the hybrid type of C4 null allele, which 
shares both C4A and C4B characteristics, has yet to be established.
Identification of homoexpression and isoexpression types of C4 
haplotypes was based on extensive family studies (Schneider et al., 
1986; Palsdottir et al., 1987b; Fredrikson et al., 1991). Schneider 
et al. (1986), analysed RFLP typing patterns of 126 haplotypes from 
92 individuals in 32 Caucasian families, including eight patients with 
CAH, five patients with celiac disease, and four patients with multiple 
sclerosis, to determine the molecular basis of C4 null and duplicated 
variant allotypes. Healthy subjects were selected for the presence of 
haplotypes carrying C4 null alleles at one or both of the C4 gene 
loci. More than half of the C4 genes typed as C4 null by protein gel
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electrophoresis resulted from large deletions. Also, several 
unrecognised homo-duplicated C4 alleles were detected.
It is thought isoexpression and homoexpression on a haplotype are 
the second product of unequal cross-over between homologous 
chromosomes (Schneider et al., 1986). This results in one haplotype 
with duplicated C4 genes, whilst the second haplotype has a deleted 
C4 gene locus (Figure 1.3). Schneider et al. (1986), suggested that 
the frequencies of null alleles determined by Fielder et al. (1983), 
and duplications determined by Raum et al.( 1984), (both of which 
were based on C4 protein typing data), may be underestimated, and 
that C4 gene deletions and duplications may be more common than 
previously thought. Schneider et al. (1986), found all non-deleted 
C4B null alleles were of the large 23 kb gene size. This was likewise 
reported by other researchers such as Carroll and Alper (1987b), and 
Jenhani et al. (1992). This is an interesting observation as all 
duplicated C4 genes resulting in isoexpression and homoexpression 
are associated with long C4 genes at both loci I and II. It may be 
possible in these cases, that the haplotype having the C4B null 
allotype may consist of two functional C4A alleles and no C4B allele.
The C4A/C4B hybrid type of C4 null allele, described above, has 
similar properties to the C4A *7 and C4B *5 allotypes (Yu et al.,
1986). It has been suggested that a gene conversion-like mechanism 
is responsible for mixing the generally discrete serological allotypes 
between C4A and C4B in these alleles (Palsdottir et al., 1987b).
The hybrid type of C4 allele reported by Yu and Campbell (1987), 
was detected by RFLP analysis. Restriction analysis of a C4A gene 
with Nla IV results in fragment sizes 276 bp and 191 bp. A C4B  
gene, however, produces a fragment size of 467 bp. DNA encoding 
Rgl antigenic determinants produce 565 bp Eco0109 fragments by 
restriction analysis, whereas DNA encoding Chi produces 458 bp 
fragments (Partanen and Campbell, 1989).
In summary, both large deletions of C4A and C4B alleles, and the 
small 2 bp insertion in C4A null alleles, can be identified without 
family analysis, as the molecular basis of these C4 null allotypes has 
been determined. Gene duplications are associated with the C4 null
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allotype, and occur with quite high frequencies. However, gene 
duplications reported as homoexpression and isoexpression cannot be 
assigned with a high degree of certainty without family studies.
There is now evidence for hybrid types of C4 genes being associated 
with the C4 null allotype. However, the molecular basis for this 
association has not been established. In addition, as mentioned 
above, there are a number of other C4 alleles which appear to be 
intact but are dysfunctional. The molecular basis of these is 
unknown.
1.11.4 Association of C4 null alleles with HLA haplotypes
C4A and C4B null alleles appear to be associated with specific 
haplotypes in different ethnic populations. Certain C4 gene deletion 
combinations were found to segregate with specific extended 
haplotypes in Caucasians, such as C4B/CYP21 with HLA-5w 47, DR 
7, FC 91,0, and C4A/CYP21A with HLA-A 1, Cw 7, B 8, DR 3, C4A 
QO, C4B 1 (Schneider et al., 1986). The allelic combination HLA-5 
18, Bf FI, C2 C, C4A 3, C4B QO, DR 3 was shown to be associated with 
IDDM in Caucasians (Dawkins et al., 1983), and HLA-A 2, C w5, B 
44, B f S, C4A 3, C4B QO, DR 4 associated with D-Penicillamine- 
induced Thrombocytopenia in Caucasian patients (Dawkins et al., 
1983). However, the molecular basis of these null alleles was not 
determined in these studies. The 2 bp insertion mutation (described 
above), was found to be in linkage disequilibrium with the haplotype 
YIYA-B60, DR6 in seven of 10 Caucasian donors (Barba et al., 1993).
In Thai/Chinese over 90% of C4A QO alleles are associated with two 
particular allelic combinations, namely HLA-A w33, B 44, C4A QO,
C4B 1, BfS,  DR 7, and HLA-A w33, B 17, C4A QO, C4B 1, B f F, DR x 
(where x is an unassigned DR antigen), (Kay et al., 1987b).
However, the molecular basis for the C4 null allotype was not 
determined. These two allelic combinations have minimum 
population frequencies of 6% and 3%, respectively. In the 
Thai/Chinese population, 70% of C4B QO alleles were associated with 
the allelic combination HLA-A w33(ll), B 17, C4A 3, C4B QO, B f S,
DR 3, and the null allele had a minimum frequency of 8% (Kay et 
al., 1987b).
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Very few studies have investigated the association of non-deleted 
C4 null alleles with particular HLA alleles. Schneider et al. (1986), 
did not detect linkage disequilibrium of non-deleted C4A *QO alleles 
with any specific HLA type. However, a study by Kemp et al. (1987), 
suggested that non-deleted C4A *Q0 alleles are associated with D R 
2 in white Caucasian SLE patients. Schneider et al. (1986) found 
that 12 of 17 non-deleted C4B QO alleles were associated with HLA- 
B 44, Bf S, C2 C, C4A 3, C4B QO, and seven with the extended 
haplotype B 44, DR 4, Bf S, C2 C, C4A 3, C4B QO. All non-deleted C4B 
null alleles were found in the common Bf S, C2 C, C4A 3, C4B QO and 
Bf F, C2 C, C4A 3, C4B QO complotypes.
1.12 Summary of review material most relevant to research studies 
undertaken for this thesis
A wealth of information is available concerning the C4 protein, the 
gene region which encodes this protein, and the role of this protein 
within the classical complement activation pathway. Studies of the 
association between C4 null alleles and autoimmune disease have 
indicated a number of areas needing further research. These include 
the role of C4 protein in the immune response, the factors which 
regulate C4 protein activity, the molecular basis of C4 alleles 
including C4 null alleles, and genetic mechanisms operating within 
the C4 gene region which have led to its evolution.
Many of the earlier C4 protein functional and disease association 
studies were based on C4 protein allotyping. However, availability of 
contemporary molecular techniques such as restriction fragment 
length polymorphism (RFLP), allele-specific oligonucleotides (ASO), 
pulsed-field gel electrophoresis (PFGE), polymerase chain reaction 
(PCR), and DNA sequencing, has facilitated the molecular analysis of 
the C4 gene. This has provided much of the basic information and 
methodology required for developing a molecular-based C 4 
allotyping protocol, a major aim of this thesis.
The C4 gene locus has proved to be more complicated than originally 
thought. Not only does the C4 gene region have two genes, C4A and 
C4B, but occasionally C4 may have two C4A- or two C4B- like
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genes on the same haplotype. C4 alleles including some null alleles 
have been found to have mixed C4A and C4B antigenic 
determinants. Also, some C4A alleles have antigenic determinants 
commonly found in C4B alleles, and some C4B alleles have antigenic 
determinants commonly found in C4A alleles.
Previous research has led to changing hypotheses as to which factors 
generate a C4 QO allotype. Initial studies of the C4 null allele found 
that large deletions were the molecular basis of this allotype.
However, family studies have shown that some C4 QO allotypes are 
not the result of gene deletion but rather two alleles of the same 
isotype. The frequencies of null alleles and frequencies of 
duplications in association with C4 QO alleles (0.10-0.15, and 
0.0075-0.01, respectively), do not correspond in the Caucasian 
population. This indicates that other genetic mechanisms besides C4 
gene duplication are operating to create this allotype. More recent 
molecular studies of C4 null alleles have shown that a number of 
genetic mutations are responsible for the C4 null allotype (as occurs 
with the accompanying CYP21 gene loci). Besides the earlier 
described large deletion type of C4 null alleles, a 2 bp insertion, and 
apparently intact alleles which have unusual combinations of C4A  
and C4B isotypic amino acid residues, have been found in association 
with this allotype. The molecular basis of the C4A/C4B hybrid types 
of C4 Q0 allotype remains unresolved. Only RFLP analysis has been 
applied to these aberrant null alleles to study the known 
polymorphic sites.
The presence or absence of the large 7 kb intron at the second C 4 
gene locus has probably increased the instability of this gene region. 
This would therefore be a promising site to investigate the molecular 
basis of C4 null alleles. The interaction of this intron with the C4 
gene region from the accompanying chromatid, may be important in 
misalignment of the C4 alleles, and could be involved in gene- 
conversion-like events between the C4A and C4B alleles.
The reported frequencies of C4 QO alleles in the general population 
as determined by protein gel electrophoresis may be inaccurate.
These frequencies could possibly be lower than previously thought, if 
those haplotypes which have two of the same active C4 isotypes on
45
one chromatid (isoexpression and homoexpression) are at all 
common. This type of C4 gene organisation could not be identified 
by C4 protein allotyping, and therefore emphasises the need for a 
C4 molecular typing method. C4 protein allotyping has, however, 
shown the frequency of C4 QO alleles to be higher in disease-risked 
individuals, and therefore reinforces the importance of the 
association of C4 null alleles with disease.
Polymorphism of C4 alleles makes them valuable genetic markers 
for population and evolutionary studies. A molecular-based C4 
allotyping protocol would be useful in studying population origin and 
migration by recording the distribution of polymorphic C4 alleles.
This is made possible by the fact that C4 alleles occur with different 
frequencies and segregate with specific complotypes in specific 
ethnic groups (Schendel et al., 1984; Partanen et al., 1987; Ayed 
and Gorgi, 1990).
At the present time, although analysis of C4 allelic distribution as 
determined by protein gel electrophoresis withstands the test of fit 
to the Hardy-Weinberg equilibrium in the majority of cases, 
molecular analysis of C4 alleles indicates that the serological method 
may not always provide a true description of C4 alleles nor 
necessarily identify all of the C4 alleles carried by a donor. A 
technique using optical density analysis (Christiansen et al., 1983) 
may be used to rectify the problem of overlapping C4 alleles by 
protein gel electrophoresis. However, C4 alleles with identical 
migration patterns will not be easily identified and therefore can 
lead to a false indication of the distribution of these alleles in a 
population.
C4 allele frequency studies of Aboriginal Australians and Papuans 
from Papua New Guinea may be useful in resolving unanswered 
questions with respect to their relationships and origin. However, 
study of isolated populations has previously been hindered by the 
difficulty in obtaining non-degraded samples of C4 protein due to 
the unavailability of suitable storage facilities. A molecular-based 
protocol which accurately defines C4 allotypes would not only be
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valuable in disease association studies, but would enable typing of 
DNA, a more stable source of material for study of remote 
populations.
There are a number of sound reasons for analysing the C4 gene 
region, both from an evolutionary perspective in relation to 
population and gene origins, and from a disease association 
perspective in relation to the aetiology of different disease states. 
The wealth of information available on studies of this gene region in 
humans and animals, especially with recently developed molecular 
technologies, provides a sound basis for research conducted here.
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1.13 Hypothesis of studies for this thesis
1. To test whether indigenous people of PNG and Aboriginal 
Australians have shared a common gene pool by investigation of the 
distribution of polymorphic C4 alleles.
2. To test whether the high frequency of C4 null alleles reported 
for the northern located Darwin Aboriginal population was an 
isolated incident or whether other northern located Aboriginal 
Australian population's have a high frequency of C4 null alleles.
3. To test whether the polymorphic C4d region of C4 genes may 
be used by molecular means to identify and type C4 alleles.
4. To test if the genetic basis of Aboriginal Australian C4 null 
alleles is the same as that reported for Caucasian null alleles.
Chapter 2
Materials and Methods
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2.1 Materials
Reagents used in experimental work, and their place of origin are 
listed below in alphabetical order of manufacturer:
Ajax chemicals, Auburn, N.S.W, Australia: acetic acid;
barbituric acid; boric acid; bromophenol blue; chloroform; EDTA; 
ethanol; HC1; iso-amyl alcohol; iso-propyl alcohol; KC1; methanol;
MgCl2; Na barbiturate; NaCl; NaHC03; NaH2P 04.2H20; Na2HP04; NaHP04; 
Na0EDTA; Na4EDTA; CH3COONa; xylene cyanol
Aldrich Chemicals, Castle Hill, N.S.W, Australia: tetramethyl- 
NH4C1
Amersham Int., Amersham, Buckinghamshire, UK: mp8
ssDNA standard; Nick translation kit containing reaction reagents 
dCTP, dGTP, dTTP and DNA polymerase I 
Amicon Inc, MA, USA: microcon 100 columns 
Applied Biosystems, Foster City, CA, USA: 
deoxy/dideoxynucleotide triphosphate (d/ddNTP) mixes; dye- 
labelled oligonucleotide primers
BDH Chemicals, Poole, Dorset, UK: 2-mercaptoethanol; NH4OAc; 
polyethylene glycol6000 (PEG6000); sodium citrate; ultra pure sodium 
dodecyl sulphate (SDS)
Boehringer Mannheim, Castle Hill, NSW, Australia: alkaline 
phosphatase; EcoRI-, Haelll-, MspI-, Smal- restriction 
endonucleases; X-gal
Bresatec Ltd, Adelaide, SA, Australia: ( a - 32P)dATP, 3000 
Ci/mmol; (y-32P)ATP, 4000 Ci/mmol; PvuII restriction endonuclease 
CUNO laboratory products, NM, USA: Zetabind nylon membrane 
DIFCO Laboratories, Detroit, MI, USA: bacto agar; bacto 
tryptone; yeast extract
Fluka, Chemische Fabrik, Buchs, Switzerland: diethyl 
pyrocarbonate (DEP); formamide; guanidinium thiocyanate 
FMC Corporation, Rockland, ME, USA: Seakem ME agarose; Gel 
Bond
Fuji Photo Film Co., Tokyo, Japan: X-ray film
Gambro AB, Lund, Sweden: Lundia IC 3N plate dialyzer cellophane
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H oefer Scientific Instrum ents, TKO, USA: Hoechst fluorimeter 
dye
M&B (Mary and Baker) Laboratory Reagent, A ustralia Pty. 
Ltd, Victoria: Na9C 0 3
M allinckrodt Inc, Kentucky, USA: CaCl9; dimethyl sulfoxide 
(DMSO); glycerol
M erck, Darmstadt, Frankfurter Strasse, FRG: NaOH; Na(BH4) 
N ational D iagnostics, Atlanta, G eorgia, USA: polyacrylam ide 
'Accugel' 40™
New England Biolabs, MA, USA: Aci /-, Alu /-, BstU /-, Fnu4H  
/-, Fok /-, Hha /-, Mnl /-, Pie /-, restriction endonucleases 
Pharm acia, Uppsala, Sweden: ATP; dextran sulphate; DNA 
polymerase I large fragment (Klenow); dNTP's; Ficoll 400; Moloney 
murine leukemia virus reverse transcriptase; M l 3 m p l8  and 
m pl9  vector DNA; plasmid pBR322 ; T4 polynucleotide kinase; T4 
DNA ligase; terminal deoxynucleotide transferase 
Polaroid Co., Cambridge, MA, USA: polaroid film 
Progen, Q ueensland, Australia: SSP-I bacteriophage, DNA- 
molecular weight marker restricted with Eco W; A DNA restricted 
with Hind III and Eco R1
Prom ega, M adison, WI, USA: Not 1 Poly T' primer; sequencing 
grade Thermus aquaticus (Taq) DNA polymerase; Taq /-restriction 
endonuclease
Sigma Chemical Co., St Louis, MO, USA: agarose Type II; AgN03; 
bovine serum albumin (BSA); Carboxypeptida.se B (Type I); 
coomassie brilliant blue dye; deoxyribonuclease; dithiothreitol (DTT); 
dialysis tubing; ethidium bromide; formaldehyde; gelatin; glycine; 
guanidinium hydrochloride; IPTG; mineral oil; MOPS; neuraminidase 
(Type VI); polyvinyl pyrrolidone (PVP); proteinase K; salmon sperm 
DNA; sodium sarcosyl; tris
Silenus L aboratories, H aw thorn, A ustralia: Anti-human C 4 
an tiserum
Stratagene, La Jolla, USA: Pfu Taq DNA polymerase
W hatm an International Ltd, M olestone, England: Whatman #1
filter paper; Whatman 3MM chromatography paper
W ako Pure Chem ical Ind., Novachem , Sw itzerland: phenol
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2.2 Methods
The methods used in this thesis are listed below. Those methods, 
such as the polymerase chain reaction (PCR), which have specific 
conditions are outlined in this chapter and described in detail in each 
relevant chapter.
2.3 Study populations
Aboriginal Australians from two Cape York communities, Groote 
Island and Darwin were selected for analysis of the polymorphic C 4 
gene locus in population studies and development of a molecular 
based C4 typing technique, as well as for analysis of the molecular 
basis of C4 null alleles. Papuans from three different geographic 
regions of PNG were chosen for analysis of the polymorphic C4 gene 
locus in population studies. Aboriginal Australians and Papuans were 
chosen as little is known about the distribution of C4 alleles in these 
indigenous people. Individuals selected for analysis were chosen at 
random and are believed to be representative of the respective 
populations. Peripheral blood specimens from 101 Aboriginal donors 
in two Cape York communities were obtained by Dr Anthony Veale 
(National Center for Epidemiology and Population Health, ACT). 
Immediately after collection samples were placed on dry ice for 
transport to Australia, and then stored at -70 °C. PNG blood 
specimens provided by Dr Kuldeep Bhatia (PNG Institute of Medical 
Research, Goroka), were collected from 49 mothers attending the 
Goroka Base Hospital for routine antenatal check-ups, and from 51 
patients participating in a population genetic survey of the Wosera 
Subdistrict. Samples (120), were collected from Koki, Port Moresby. 
Plasma samples were separated from buffy coats within one to two 
hours of collection, treated with 0.2 M EDTA to prevent protein 
deterioration, and snap frozen in liquid nitrogen. Samples were 
transported on dry ice to the John Curtin School of Medical Research 
(JCSMR), Canberra. Specimens from a Groote Island Aboriginal family 
were provided by Drs Bart Currie and Tim Burt (Menzies School of 
Health Research). Three Darwin Aboriginal cell line samples Hl l ,  H14 
and H19, known to be homozygous for C4A or C4B null alleles as 
ascertained by electrophoresis and immunofixation, and Groote
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Island Australian Aboriginal peripheral blood samples, were 
provided by Bart Currie, collected by Tim Burt, and were used for 
DNA analysis.
2.4 Caucasian donors
Staff members of JCSMR, ANU, Canberra, provided blood samples for 
use as controls in C4 protein allotyping and in the development of 
the C4 molecular typing technique. Additional samples of interest 
were ascertained from the records of the Human Genetics Group 
(JCSMR). These included certain patients with insulin-dependent 
diabetes mellitus (IDDM), some of which carried C4A or C4B null 
alleles, as determined by routine C4 allotyping by electrophoresis 
and immunofixation. IDDM patient cell lines were provided by the 
Royal Childrens Hospital (RCH) in Melbourne, and Woden Valley 
Hospital (denoted with ASD), Canberra. Both RCH and ASD groups 
were used in the development of the molecular C4 typing protocol. 
These groups were used as they had rare C4 alleles which were not 
found in the Aboriginal Australians and provided Caucasian samples 
of different C4 alleles for comparison with the Aboriginal Australian 
C4 alleles. 10th International Histocompatibility Workshop cell lines, 
including EW-VAVY, EW-DUCAF and EW-L0081785, of known 
homozygosity for either C4A or C4B null alleles, were used for C4 
null allele analysis and for development of the molecular C4 typing 
technique. A series of 50 SLE Caucasian patients numbered SLE502 to 
SLE686 were from Canberra and were provided by Paul Gatenby. SLE 
Caucasian patients were chosen as many of these patients had C4B  
Q0 alleles, as determined by protein gel electrophoresis, compared 
to other Caucasian donors which had been C4 allotyped in our 
laboratory. These patients were used in screening for a novel C4A  
*CAN1 allele which was identified in these studies and shown to be 
in association with a C4B null allele by protein gel electrophoresis in 
Aboriginal Australians.
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2.5 C4 protein allotyping
C4 allotyping was performed by a protein electrophoretic migration 
technique described by Awdeh and Alper (1980). Unusual C4 
allotypes including C4 null alleles were confirmed by treatment of 
serum samples with carboxypeptidase B prior to electrophoresis, as 
described by Sim and Cross (1986).
2.5.1 Gel preparation
The agarose gel solution consisted of 0.75 % SEAKEM ME agarose,
16 ml of electrophoresis buffer (0.2 M Tris, 0.4 M Glycine, 30 mM Na 
Barbiturate, 6 mM Barbituric acid, pH approximately 8.8), 1.6 ml of 
0.2 M EDTA solution (0.1 M Na2EDTA, 0.1 M Na4EDTA), and distilled 
water to a total volume of 40 ml. The gel solution was boiled and 
placed in a gel mould prepared in the following way. The 
hydrophobic side of a piece of 'Gel Bond' (24.3 cm by 12.5 cm), was 
placed on a glass plate of identical size. A mould was formed by using 
a second siliconized glass plate and two 1 mm gaskets to separate the 
glass plates, and was held together using bulldog clips. Gels were 
cooled to 4 °C prior to use. EDTA solution was stored at -20 °C, and 
once thawed was discarded after one week.
2.5.2 Dialysis
Dialysis buffer stock solution (pH approximately 6.8), consisted of 
0.3 M NaH2P 0 42H20, 0.2 M Na2H P04, and 0.03 M Na4EDTA. This 
solution was discarded after one week. 1 L of diluted dialysis buffer 
(1 part stock solution to 5 parts distilled water) was used for each 
dialysis. Cellophane membrane was placed on towelling (previously 
soaked in dialysis buffer), extending across a wick with one end 
suspended in dialysis buffer and the other in an empty container. 
This arrangement allowed the movement of buffer from one 
container to the next. Serum samples were dialysed at 4 °C overnight 
by mixing 10 pi serum sample with 2pl neuraminidase (50 units 
dissolved in 1.4 ml of 0.2 M EDTA solution and stored at -20 °C) on 
the cellophane.
53
2.5.3 Electrophoresis
An applicator strip, the length of the glass plate with slots 8-10 mm, 
0.75 mm wide and 2 mm apart, was made from gel bond. This 
applicator strip was placed (hydrophobic side up) along the cathode 
side of the gel where excess water had been removed by blotting 
with Whatman No.l filter paper. Dialysed samples (10 pi), were 
loaded into each slot. A haemoglobin sample containing HbA was co- 
electrophoresed as a marker. Gels were left to stand for 30 min prior 
to electrophoresis to allow the movement of serum into the gels. 1 L 
of undiluted electrophoresis buffer was used in each gel tank. 
Saturated wicks, made from cotton wool, were extended from the 
cathode and anode ends of the gel into the electrophoresis buffer. 
Gels were covered with a glass plate to prevent dehydration, and 
electrophoresed at 85 mA for 6 hours at 6 °C.
2.5.4 Immunoprecipitation and staining
Gels were overlaid with diluted anti-human C4 antiserum (0.4 ml 
antiserum and 2 ml saline), and incubated for 1 hour at room 
temperature in a moist chamber to prevent desiccation. Gels were 
washed gently with running water, then water was removed by 
blotting the gel with absorbent paper for 10 min. Gels were soaked 
overnight in 0.9 % saline. Gels were washed again, blotted, air dried 
and stained in 0.2 % Coomassie Brilliant Blue in 9 parts methanol, 2 
parts acetic acid, and 9 parts distilled water, then destained in the 
solvent.
2.5.5 Carboxypeptidase B treatm ent
Unusual C4 allotypes and C4 null alleles were confirmed by 
treatment with Carboxypeptidase B , where 1.6 units of 
Carboxypeptidase B in 100 mM NaCl was added to 10 pi of plasma, 
incubated at room temperature for 30 min, then dialysed as 
described in section 2.5.2.
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2.6 Statistical analysis
Maximum likelihood estimates of C4 allele frequencies were 
calculated from phenotype distributions using an iterative computer 
programme to determine the best fit to Hardy-Weinberg equilibrium. 
That is p2 + q2 + 2pq = 1, where p = frequency gene 1, and 
q ^frequency gene 2. This computer analysis was necessary to 
estimate the population frequency of double heterozygosity for null 
alleles which could not be detected by C4 protein allotyping.
2.7 Genomic DNA extraction
Heparinised whole blood samples were centrifuged at 2000 rpm for 
10 min at room temperature, prior to removal of the plasma and red 
blood cell interphase (buffy coat), with siliconised glass pipettes. 
Buffy coats were washed multiple times with T90E5 (20 mM Tris/HCl, 
5 mM EDTA, pH 8.0), and centrifuged at 4000 rpm for 10 min at 
room temperature, until the remaining cell pellet appeared white.
Cell line material was washed once with this solution. Genomic DNA 
was extracted by resuspending pellets in 3 ml T10Ej (10 mM 
Tris/HCl, 1 mM EDTA, pH 8.0), 400 pi of 10 % SDS, and 1.2 mg of 
Proteinase K, followed by incubation at 37 °C overnight. Cell debris 
was precipitated by the addition of 1 ml saturated NaOAc, mixed 
vigorously for 15 sec, and centrifuged at 1500 rpm for 15 min. DNA 
in the supernatant, was precipitated in a fresh tube by the addition 
of an equal volume of iso-propyl alcohol. DNA was removed with 
siliconised looped pipettes, air-dried and resuspended in T ^ E j to a 
final concentration of 0.3 pg/pl.
2.8 DNA digestion
Digestion of DNA samples was carried out according to procedures 
described by the manufacturer of each enzyme. Core buffers were 
provided by the manufacturer at ten times the concentration 
required for digestion. Samples were digested at 65 °C for two hours, 
or overnight at 37 °C, depending on specific enzyme used. The
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digestion reaction was stopped by the addition of 0.5 M EDTA 
(pH 8.0), and heating to 65 °C for 10 min.
2.9 Gel electrophoresis
A variety of agarose (Type II, Sigma), and polyacrylamide gel 
concentrations were used depending on the size of DNA fragments to 
be separated. In each case a 6 x loading buffer {30 % (v/v) glycerol, 
0.25 % (w/v) xylene cyanol, and/or 0.25 % (w/v) bromophenol blue) 
was added to 1 x final concentration, samples were heated to 65 °C 
for 10 min and cooled on ice for 10 min prior to loading. Agarose gels 
were electrophoresed at room temperature, with constant voltage, in 
1 x Tris-acetate EDTA (TAE) buffer (0.04 M Tris-acetate, 1 mM EDTA, 
pH 8.0), whilst polyacrylamide gels were electrophoresed at 6 °C with 
constant current and 1 x Tris-borate EDTA (TBE) buffer (0.045 M 
Tris-borate, 1 mM EDTA, pH 8.0). Standard DNA molecular weight 
markers (~0.5 pg), listed in Figure 2.1, were used to estimate DNA 
fragment sizes.
2.10 Gel staining with EtBr and silver
Agarose gels were prepared containing EtBr at a final concentration 
of 0.5 fig/ml, whereas polyacrylamide gels were stained with EtBr 
(0.5 pg/ml) in distilled water, after electrophoresis for 15 min. Gels 
were photographed with UV transmitted light (254 nm) using an 
orange filter and a Polaroid camera. Gels which contained DNA 
fragments not easily interpreted by EtBr staining were stained with 
silver. This method of staining was based on the protocol supplied 
with Qiagen TGGE apparatus (Diagen GmbH, Düsseldorf, FRG), and 
adapted from Merril et a/.(1981). Each gel was fixed by two 3 min 
washes with 9.95 % ethanol and 0.5 % acetic acid. Silver adhered to 
the DNA by the addition of 0.1 % AgN03 for 10 min, followed by two 
rinses with water. Gels were developed for approximately 20 min 
with 1.5 % NaOH, 0.01 % NaBH4, and 0.1 % formaldehyde, and then 
fixed for 10 min in 0.75 % Na2C 0 3. Silver stained gels were 
photographed with a Polaroid camera using a light box and a violet 
coloured filter.
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Figure 2.1 DNA molecular weight standards
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2.11 Southern Blotting
DNA fragments were transferred from a gel to nylon membrane 
(Zetabind), using the general method described by Maniatis et al. 
(1982). Gels were soaked in 0.25 M HC1 for 10 min to depurinate the 
DNA prior to capillary blotting using 0.4 M NaOH as a transfer buffer 
(Reed and Mann, 1985). After transfer was complete membranes 
were neutralised by rinsing in 1.5 M NaCl, 0.5 M Tris (pH 7.5) for 
5 min, and then DNA was cross-linked to the membrane with 254 nm 
UV light for 5 min and dried at 65 °C for one hour.
2.12 Radioactive labelling of DNA probes and hybridisation
2.12.1 Nick translation of C4 pAT-A
The C4 pAT-A cDNA probe containing an entire plasmid vector 
'pAT-A1, and a C4 specific insert, was provided by Dr M. Carroll (The 
Childrens Hospital, Boston, USA). This probe (0.5 pg) was radio- 
labelled using an Amersham nick translation kit following the 
procedure described by Maniatis et al. (1982). The following 
reagents were combined: 1 pi (0.5 pg) of C4 pAT-A\ 2pl of each dNTP 
'C7G', and T ;  3 pi DNA polymerase I enzyme; 3 pi of a -32P dATP; and 
17 pi of distilled water. The reaction was carried out at <15 °C for 1 
hour, and then stopped by the addition of 1 pi 0.5 M EDTA (pH 8.0). 
Samples were precipitated with 15 pi of 7.5 M ammonium acetate 
and 90 pi of absolute ethanol, collected by centrifugation, and 
resuspended in 50 pi T10Ej.
2.12.2 Hybridisation of nick translated probes
Prior to pre-hybridisation, filters were incubated in a 0.1 x SSC,
0.5 % SDS solution for 1 hour at 65 °C to minimise background 
hybridisation created by the dye which had transferred from the gel 
to the filter during blotting. Pre-hybridisation and hybridisation 
were performed in a rotisserie Hybaid oven (Hybaid, Middlesex, 
United Kingdom) at 65 °C. Pre-hybridisation and hybridisation 
solution consisted of 150 pi heat denatured salmon-sperm DNA
58
(10 mg/ml), 7.5 ml Nasmyth solution (18.5 % dextran sulphate,
1.85 % sodium sarcosyl, 0.6 M NaCl, 0.18 M Na2H P04, 6 mM Na0EDTA) 
and 7.5 ml distilled water. Following pre-hybridisation of filters 
overnight, nick translated probes were boiled in 5 ml of hybridisation 
solution for 10 min and then added to filters for incubation 
overnight. To remove excess and non-specifically bound probe, filters 
were washed in 2 x SSC and 0.1 % SDS at room temperature for 5 
min, 2 x SSC, 0.1 % SDS at 65 °C for 15 min, 1 x SSC, 0.1 % SDS
at 65 °C for 15 min, and 0.5 x SSC, 0.1 % SDS at 65 °C for 15 min. 
Once the filters had a reading of 10-20 cps, they were exposed to 
autoradiographic X-ray film, using single sided intensifying screens 
(0.5 dpm/mm2 sensitivity), at -70 °C for 3 to 5 days, after which time 
films were developed using an automatic film developer.
2.12.3 Labelling 5' end of DNA oligonucleotides
The following protocol was used for the radio-labelling of small DNA 
fragments of approximately 20 nucleotide bases in length. T4 
polynucleotide kinase was used to catalyse the transfer of the 
terminal gamma phosphate of ATP to the 5'-hydroxyl terminus of the 
DNA fragment to be labelled. 10 pmoles of oligonucleotide were 
radio-labelled by the addition of 3 pi of 10 x kinase buffer (50 mM 
Tris/HCl pH 7.5, 20 mM MgCl2, 20 mM DTT), 3 pi of y 32P-ATP, 1 pi of 
T4 polynucleotide kinase (10 units), and distilled water to a total 
volume of 30 pi. Samples were incubated at 37 °C for 30 min and 
then stopped by the addition of 1 pi 0.5 M EDTA pH 8.0.
2.12.4 Hybridisation of 5’ end-labelled oligonucleotides
Filters were prepared for hybridisation by washing in 0.1 x SSC,
0.5 % SDS for 1 hour at 65 °C, followed by pre-hybridisation for 
2 hours at 42 °C in 15 ml of a solution containing 15 % formamide,
0.1 % Denhardt's solution (0.1 % BSA, 0.1 % PVP, 0.1 % Ficoll 400),
5 x SSPE (5 mM EDTA, 50 mM NaH2P 0 4H20, 900 mM NaCl, pH 7.4),
0.2 mg/ml heat denatured salmon sperm, and 1 % SDS. Radio-labelled 
oligonucleotides were added to the pre-hybridisation solution and 
hybridised to filters at 42 °C for 1 hour. Excess and non-specifically
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bound probe was removed by washing the filters twice in 3 x SSC at 
room temperature, and 30 min at 59 °C in a filtered solution of 3 M 
tetramethyl NH4C1, 50 mM Tris/HCl pH 8.0, 2 mM EDTA, and 1 % SDS. 
Filters were autoradiographed by exposure to X-ray film with an 
intensifying screen (0.5 dpm/mm2 sensitivity), for 2-24 hours at 
-70 °C.
2.13 Total RNA extraction
2.13.1 RNA preparation
Isolation of total RNA was by a single extraction with an acid 
guanidinium thiocyanate-phenol-chloroform mixture, as described by 
Chomczynski and Sacchi (1987). RNA was extracted from cell line 
material (1 x 107 cells) by firstly, denaturing cellular protein in 
500 pi of solution D (4 M guanidinium thiocyanate, 25 mM sodium 
citrate {pH 7.0}, 0.5 % sodium sarcosine, 0.1 M 2-mercaptoethanol). 
Secondly, 50 pi of 2 M diethyl pyrocarbonate (DEP) treated NaOAc 
pH 4.0, 500 pi phenol and 100 pi chloroform:iso-amyl alcohol (24:1) 
were added, mixed thoroughly and cooled on ice for 15 min. Cell 
debris was collected by centrifugation at 10,000 g for 20 min at 
4 °C, and the supernatant containing RNA was removed to a fresh 
tube. RNA was precipitated by the addition of 500 pi iso-propyl 
alcohol and incubation at -20 °C for 1 hour. The RNA precipitate was 
collected by centrifugation at 10,000 g for 20 min at 4 °C, and then 
resuspended in 150 pi of solution D before a second precipitation 
with iso-propyl alcohol. The final precipitate was washed in 20 pi of 
75 % ethanol, vacuum dried for 15 min, and then dissolved in 20 pi 
DEP-treated distilled water.
2.13.2 Estimation of RNA concentration and protein contamination
A spectrophotometer was used to measure the concentration of RNA 
by recording the optical density for 1 pi of RNA in 1 ml water, at 260 
nm and 280 nm. The presence of protein contamination in an RNA 
sample was detected if the ratio of 260 nm : 280 nm readings was 
less than 2.
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2.13.3 Electrophoresis of RNA
Total RNA extractions were separated on a 1.4 % agarose gel (Type II, 
Sigma) containing 36 ml of DEP-treated water, 10 ml of 10 x MOPS 
buffer (0.4 M MOPS pH 7.0, 0.1 M NaOAc, 0.01 M EDTA, 0.1 % DEP), 2 
ml of formaldehyde (37 %), and 5 pi of EtBr (10 mg/ml). This solution 
was especially formulated to prevent the degradation of RNA. 
Approximately 10 pg of RNA suspended in T10Ej, 2 mM of 
dithiothreitol (DTT), and 1 unit/pl of RNasin, were prepared for 
electrophoresis by the addition of 2 pi 10 x MOPS buffer, 3.3 pi 
formaldehyde solution (37 %) and distilled water to 20 pi. Prior to 
electrophoresis samples were heated at 55 °C for 15 min, cooled on 
ice for 5 min, followed by the addition of 2 pi 10 x RNA sample 
buffer (50 % glycerol, 0.5 mM EDTA {pH 8.0}, 0.25 % {w/v} 
bromophenol blue). RNA samples were electrophoresed for 5 hours at 
65 volts, and then visualised by UV transmitted light.
2.14 Northern blots and hybridisation
RNA was transferred to a nylon membrane (Zetabind), by blotting 
overnight using 1 x MOPS buffer, following the method described in 
section 2.11. Pre-hybridisation and hybridisation of filters were 
carried out in a Hybaid oven, using a high stringency buffer 
containing 5 x SSPE (5 mM EDTA, 50 mM NaH0P 0 4.HoO, 900 mM NaCl, 
pH 7.4), 7 % SDS and 40 % formamide. Filters were pre-hybridised for
2 hours at 42 °C, and then hybridised overnight with C4 pAT-A nick 
translated probe prepared as described in section 2.12.1. Excess, and 
non-specifically bound probe was removed by washing filters in 2 x 
SSC, 0.1 % SDS for 5 min at room temperature, 2 x SSC, 0.1 % SDS for 
15 min at room temperature, 0.5 x SSC, 0.1 % SDS for 15 min at room 
temperature, 0.1 x SSC, 0.1 % SDS for 15 min at room temperature, 
and 0.1 x SSC and 1 % SDS for 30 min at 42 °C. Filters (-10-20 cps) 
were exposed to X-ray film with an intensifying screen at -70 °C for
3 to 5 days.
61
2.15 First strand cDNA synthesis
C4-specific and non-specific first strand cDNA were synthesised 
from total RNA by using a 3’ C4-specific antisense primer 5'-TGGGA 
CTTGAACCCATTCCG-3' (corresponding to nucleotide bases encoding 
amino acid residues #1317 to #1323 in exon 30), and a 3’ non­
specific antisense primer Not 1, Poly T  primer 5'-CAATTCGCGGCCG 
C(T)15-3', respectively. Both C4-specific and non-specific cDNAs were 
prepared by incubating 10 pg of total RNA (previously incubated at 
65 °C for 3 min, and on ice for 5 min), with 1 x cDNA synthesis buffer 
{500 mM Tris/HCl (pH 8.3), 750 mM KC1, 30 mM MgCl2, 100 mM 
DTT), 50 pmoles of antisense primer, 2 mM of dNTP’s, 15 units of 
RNasin, and 40 units of reverse transcriptase in a total volume of 
50 pi, at 37 °C for 4 hours. cDNA was purified by the addition of 
150 pi DEP-treated water, 100 pi phenol and 100 pi of 
chloroform:iso-amyl alcohol (24:1), mixed vigorously, and centrifuged 
for 3 min at 14,000 g. The aqueous phase was recovered and the 
cDNA concentrated by using a microcon 100. A sample (1 pi) of the 
cDNA preparation was electrophoresed on a 0.8 % agarose (Type II, 
Sigma) gel containing EtBr (0.5 pg/ml), at 120 volts for 30 min, and 
visualised by UV light.
2.16 PCR amplification
Polymerase chain reaction (PCR) was used to amplify a segment of 
DNA between two regions of known sequence. Each PCR reaction 
contained 0.3 pg/pl of template DNA, 10 % DMSO, 0.2 mM dNTP mix 
(dATP, dCTP, dGTP, dTTP), 1 x Promega Taq buffer containing MgCl2 
(25 mM), 0.3 pg/pl of each oligonucleotide, and 0.25 units of either 
Promega Taq or Pfu Taq DNA polymerase in a total volume of 100 pi. 
Each reaction was covered by 70 pi of mineral oil to prevent 
evaporation. For each PCR cycle template DNA was denatured by 
heating to 96 °C and then cooled to a temperature between 58 °C and 
60 °C, which allowed the oligonucleotides to anneal to their target 
sequences, followed by primer extension at 72 °C. This cycle of DNA 
denaturation, annealing and primer extension was repeated for 30- 
35 cycles. Optimum conditions varied for each PCR reaction 
depending on the base composition of each oligonucleotide, and the
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length of template DNA to be amplified. Annealing temperatures for 
each PCR were determined by the theoretical melting temperature 
(Tm) of each oligonucleotide, given by Tm °C = 4 (C + G) + 2 ( A + T ). 
PCR products were visualised by electrophoresis at 120 volts for 
30 min on a 1 % agarose (Type II, Sigma) gel containing EtBr (0.5 
pg/m l).
2.17 Electro-elution of PCR fragments from agarose gels
PCR fragments of interest were visualised by EtBr staining and long 
wavelength (300-360 nm) UV transmitted light, then excised from 
the agarose gel with sterile scalpel blades. Agarose containing DNA 
was placed in 2 cm wide dialysis tubing (held together with dialysis 
clips), with 500 pi of 0.1 x Tris-acetate buffer. Elution was carried out 
in a gel electrophoresis tank for 30 min at 290 volts, followed by 
reversal of the current for 30 sec to prevent binding of DNA to the 
dialysis tubing. Samples were purified with a phenol/chloroform:iso- 
amyl alcohol (24:1) extraction, and then precipitated with 1/10 th 
the total volume 7.5 M NH4OAc. Samples were air-dried and 
resuspended in 100 pi distilled water.
2.18 Cloning of C4 specific DNA fragments
2.18.1 Sticky-end cloning
2.18.1.1 Preparation of PCR DNA
Total PCR reactions (100 pi) were concentrated using a centricon 100 
to a volume of approximately 35 pi. PCR samples (35 pi) were 
restricted at 37 °C for 4 hours with Eco R1 (50 units) and Sal I (20 
units), using 1 x reaction buffer 'H' (high salt buffer provided by the 
manufacturer), in a total volume of 100 pi. Restriction reactions were 
stopped by the addition of 2 pi of 0.5 M EDTA, followed by ethanol 
precipitation with 1/10 th the total volume of 7.5 M NH4OAc. DNA 
was pelleted and rinsed in 70 % ethanol. Digested PCR samples were 
air-dried and resuspended in 35 pi of distilled water.
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2.18.1.2 Preparation of M13 cloning vectors
M13 vectors (2 pg of each) mpl8 (for sequencing the sense strand) 
and mpl9 (for sequencing the anti-sense strand), were restricted 
with Eco R1 and Sal I using the same reaction conditions, as 
described for the preparation of PCR DNA, and resuspended in 60 pi 
of sterile distilled water. Restricted vector fragments were 
de-phosphorylated to prevent re-ligation by the addition of 1 pi of 1 
M Tris (pH 8.0), and 1 pi of alkaline phosphatase, in a total volume of 
100 pi, followed by incubation for 30 min at 37 °C. Vector samples 
were then phenol extracted and ethanol precipitated (as described 
above), air-dried, and resuspended in 100 pi of T jqE j to a final 
concentration of 20 ng/pl.
2.18.2 Blunt-end cloning
2.18.2.1 Preparation of PCR DNA
Total PCR reactions (100 pi) were purified by phenol/chloroform:iso- 
amyl alcohol (24:1) extraction, followed by ethanol precipitation 
using 1/10 th volume of 7.5 M NH4OAc, and rinsing with 70 % 
ethanol. PCR samples were air-dried and resuspended in 13 pi of 
distilled water. PCR fragments were phosphorylated by incubating 
for 45 min at 37 °C in a 20 pi reaction containing 50 mM Tris/HCl (pH 
7.5), 20 mM MgCl2, 20 mM DTT, 2 mM ATP and 10 units of T4 
polynucleotide kinase. Phosphorylated PCR-DNA was then purified by 
electro-elution as described in section 2.17.
2.18.2.2 Preparation of M l3 cloning vectors
Vector M l3 was linearised by digestion at 30 °C for 2 hours in a 
reaction containing 2 pg of M13 (mpl8 or mpl9), 1 x One-Phor-All 
reaction buffer (Pharmacia), and 20 units of restriction enzyme Sma  
I. To minimise recircularisation, vector DNA was dephosphorylated 
with 1 pi Tris (pH 8.4) and 1 pi alkaline phosphatase, in a total 
volume of 100 pi at 37 °C for 30 min. Vector preparation was 
purified by phenol/chloroform:iso-amyl alcohol (24:1) extraction, and 
precipitated with 1/10th volume 7.5 M NH4OAc and 2 volumes
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absolute ethanol, then rinsed once with 80 % ethanol and once with 
95 % ethanol. Vector samples were air-dried and resuspended in 100 
M-l ofT10E,.
2.18.3 Ligation of PCR insert and vector DNA
Both sticky-end and blunt-end ligation reactions were carried out 
using a molar ratio of 3:1 of PCR insert to vector. This ratio was 
determined by visualisation of electrophoresed vector and insert PCR 
DNA. Each ligation reaction contained PCR insert, vector DNA,
1 x BRL ligation buffer (50 mM Tris/HCl (pH 7.6), 10 mM MgCl2, 5 % 
polyethylene glycol (PEG6000), 1 mM ATP, 1 mM DTT), and 1 unit of 
T4 DNA ligase in a total volume of 10 pi. Sticky-end cloning reactions 
were incubated at 15 °C overnight, whereas blunt-end cloning 
reactions were left at room temperature overnight.
2.18.4 Preparation of competent E.Coli cells
Strain TG-1 E.Coli competent cells were prepared on the same day as 
transformation by diluting (1 in 100) an overnight culture of cells in 
20 mis of 2YT media (1.6 % bacto tryptone, 1 % yeast extract,
0.5 % NaCl), followed by incubation with shaking at 37 °C for 2 hours. 
Once the cells had reached exponential growth phase, they were 
harvested by centrifugation at 2000 rpm, for 7 min at 4 °C. The 
supernatant was removed, and the cells were gently resuspended in 
10 ml of cold 50 mM CaCl2, and left on ice for 30 min. Cells were 
harvested again by centrifugation at 2000 rpm for 7 min, at 4 °C, and 
then gently resuspended in 2 ml of 50 mM CaCl0, and incubated on 
ice for 30 min prior to transformation.
2.18.5 Transformation of competent cells
To transform the competent cells 10 pi of the ligation mixture was 
incubated on ice for 45 min with 200 pi of competent cells, and then 
heat-shocked for 3 min at 42 °C, and left on ice for 10 min. 
Transformed cells were combined with 200 pi of exponentially grown 
TG-1 cells, 10 pi of 100 mM IPTG, 35 pi of 20 pg/ml X-gal, and 3 ml
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of 48 °C H-Top agar (1 % bacto tryptone, 0.5 % yeast extract, 0.8 % 
NaCl, 0.8 % bacto agar), and then spread onto H-plates (1 % bacto 
tryptone, 0.8 % NaCl, 1.2 % bacto agar). After the H-top mixture had 
set, plates were inverted and incubated overnight at 
37 °C.
2.18.6 Selection of recombinant plaques
Cells containing M13 recombinants appeared as colourless plaques 
whereas cells infected with M13 vector appeared as blue plaques. For 
PCR DNA inserts representing a gene in heterozygous form, a 
minimum of 8 plaques were recovered from transformation, whereas 
for those representing a gene in the homozygous form, a minimum of 
4 plaques were chosen. Plaques were extracted using sterile glass 
pipettes, resuspended in 2 ml of 2 x YT media, with 10 pi of 
exponentially grown TG-1 cells, and incubated overnight at 37 °C 
with shaking. Supernatant containing M l3 recombinants were 
harvested by taking 1 ml of culture and centrifuging for 10 min, and 
then stored at 4 °C.
2.18.7 Direct Gel Electrophoresis (DIGE), and hybridisation selection 
of recombinant clones
To determine whether the selected M l3 recombinants contained a 
C4 insert, 20 pi of phage M13 supernatant was combined with 5 pi 
of DIGE dye (3 % SDS and 0.25 % bromophenol blue in 30 % glycerol), 
heated to 65 °C for 10 min, placed on ice for 10 min, and then 
separated by gel electrophoresis on a 0.7 % agarose gel (Type II, 
Sigma) as described in section 2.9, for 4 hours at 60 volts. Samples 
containing an insert could be identified by differential size to a 
control M l3 sample with no insert (blue plaque). Gels were blotted 
by capillary transfer as described in section 2.11, probed with nick- 
translated C4 pAT-A (section 2.12.1), and hybridised as in section 
2.12.2 to confirm that samples contained a C4 specific insert.
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2.19 Automated DNA sequencing of recombinant clones
2.19.1 Preparation of single stranded DNA template
Single stranded DNA (ssDNA) was prepared from positive 
recombinant clones by combining 1 ml of M13 supernatant with 
250 pi of PEG (20 % PEG600q, 2.5 M NaCl), and incubated at room 
temperature for 30 min. To collect the PEG precipitate containing 
ssDNA, samples were centrifuged for 10 min, the supernatant was 
discarded, and the precipitate was resuspended in 100 pi T10Ej. 
ssDNA was purified with a phenol/chloroform:iso-amyl alcohol (24:1) 
extraction, followed by ethanol precipitation with 7.5 M NH4OAc. 
Precipitates were washed with 80 % cold ethanol, air-dried, and 
resuspended in 20 pi of distilled water.
2.19.2 Estimation of concentration of ssDNA template
The concentration of ssDNA was determined by a DNA fluorometer 
(Hoefer Scientific Instruments, TKO 100, U.S.A), and a fluorescent dye 
called 'Hoechst dye' (0.1 pg/ml) which was provided by Hoefer 
Scientific Instruments. A 100 ng/pl ssDNA standard 'mp8', was used 
to compare with prepared ssDNA template. Readings ranged from 
70 ng/pl to 200 ng/pl.
2.19.3 Single cycle sequencing
Single cycle sequencing was performed using an automated 
sequencing kit from ABI (Applied Biosystems) which contained 
dATP, dCTP, dGTP, dTTP, M13 dye primers for each nucleotide 
sequencing reaction, and Taq DNA polymerase (0.25 units). A total of 
1600 ng ssDNA template was required for sequencing of cloned 
material. Template and reagents were divided into four reaction 
mixes containing 200 ng of ssDNA template, 1.8 pi of 5 x sequencing 
buffer (50 mM Tris/HCl {pH 8.4}, 50 mM MgCl0, 250 mM NaCl), and 
0.4 pmoles of dye primer ('Joe' for 'A' mix and 'Fam' for 'C  mix), in 
the 'A' and 'C  reaction mixes in a total volume of 6 pi, and double 
these amounts for all reagents in the respective 'G' and 'T' reaction
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mixes (using Tamra' for 'G' and 'Rox' for T' reaction mixes), for a 
total volume of 12 fil. Dye primers annealed to template by heating 
each reaction mix to 65 °C for 10 min, and cooling to room 
temperature for 20 min. Prior to primer extension 1 pi of the 
respective dNTP for ’A’ and 'C  reactions, and Taq polymerase diluted 
to 0.5 units in 50 mM KC1, 10 mM Tris (pH 8.3), 1.5 mM MgCl2, and 
0.01 % gelatin (w/v), were added to each reaction. Quantities were 
doubled for 'G' and T ’ reactions. Extension of primers with Taq 
polymerase was performed by incubating samples at 70 °C for 
10 min, followed by 37 °C for 10 min. Interpretation of the first 50 
to 100 base pairs is often difficult due to 5’ to 3' exonuclease activity 
of DNA Taq polymerase. To rectify this problem a second reaction 
was performed known as 'Klenow Chase'. The Klenow enzyme (large 
fragment of E.coli DNA polymerase I), was diluted to 0.7 units/pl in 
1 x sequencing buffer prior to use. For 'A' and 'C' sequencing 
reactions 0.7 units of enzyme were used, whereas 1.4 units were 
used in the 'G' and T ' reactions. Samples were incubated at 37 °C for 
5 min, and then immediately placed on ice. Contents of ’A’, ’C , ’G’, and 
T ’ reactions for each sample were precipitated together by adding 
sequentially to 130 pi of 95 % ethanol and 5 pi of 3 M NaOAc (pH5.2), 
followed by incubation on ice for at least 10 min. Precipitates were 
collected by centrifugation for 30 min, and rinsed with 100 pi of 70 % 
ethanol, followed by a second centrifugation for 5 min. DNA pellets 
were air-dried for 7 min, and stored at -20 °C in the dark until 
electrophoresis. Samples were electrophoresed by the Biomolecular 
Resources Facility at JCSMR, Canberra, using an ABI (Applied 
Biosystems) version 1.30 software package to perform automatic 
fluorescence analysis and base calling.
2.20 Computer analysis of derived C4 protein sequences to estimate 
their isoelectric point, denoted as ’PI’ (Predicted Isoelectric Point)
A Sequence Analysis Software package, version 7.2, called ’isoelectric’ 
was provided by the Genetics Computer Group, Madison, Wisconsin, 
USA. This programme was used to estimate the PI of a given protein 
sequence by calculating the sum of the number of positively charged 
residues (protonated lysine, arginine, histidine), minus the number of 
negatively charged residues (deprotonated tyrosine, cysteine,
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glutamate, aspartate), plus the number of protonated amino termini, 
minus the number of deprotonated carboxyl termini.
For each amino acid residue of interest, the protein analysis 
programme calculated the number of protonated residues by the
following equation: Np = Nt[H+] / ([H+] + Kjq), where Np = number of 
protonated residues, Nt = total number of residues of a specific amino
acid, [H+] = hydrogen ion concentration, and Kjq = dissociation 
constant for the amino acid of interest that is equal to the following: 
10~Pk N
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Chapter 3
Investigation of complement C4 alleles in Aboriginal 
Australian and Papua New Guinea (PNG) populations
3.1 Introduct ion
Aboriginal Australians have been isolated from other indigenous 
people since the post-Pleistocene elevation in sea level which 
separated Australia from New Guinea. Since this time these 
populations have genetically differentiated as a result of random 
genetic drift, differential selection, new mutations, and the 
introduction of different genes as a result of occasional contact with 
other ethnic populations (Kirk, 1972).
Investigation into the origin of Aboriginal Australians has included 
populations from the Cape York Peninsula (north-eastern Australia), 
because of their geographical proximity to other indigenous people, 
such as those from PNG. These populations are thought to be more 
likely to show evidence of gene flow into Australia compared with 
centrally and southern located populations. Linguistic (Simmons et 
al., 1958), skeletal (Macintosh and Larnach, 1972), and serum 
protein studies (Kirk, 1972), provide evidence which suggests that 
Aboriginal Australians from the Cape York region are similar to 
Melanesian and PNG populations. Comparative studies of the genetic 
make-up of each ethnic group would provide further evidence for 
any relationship.
Comparison of the C2 and Bf loci in Aboriginal Australian and PNG 
highlander populations found each population to be monomorphic, 
encoding C2 1 and Bf S (Ranford, 1989). These studies and those by 
Kirk (1972), suggest that Aboriginal Australians and PNG populations 
(especially highland populations) may have a common genetic origin. 
This observation has prompted population genetic analysis of 
polymorphic gene regions between indigenous people of these 
countries. Hence the polymorphic C4 gene region was considered to 
be an ideal gene region for this analysis.
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There is a lack of information on C4 allotyping in the Southwest 
Pacific. Only two other studies have investigated the distribution of 
C4 alleles in this region, one, involving Aboriginal Australian 
populations from central and northern Australia (Ranford et al., 
1987), and the other, involving isolated populations of PNG (Bhatia 
et al., 1991). C4 proteins are extremely labile, and therefore 
deteriorate rapidly unless stored below -70 °C soon after collection. 
Suitable storage facilities are difficult to obtain in remote areas of 
PNG and Australia, accounting for the lack of C4 allotyping data in 
these regions.
C4 allotype analysis of two populations of Aboriginal Australians by 
Ranford (1989), found them to be different from both Asians and 
Pacific Islanders, as well as from each other. Ranford et al. (1987), 
found the highest frequency ever reported of C4 null alleles in a 
northern Aboriginal Australian population at both the C4A and C4B  
loci (29 % and 26 %, respectively). Also, each Aboriginal Australian 
population had two more frequently occuring C4A alleles, 'A 3' and 
'A 4', whereas other populations of the Southwest Pacific usually 
had one frequently occuring C4A allele (summarised by Ranford, 
1989). At the C4B gene locus of Aborigines, 'B F  and 'B 2' were 
found to be the most frequently occuring alleles, whereas 'B F was 
usually the more frequently occuring C4B allele in other Southwest 
Pacific populations (Ranford, 1989).
Concurrent with studies in this thesis, Bhatia et al. (1991) conducted 
complement MHC class III studies on PNG highland and lowland 
populations, and detected genetic variation at the Bf, C4A, and C4B 
gene loci. There was significant allelic diversity associated with all 
three loci in the lowland population, but significant allelic diversity 
occurred only at the C4B locus in the highland population. The 
estimated percentage of C4 null alleles at both C4A and C4B gene 
loci (9.0 % and 7.4 %, respectively), was high, but not as high as that 
found in the northern Aboriginal Australian population by Ranford 
et al. (1987). In addition, a low frequency of Bf F was detected in 
the highland region of PNG, Bf S being the most frequently occuring
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allele (Ranford, 1989; Bhatia et al., 1991), whereas Bf F was the 
most frequently occuring allele in the lowland region (Bhatia et al., 
1991).
3.2 Aim
The main aims of this study were: (1) To investigate genetic 
similarities and differences between northern Aboriginal Australians 
and populations from coastal, highland and inland regions of PNG; (2) 
To identify individuals with null or rare C4A and C4B alleles for 
subsequent analysis at the molecular level, and to identify C4 
allotypes for subsequent correlation with C4 alleles identified by 
DNA analysis for the purpose of developing a method for molecular 
typing of C4. In addition, this study enabled a comparison of C 4 
null allotypes of other northern located Aboriginal Australians with 
the high frequencies found in this region by Ranford et al. (1987).
3.3 Materials and Methods
3.3.1 Aboriginal Australian and PNG population donors
Peripheral blood specimens were obtained from 101 Aboriginal 
Australian donors in two Cape York communities, namely East Cape 
York (ECY) and West Cape York (WCY). Immediately after collection, 
samples were placed on dry ice, then stored at -70°C. PNG blood 
specimens were collected from 49 mothers attending the Goroka Base 
Hospital for routine antenatal check-ups in the highland (H) region of 
PNG. Further PNG specimens were taken from 51 donors participating 
in a population genetics survey of the Wosera inland (I) sub-district, 
and from 120 donors of the coastal (C) region of Koki, Port Morseby. 
All PNG plasma samples were separated from buffy coats within one 
to two hours of collection, treated with 0.2 M EDTA to prevent 
protein deterioration, and snap frozen in liquid nitrogen. Samples 
were transported on dry ice to the John Curtin School of Medical 
Research (JCSMR), Canberra for C4 protein analysis.
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3.3.2 C4 protein allotyping
C4 allotyping was performed by protein gel electrophoresis and 
immunofixation, following the method described by Awdeh and 
Alper (1980), and as described in Chapter 2, section 2.5. C4 
allotyping results in the separation of C4 proteins according to their 
size and overall net charge. Unusual C4 allotypes and C4 null alleles 
were confirmed by treatment with Carboxypeptidase B prior to 
electrophoresis, as outlined in section 2.5.5. Homozygous null alleles 
were identified by the absence of C4 protein at either the anodal or 
cathodal region of the gel. Resulting C4 allotypes were analysed 
independently by at least one other person. To ensure typing results 
were reproducible all donors were C4 allotyped at least two times.
3.3.3 Estimation of C4 allelic frequencies
Maximum likelihood estimates of C4 gene frequencies were 
calculated from allotype distributions using an iterative computer 
programme to determine the best fit to Hardy-Weinberg equilibrium. 
This computer analysis was necessary to estimate the population 
frequency of double heterozygous null alleles which cannot be 
detected by protein gel electrophoresis. C4 allotypes which have one 
C4A or C4B null allele, such as C4A 3,Q0 B 2, can be recognised by 
a less intense banding pattern for the 'A 3' protein in comparison to 
the 'B 2' protein. The banding pattern for the 'B 2' alleles, in this 
allotype would be twice as dense as that of the A 3,Q0 alleles. A 
double heterozygous C4 null allotype, such as A 3,Q0 B 2,Q0, would 
have C4A and C4B protein bands of equal intensity. Due to the 
variability in the normal level of circulating C4 protein in a 
population, it is virtually impossible to identify double heterozygous 
C4 null alleles in any particular allotype, and therefore these must 
be estimated by statistical analysis.
3.3.4 Statistical analysis
Chi-square (X 2) was used to test the significant difference between 
observed and expected numbers of C4 alleles for each population 
and for comparing the estimated C4 gene frequencies. Differences in
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the distribution of C4A and C4B allotypes between each population 
were tested by chi-square with continuity correction. If a allotype 
frequency was below five within the cell of a 2 x 2 contingency table, 
the exact probability was calculated (Armitage, 1971). To establish if 
linkage disequilibrium existed between the most frequently occuring 
C4 haplotypes in each population, frequencies of these haplotypes 
were calculated according to Mittal et al. (1973). The non-random 
association of C4A and C4B alleles was measured by the 
disequilibrium statistic delta (Mittal et al., 1973). The significance of 
linkage disequilibrium was tested by chi-square. A kinship 
coefficient equation (Cavalli-Sforza and Bodmer, 1971a), was used to 
estimate the genetic distance between each population based on C4A  
and C4B gene frequencies.
3.4 Results
3.4.1 C4 allotypes identified by protein gel electrophoresis and 
im m unofixation
Figure 3.1, shows various C4A and C4B allotypes in East and West 
Cape York Aboriginal populations, and Figures 3.2 and 3.3, show C4 
allotypes from each PNG population. C4 allotypes represented by 
three protein bands (as in Figure 3.1 'C'), had been desialysed with 
neuraminidase prior to electrophoresis, and those represented by one 
protein band (as in Figure 3.1 'D'), had been treated with 
Carboxypeptidase B and neuraminidase. Carboxypeptidase B was 
used on serum samples suspected to be degraded, and was used to 
distinguish C4 allotypes of individuals who had overlapping C4 
protein bands.
3.4.2 C4 allelic polymorphism
Four to six different C4A alleles were detected in both Aboriginal 
Australian (Table 3.1) and PNG populations (Table 3.2), except for the 
relatively monomorphic inland population of PNG where only two 
types of C4A alleles were detected. Of the PNG populations, the 
inland population was least polymorphic followed by the highland
Figure 3.1 C4 allotypes in East and West Cape York Aboriginal 
Australian populations. Schematic diagram showing the relative 
migration distances of C4 allotypes (VI complement genetics 
workshop reference typing), is reproduced with permission from 
WHO Bulletin JO: 531-535, (1992). Proteins represented by three 
bands, for example in 'C, were treated with neuraminidase prior to 
electrophoresis, and those represented by one band such as in 'D', 
were treated with neuraminidase and Carboxypeptidase B
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Figure 3.2 C4A allotypes in coastal, inland and highland regions of 
PNG. Schematic diagram showing the relative migration distances of 
C4 allotypes (VI complement genetics workshop reference typing), 
is reproduced with permission from WHO Bulletin,!0: 531-535, 
(1992). Proteins in 'A', 'B', 'C and 'D' were treated with 
neuraminidase and Carboxypeptidase B, whereas those in 'E' were 
treated with neuraminidase prior to eletrophoresis
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Figure 3.3 C4B allotypes in coastal, inland and highland regions of 
PNG. Schematic diagram showing the relative migration distances of 
C4 allotypes (VI complement genetics workshop reference typing), 
is reproduced with permission from WHO Bulletin JO: 531-535, 
(1992). Proteins in ’A', 'B' (third lane), 'C and 'E' (first lane) were 
treated with neuraminidase, whereas those in 'B’ (first two lanes), 'D', 
and 'E' (second lane) were treated with neuraminidase and 
Carboxypeptidase B prior to eletrophoresis
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Table 3.1 Observed and expected numbers of C4A allotypes 
in East and West Cape York Aboriginal Australians
ECY WCY
A llotype Observed 
n F
Expected
n
Observed 
n F
Expected
n
A 2,2/2,Q0 1 1.3 1.91 0 0.0 0.52
A 2,3 1 1.3 1.94 1 3.9 0.53
A 2,4 7 9.3 4.33 1 3.9 0.86
A 2,6 0 0.0 0.42 0 0.0 0.04
A 2,X 0 0.0 0.06 0 0.0 0.00
A 3,3/3,Q0 15 20.0 9.58 8 30.8 5.17
A 3,4 *6 8.0 15.83 * 1 3.9 5.98
A 3,6 #5 6.7 1.53 1 3.9 0.27
A 3,X 0 0.0 0.22 0 0.0 0.00
A 4,4/4, Q0 36 48.0 31.04 14 53.9 10.39
A 4,6 2 2.7 3.41 0 0.0 0.45
A 4,X 1 1.3 0.48 0 0.0 0.00
A 6,6/6, Q0 0 0.0 1.46 0 0.0 0.26
A 6,X 0 0.0 0.05 0 0.0 0.00
A X,XJX, Q0 0 0.0 0.19 0 0.0 0.00
A Q0,Q0 1 1.3 2.55 0 0.0 1.54
Total #75 100.0 75.00 26 100.0 26.00
* = 0.01 < p < 0.05; # = p < 0.01; 'if = number; 'F'= frequency of observed 
numbers shown as a percentagefX' refers to a novel C4A  allele which 
migrates between an A 2 and an A 7 allele by protein gel 
e le c t ro p h o re s is
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Table 3.2 Observed and expected numbers of C4A a l le les
in three PNG populations
H igh land I n l a n d Coastal
Allotype Observed Expected Observed Expected Observed Expected
n F  n n F n n F n
A 2 ,2 /2 , QO 0 0 0.00 0
A 2 ,3 1 2.0 0.98 1 2.0 0.99 0
A 2 ,5 0 0.01 0 0
A  2 ,6 ,6 0 0.01 0 0
A 3 ,3 /3 ,Q 0 46 93.9 46.02 50 98.0 50.01 99 82.5 99.62
A 3 ,4 0 0 8 6.7 7.05
A 3 ,5 1 2.0 0.99 0 9 7.5 7.94
A 3,51 0 0 1 0.8 0.91
A 3 ,6 0 0 2 1.7 2.80
A 3 ,6 ,6 1 2.0 0.98 0 0
A  4 ,4 /4 , QO 0 0 0 0.37
A 4 ,5 0 0 0 0.30
A 4 ,51 0 0 0 0.03
A  4 ,6 0 0 0 0.1 1
A 5 ,5 /5 ,Q 0 0 0 0 0.44
A 5 ,51 0 0 0 0.04
A  5 ,6 0 0 0 0.12
A  5 ,6 ,6 0 0.01 0 0
A  5 1 ,5 1 /5 1 ,QO 0 0 0 0.03
A 5 1 ,6 0 0 0 0.01
A 6 ,6 /6 , QO 0 0 # 1 0.8 0.12
A 6 ,6 ,6 ,6 0 0 0
A QO, QO 0 0 0.00 0 0.11
Total 49 100.0 49.00 51 100.0 51.00 120 100.0 120.00
# = p < 0.01; 'n' = number; 'F' = frequency of observed numbers shown as
p e r c e n t a g e
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then coastal populations. Both East and West Cape York Aboriginal 
populations were found to be equally polymorphic at the C4A gene 
locus. The C4B gene locus was equally polymorphic, where four to 
five different alleles were detected in the East and West Cape York 
Aboriginal populations (Table 3.3) and each of the three PNG 
populations (Table 3.4).
3.4.3 Testing the goodness of fit of the C4 allele frequencies to the 
Hardy-Weinberg Equilibrium
Numbers of observed and expected C4 allotypes and frequencies of 
observed C4 allotypes of each population studied are shown in 
Tables 3.1-3.4. Chi-square statistical analysis of the C4A and C4B 
allele frequencies did not detect a significant difference between the 
number of observed and expected C4A and C4B alleles for each 
population, except for the C4A alleles of East Cape York Aborigines.
In this population, the total chi-square value for the observed allele 
frequencies was significantly different to that of the expected allele 
frequencies (p < 0.01). This discrepancy resulted from a lack of C4A
3.4 heterozygotes (0.01< p < 0.05), and an abundance of C4A 3,6 
heterozygotes (p < 0.01). Similarily, a lack of C4A 3,4 heterozygotes 
were detected in the West Cape York population (0.01 < p < 0.05) 
when this particular allotype was tested. However, a significant 
difference was not detected when the total chi-square value of all 
observed C4A allotype frequencies in the West Cape York population 
were tested. The only other population where C4A 3,4 heterozygotes 
were detected was the coastal PNG population. In this population a 
significant difference between observed and expected allotype 
frequencies was not evident when testing for Hardy-Weinberg 
equilibrium .
3.4.4 C4 gene frequency analysis
From the observed C4A and C4B allele frequencies of each 
population, the iterative computer programme estimated gene 
frequencies expressed as percentage for each C4 allele. C4A and 
C4B gene frequencies for the two Aboriginal Australian and three 
PNG populations are shown in Tables 3.5 and 3.6, respectively.
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Table 3.3 Observed and expected numbers of C4B alleles 
in East and West Cape York Aboriginal Australians
ECY WCY
Allotype Observed 
n F
Expected
n
Observed 
n F
Expected
n
B 1 ,1 /1 ,Q 0 19 25.3 22.25 5 19.2 4.09
B 1,12 1 1.3 0.44 1 3.9 0.53
B 1,2 32 42.7 26.50 5 19.2 6.69
B 1,4 0 0.0 0.82 0 0.0 0.00
B 1 2 ,1 2 /1 2 ,Q0 0 0.0 0.15 1 3.9 0.46
B 12,2 0 0.0 0.43 0 0.0 1.12
B 12,4 0 0.0 0.01 0 0.0 0.00
B 2,2/2, Q0 18 24.0 21.85 14 53.9 12.15
B 2,4 2 2.7 0.81 0 0.0 0.00
B 4,4/4, Q0 0 0.0 0.28 0 0.0 0.00
B Q0,Q0 3 4.0 1.46 0 0.0 0.96
Total 75 100.0 75.00 26 100.0 26.00
'n' = number; 'F' = frequency of observed numbers shown 
as a percentage
Table 3.4 Observed and expected numbers of C4B alleles 
in three PNG populations
81
H igh land I n l a n d Coastal
Allotype Observed Expected
n F n
Observed Expected 
n F n
Observed Expected 
n F  n
B 1,1/1,Q0 30 61.2 28.92 42 82.4 41.31 101 84.1 100.12
B 1,2 12 24.5 14.14 7 13.7 6.67 1 0.8 0.74
B 1,4 0 0 1 0.8 2.19
B 1,5 0 0 0.94 7 5.8 7.08
B 1,6 0 0 0.94 0
B 1,95 1 2.0 0.67 0 0
B 1,96 0 1 2.0 0.94 0
B 2,2/2,Q0 6 12.2 4.42 0 0.07 0 0.24
B 2,4 0 0 0 0.01
B 2,5 0 0 0.07 0 0.04
B 2,6 0 0 0.07 0
B 2,95 0 0.21 0 0
B 2,96 0 0 0
B 4,4/4, Q0 0 0 1 0.8 0.72
B 4,5 0 0 1 0.8 0.13
B 5,5/5,Q0 0 0 2 1.7 2.46
B 5,6 0 # 1 2.0 0.01 0
B 5,96 0 0 0.01 0
B 6,6/6, QO 0 0 0.01 0
B 6,96 0 0 0.01 0
B 95,95/95, QO 0 0.11 0 0
B 96,96/96, QO 0 0 0.01 0
BQ0,Q0 0 0.52 0 0.06 6 5.0 6.19
Total 49 100.0 49.00 #5 1 100.0 51.00 120 100.0 120.00
# = p < 0.01; 'n' = number; 'F' = frequency of observed numbers shown 
as a percentage
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Results from this analysis are reported below.
3.4.4.1 C4A gene frequency analysis
Analysis of the C4A gene frequencies in East and West Cape York 
Aboriginal Australian populations found three most frequently 
occuring alleles, A 3\ 'A 4' and A Q0\ at the C4A gene locus, 
where A 4 had the highest frequency in each population. Ranford 
et al. (1987), also found that in studies of central and northern 
Aboriginal Australian populations the C4A gene locus had the same 
most frequently occuring alleles. A 3' and A 4' allele frequencies 
(42.8 % and 39.9 %, respectively) were not significantly different in 
the central population, however, the A 3' allele frequency was 
significantly higher than A 4 ’ (47.2 % and 22.0 %) in the northern 
population. The A 3' allele frequency between central and northern 
Aboriginal Australian populations was not significantly different, 
however, a significant difference between the A 4' allele frequency 
in these two populations was detected. The frequency of C4A Q0 
alleles in West Cape York Aboriginals was high (24.3 %), which was 
similar and not significantly different to that of the northern 
Aboriginal Australian population (28.8 %) studied by Ranford et al. 
(1987). East Cape York has a lower frequency of C4A Q0 alleles (18.4 
%), which is not significantly different to the central Aboriginal 
Australians (12.3 %), reported by Ranford et al. (1987), and to the 
Caucasian population (16.8 %), reported by Ranford et al. (1986).
As distinct from the Aboriginal Australians, the C4A gene locus of 
each PNG population was dominated by one allele, A 3'. All other 
C4A alleles had relatively low frequencies. The highest frequencies 
of the A 3' allele were detected in the inland and highland PNG 
populations (99.5 % and 97.4 %, respectively), whilst the coastal 
population was more heterogeneous resulting in a slightly lower and 
significantly different A 3' frequency (88.2 %). Bhatia et al. (1991), 
found the A 3' allele to be the most frequently occuring C4A allele 
in a study of PNG populations. Bhatia et al. (1991) reported the 
highland population to have a significantly higher A 3' frequency of 
88.4 %, compared to the lowland population with a frequency of 72.2 
%. The highest A 3' allele frequency was found in the inland PNG
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population, in this study, which is significantly different to that of the 
highland PNG population reported by Bhatia. The lowest 'A 3' allele 
frequency, found in the coastal PNG population is significantly 
different to that reported for the lowland PNG population by Bhatia.
A significant difference was found here between the frequency of 
C4A QO alleles in PNG populations compared to the Aboriginal 
Australian populations. C4A QO alleles were absent in both highland 
and inland populations of PNG, and occurred with a very low 
frequency (3.0 %), in the coastal population. By comparison, Bhatia 
et al. (1991), found a slightly higher frequency of C4A QO in PNG,
10.8 % in the lowland population (not significantly different to the 
Aboriginal Australians of Cape York) and 7.4 % in the highland 
population (significantly different to the Aboriginal Australians of 
Cape York).
Besides the most frequently occuring C4A alleles, rare C4A alleles 
were also detected in each population, and many were unique to 
either Aboriginal Australian or PNG populations. Rare C4A alleles 
which were detected in both Aboriginal Australian and PNG 
populations included 'A 2 ’, and 'A 6'. Those which appeared to be 
unique to a particular population included; A 5', detected only in 
the highland and coastal PNG populations; A 51', found in the 
coastal PNG population; A 6', in Aboriginal Australian and PNG 
coastal populations; a duplicated A 6,6' allele (as determined by 
different protein band intensities), found only in the PNG highland 
population, and A X' (an allele which has not previously been 
reported), was found in the East Cape York Aboriginal population.
The A X' allele migrated between A 2' and A 1' alleles by protein 
gel electrophoresis. A similar array of rare C4A alleles was detected 
in the Aboriginal populations studied by Ranford et al. (1987). 
However, Ranford et al. (1987) found another C4A allele, A 12', in 
the central Australian population which was not detected here. 
Bhatia et al. (1991), found A 12' and A 55' alleles in a lowland 
population of PNG which were absent in PNG populations studied 
here.
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3.4.4.2 C4B gene frequency analysis
Estimated C4B gene frequencies of ECY and WCY Aboriginal 
Australian populations and of the PNG populations are listed in 
Table 3.6. Results show that, similar to the C4A gene locus of East 
and West Cape York Aborigines, a number of more frequently 
occuring types of C4B alleles were found at the C4B gene locus.
Alleles B  1' and B 2 ’ occurred with the highest frequencies, 
followed by the 'B QO' allele which had a slightly lower frequency. 
Both B 1' and 'B 2' alleles occurred with similar and not 
significantly different frequencies in the East Cape York population 
(42.3 % and 41.8 %, respectively), whereas the 'B 2' allele occurred 
with a higher and significantly different frequency than the B  1 ' 
allele (51.8 % and 24.8 %, respectively) in the West Cape York 
population. Similarly, Ranford et al. (1987), found that the central 
and northern Aboriginal populations had high frequencies of the 
'B l ' , 'B  2' and 'B QO' alleles, the most frequently occuring being 'B 
1' and B  2'. Ranford et al. (1987), found that frequencies of these 
alleles varied between populations. The B 2' allele of the central 
Aboriginal Australian population, like that of the West Cape York 
population, had the highest frequency, however was not significantly 
different to the B 1' allele which was the most frequently occuring 
C4 allele in the northern Aboriginal Australian population.
Frequencies of C4B QO alleles (14.0 % to 19.2 %), found here, were 
similar and not significantly different to those found by Ranford et 
al. (1986), in Caucasians (20.0 %), and central Aboriginal Australian 
(18.0 %), and northern Aboriginal Australian populations (25.7 %) 
reported by Ranford et al. (1987).
In the PNG populations, C4B gene frequencies were similar to those 
of the C4A gene, having one frequently occuring C4B allele, namely 
B 1' (Table 3.6). The highest frequency of B  1' was detected in the 
inland PNG population (93.6 %), whereas both highland and coastal 
populations had similar, although slightly lower B  1' allele 
frequencies (67.2 % and 71.4 %, respectively). The B  2' allele was 
the second most frequently occuring C4B allele in the highland 
population (21.5 %), but low frequencies of the B  2' allele occurred
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in both inland and coastal populations (7.0 % and 0.4 %, respectively). 
Bhatia et al. (1991), found the 'B 1 ' and 'B 2' alleles were the most 
frequently occuring C4B alleles in each PNG population, where the 
'B 1' allele occurred with the highest frequencies of 65.4 % and 71.4 
% in the highland and lowland populations, respectively. The 'B V 
allele frequencies, reported by Bhatia et al. (1991), are not 
significantly different to each other or to those found for the 
highland and coastal PNG populations in this study, but are 
significantly different to the inland PNG population in this study. The 
'B 2' allele frequencies in both highland and lowland populations 
(24.5 % and 15.0 %, respectively) reported by Bhatia et al. (1991), 
are similar and not significantly different to the frequency of the 'B 
2' allele found here for the highland population (21.5 %), but are 
significantly different to the inland and coastal PNG populations. C4B 
Q0 alleles in this study were found in both highland and coastal 
populations (10.3 % and 22.7 %, respectively), but not in inland PNG 
populations. Frequency of C4B Q0 alleles in the coastal PNG 
population found here is similar and not significantly different to 
that reported in the northern Aboriginal Australians (25.7 %) by 
Ranford et al. (1987). Bhatia et al. (1991), detected a higher and 
significantly different frequency of C4B Q0 alleles in the lowland 
region of PNG compared to the PNG highland region (11.4 % and 3.6 
%, respectively). These frequencies are not significantly different to 
those detected in the highland PNG region, however, they are 
significantly different to those detected in the coastal PNG region in 
this study.
Rare allele variants were also detected at the C4B gene locus, many 
of which were only detected in one or two of the populations studied. 
The rare C4B allele 'B 12', occurred at a low frequency in both the 
ECY and WCY Aboriginal Australian populations of this study (0.7 % 
and 4.1 %, respectively), but was absent in the PNG populations. This 
allele was also detected with low frequencies in both central and 
northern Aboriginal Australian populations by Ranford et al. (1987). 
The 'B 12' allele frequency was not significantly different between 
each of these populations. Another C4B allele, 'B 4', was found 
without a significant difference of frequency in the East Cape York 
Aborigines and coastal population of PNG in this study. Ranford et al.
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(1987) also detected this allele, without a significant difference in 
frequency, in central Aboriginal Australians, as well as the 'B 3' 
allele in the northern Aboriginal population. The 'B 3' allele was not 
found in either of the Cape York Aboriginal populations in this study. 
Of other rare C4B alleles, recorded in this study, 'B 5', was only 
detected in the inland and coastal regions of PNG, 'B 6', was unique 
to the inland PNG population, 'B 95', was detected only in the 
highland PNG population, and 'B 96', was recorded in the inland PNG 
population. This study did not find the 'B 3' allele in both highland 
and lowland PNG populations as reported by Bhatia el al. (1991).
3.4.4.3 Significant differences in C4 gene frequencies between 
different Aboriginal Australian and PNG populations
C4 gene frequencies were compared between different Aboriginal 
Australian and PNG populations using chi-square to indicate 
populations' degree of similarity at both the C4A and C4B loci. A 
summary of those C4 gene frequencies which were significantly 
different between populations is shown in Table 3.7.
The majority of significant differences recorded between populations 
were between the most frequently occuring C4 alleles. C4A and 
C4B gene frequencies were very similar for both Aboriginal 
populations with only the 'B J' gene frequency being found to be 
significantly different. There were no significant differences of C4A 
gene frequencies between the PNG highland and inland populations. 
However, the 'A 3' gene frequencies of the PNG highland and coastal 
populations were significantly different, as were the A 3' and 'A 5' 
gene frequencies of the inland and coastal populations. There were 
more C4B gene frequency differences (namely 'B 1\ B 2\ B 5\ and 
'B QO' alleles), between PNG populations than there were for the 
C4A gene.
Comparing gene frequencies of each of the Aboriginal Australian 
populations with each of the three PNG populations, found many 
significant differences for both the C4A and C4B gene loci. The 
Aboriginal East Cape York and PNG coastal populations were most 
dis-similar with respect to their C4 gene frequencies. By
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comparison, there was greater similarity between the Aboriginal East 
Cape York and PNG highland populations, and between the Aboriginal 
West Cape York and PNG highland populations.
3.4.5 Distribution of C4A and C4B allotypes within Aboriginal 
Australian populations
Comparisons of the C4 haplotype (including both C4A and C4B 
alleles), expressed as a percentage, in each population, (Table 3.8), 
found that for the West Cape York Aboriginal population, the most 
frequently occuring allotype was A 4 B 2' (42.3 %), followed by 
A 4 B 1,2' and A 3 B 1' with equal frequency, (11.5 %). The 
frequencies of these allotypes in the East Cape York population were 
slightly different, A  4 B 2' (21.3 %) and A 4 B 1,2' (20.0 %), 
followed by A 3 B 1' (13.3 %).
3.4.6 Distribution of C4A and C4B allotypes within three PNG 
populations
The distribution of C4A and C4B allotypes are shown as numbers in 
Table 3.9, and as percentage distribution in Table 3.10. Comparing all 
C4 allotypes found in all three populations A 3 B 1' was the most 
frequently occuring, with the highest frequency of 82.4 % occurring 
in the inland population, followed by 73.3 % in the coastal population, 
and 55.1 % in the highland population. Only one other allotype was 
found frequently occuring in the inland population, namely, A 3 B 
1,2', with a frequency of 13.7 %. C4 allotypes, 'A 3 B 1,2' and 'A 3 
B 2', were reasonably common in the highland population (24.5 % 
and 12.2 %, respectively), whereas, 'A 3,5 B 1', 'A 3,4 B 1,5', and 'A 
3 B Q0', were other frequently occurring allotypes in the coastal 
population (7.5 %, 5.8 %, and 5.0 %, respectively).
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3.4.7 Significant differences of C4 allotype frequencies between 
different Aboriginal Australian and PNG populations
The degree of similarity between different Aboriginal Australian and 
PNG populations with respect to their C4A and C4B allotype 
frequencies was determined using chi-square with continuity 
correction and Fishers exact test. A summary of C4 allotype 
frequencies which were significantly different between populations 
is shown in Table 3.11.
Comparing the two Aboriginal Australian populations, results show 
that all of the C4 allotype frequencies were not significantly 
different except for allotypes having 'B2\ Comparative analysis of 
the different C4 allotype frequencies in the PNG populations found 
that the inland and highland populations were most similar. There 
were, by contrast, several significant differences in C4 allotype 
frequencies between the highland and coastal populations. Most 
differences in C4 allotype frequencies were found to occur between 
Aboriginal and PNG populations. Of the two Aboriginal populations, 
the East Cape York population was most different to the PNG 
populations, especially the coastal population.
In summary, as was previously found with comparisons of gene 
frequencies (Table 3.7), frequencies of different C4 allotypes of 
different Aboriginal Australian populations were quite similar. PNG 
populations, on the other hand were distinctly different from one 
another, whilst the majority of significant differences in C4 allotype 
frequencies were detected between Aboriginal Australians and the 
populations from PNG.
3.4.8 C4A and C4B linkage disequilibrium relationships in 
Aboriginal Australian and PNG populations
Results of C4A and C4B linkage disequilibrium relationships are 
shown in Table 3.12. 'A 3' and 'B V alleles were found to be more 
strongly linked in PNG populations compared to the Aboriginal 
Australians. This was especially so for the coastal and inland PNG 
populations. Linkage disequilibrium of A 3’ and 'B 1' alleles was
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Table 3.11 Statistically significant differences of C4 allotype frequencies 
between different Aboriginal Australian and PNG populations
A llo type WCY/ECY H/I H/C I/C ECY/C ECY/I ECY/H WCY/C WCY/I WCY/H
A 2,4 B 1,2 0
A 3 B 1 0 X 0 0  0 O O O
A 3 B 1,2 0  0 X 0 X
A 3 B 2 X 0 X X
A 3,4 B 1,2 X
A 3,4 B 1,5
A 3,5 B 1 X
A 4 B 1,2 0 0  0 0
A 4 B 2 0 0  0 0 0 0
Total A 2,4 0
Total A 3 0 0 0  0 0 0 0
Total A 3,4
Total A 3,5 0
Total A 4 0 0  0 0 0 0
Total B 1 X 0 0 0  0 0 0 0
Total B 1,2 0  0 0 0 0
Total B 1,5
Total B 2 X 0 0 0 0 0 0
X - 0.01 < p < 0.05 0 - p < 0.01
'Total', refers to the total number of allotypes with a specific combination of C4A or C 4B
alleles. 'H' is highland PNG, T is inland PNG, and 'C' is coastal PNG.
'WCY' and 'ECY': West and East Cape York Aboriginal populations, respectively
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Table 3.12 C4A and C4B allele linkage disequilibrium 
relationships in Aboriginal Australian and PNG populations
A 3 B 1
C4 h a p l o t y p e
A 4 B 2
P o p u l a t i o n HF A X 2 HF A X2
ECY 0.066 0.052 0 0.109 0 .074 0
WCY 0.055 0.037 0.230 0 .127 0
Inland PNG 0.580 0.081 X
H ighland PNG 0.130 -0.154
Coastal PNG 0.442 0.092 0
x = 0.01 < p < 0.05: o = p < 0.01
'HF': Haplotype Frequency; A : delta; z2 : chi-sqaure 
Linkage analysis was only performed on A 3 B 1 allotypes in PNG 
populations as homozygous A 4 B 2 allotypes were not detected in 
PNG populations, respectively.
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found to be significant in the East Cape York Aboriginal population. 
Linkage disequilibrium of 'A 3' and 'B 1' was not detected in the 
highland PNG population nor in the West Cape York Aboriginal 
population. There was a greater degree of linkage disequilibrium of 
A  4' with 'B 2' alleles in each Aboriginal Australian population than 
there was between A 3' and B 1' alleles. Homozygous 
A 4 B 2' allotypes were not detected in the PNG populations.
3.4.9 Determination of the genetic distance between Aboriginal 
Australian and PNG populations
Calculating a kinship coefficient between populations (Cavalli-Sforza 
and Bodmer, 1971a), was used to determine the genetic distance 
between each population. This analysis brought together the C4A 
and C4B gene frequency data, and compared this information for 
each population. Kinship coefficients between populations and a 
summary of this analysis, represented by a dendrogram, is shown in 
Figure 3.4.
This analysis showed the Aboriginal Australian populations to be 
more closely related to each other than were the PNG populations.
The inland and highland PNG populations were more closely related 
than either was with the coastal population. In contrast to the gene 
frequency and allotype frequency analysis, these results showed the 
East Cape York Aboriginal population, rather than the West Cape York 
population, to be more closely related to the PNG populations. The 
analysis also showed that the coastal PNG population was most 
closely related to the Aboriginal Australians. However, both C4 gene 
frequency and C4 allotype frequency analyses found that most 
differences occurred between the East Cape York Aborigines and the 
coastal PNG population (Tables 3.7 and 3.11).
3.5 Discuss ion
The distribution of observed C4A alleles of East Cape York 
Aborigines, did not correspond to that expected when tested for 
Hardy-Weinberg equilibrium. A statistically significant difference
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Figure 3.4 Genetic distance dendrogram based on C4A and C4B 
gene frequencies
inland PNG 
highland PNG
coastal PNG
ECY Aborigines 
WCY Aborigines
P opu la tion Kinship coeffecient
ECY/WCY 0.0183
H /I 0.0359
H/C 0.0597
I/C 0.0696
ECY/H 0.1872
ECY/I 0.2366
ECY/C 0.1848
WCY/H 0.2360
WCY/I 0.3179
WCY/C 0.2255
H, I and C represent highland, 
inland and coastal PNG populations, 
re sp ec t iv e ly .
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was found between observed and expected frequencies of A 3,4' 
and 'A 3,6' heterozygous allotypes. This indicated that an abundance 
of homozygous A 3' alleles may be masking the presence of A 3,4' 
heterozygotes. Such a discrepancy may result from technical error, as 
it is difficult to distinguish A 3,4' heterozygotes from A 3,3' 
homozygotes due to close migration of A 3' and A 4' alleles by 
protein gel electrophoresis. The combination of A 3' and A 4' 
alleles often appears as a smeared banding pattern, even after 
treatment with Carboxypeptidase B. As a result of this discrepancy, 
many donors in this population were subjected to re-analysis by C 4 
allotyping and Carboxypeptidase B treatment. Another factor which 
may affect the Hardy-Weinberg equilibrium of alleles is if a 
population size is too small. However, the size of the East Cape York 
population was relatively large (75 donors), and therefore not likely 
to be the source of this discrepancy. In the case of the West Cape 
York Aboriginal population, the chi-square value for comparing total 
observed and expected numbers of C4A alleles was not significantly 
different when tested for Hardy-Weinberg equilibrium. However, 
analysis of the single C4A 3,4 allotype, did detect a significant 
difference between observed and expected numbers in this 
population. The coastal PNG population was the only other population 
to have A 4' alleles. In this population the expected and observed 
numbers of allotypes were not significantly different, including C4A 
3,4 heterozygotes. Misinterpretation of A 3,4' heterozygous 
alleles, by C4 protein gel electrophoresis in the coastal PNG 
population would be less evident compared to the two Aboriginal 
Australian populations, as the C4A gene locus is dominated by the 
A 3' allele, and the A 4' allele occurs with a much lower frequency. 
Whereas, misinterpretation of the A 3,4' heterozygote would be 
more evident in the Aboriginal Australian populations, where both 
A 3' and A 4' alleles have high frequencies.
Observed deviations from the Hardy-Weinberg equilibrium are rare. 
Cavalli-Sforza and Bodmer, (1971b), have suggested that 
heterozygous allele deficiency, in addition to technical error, may 
result from one or more of five events: (1) Heterogeneity of the 
population, which may consist of a number of independent sub-
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populations; (2) Inbreeding; (3) Selection against the heterozygotes;
(4) The presence of a 'silent' allele which masks heterozygotes, 
making them indistinguishable from a homozygous type; and (5) 
Positive assortive mating, where individuals of like genotype mate 
with each other. It has been suggested that for most of the rare cases 
in which the Hardy-Weinberg equilibrium does not fit the observed 
data, this may be a result of a recent change in the constitution of a 
population, for example, the admixture of two different populations. 
As each Aboriginal population studied here, and those studied by 
Ranford et al. (1987), have relatively high frequencies of 'A 3' and 
A 4' alleles, it is unlikely that each has undergone a recent change 
where two populations have come together creating an imbalance of 
C4 alleles.
Analysis of HLA-extended haplotypes including HLA-A, B, and DR  
alleles, of donors from the East Cape York Aboriginal population, 
found a number had foreign admixture of haplotypes more 
commonly found in Caucasians (Gao et al., 1992a and b). However, 
the distribution of C4A allele frequencies was not affected by the 
exclusion of these donors from the population. It is thus unlikely that 
allelic heterogeneity from different ethnic groups exists in the East 
Cape York population. The most probable explanation for the 
discrepancy between expected and observed allele numbers when 
testing for Hardy-Weinberg equilibrium, is the problem associated 
with resolving proteins with the same or similar net charge by 
protein gel electrophoresis and immunofixation. This problem 
suggests that the traditional method of protein gel electrophoresis is 
unreliable, and that a more accurate technique for C4 allotyping is 
required. The discrepancy between observed and expected numbers 
of 'A 3' and 'A 4' alleles in the East Cape York Aboriginal 
population, was another reason which prompted further molecular 
research.
Even though the observed number of C4A alleles from the East Cape 
York Aboriginal population did not match those expected when 
testing for Hardy-Weinberg equilibrium, the estimated C4A gene 
frequencies for this population were not significantly different to 
those of the West Cape York population. Also, as found here, Ranford
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et al. (1987), found high frequencies of both A 3' and 'A 4' alleles 
in two Aboriginal Australian populations. These C4A allele 
frequencies were consequently used for statistical analysis in studies 
for this thesis.
Ranford (1989), found populations from the western Pacific region 
could be grouped according to the distribution of C4A gene 
frequencies. The C4A gene locus was dominated by A 3' alleles, 
while A 4' and A Q0' alleles were the next most frequently 
occurring alleles. This distribution pattern is most prominent in the 
Micronesian and Melanesian populations where the most frequently 
occuring allele is nine times more frequent than the second most 
common allele (Ranford, 1989). In other western Pacific populations 
such as Japanese, Chinese, Korean, and Thai, the most frequent A 3' 
allele is usually three to four times more frequent than the A 4' and 
A Q0' alleles. Analysis of Aboriginal Australian and PNG populations 
here, also found that these populations, as for those described above, 
could be grouped according to the distribution of C4A gene 
frequencies.
The distribution of C4A alleles of different geographic PNG 
populations studied here and by Bhatia et al. (1991), were similar to 
that reported for Micronesian and Melanesian populations (Ranford, 
1989). The coastal PNG population was the most similar except for 
having a lower frequency of C4A Q0 alleles than found for 
Micronesians and Melanesians. In the highland and lowland PNG 
populations, virtually all of the C4A alleles were A 3', whilst other 
C4A alleles had low frequencies.
Studies of Aboriginal Australians here, and by Ranford et al. (1987), 
found them to be quite different from other surrounding indigenous 
populations of the Pacific Islands, in that their most frequently 
occuring C4A allele occurs at only twice the frequency of the next 
most frequently occuring C4A allele. Slight differences in the 
frequency of A 3' and A 4' alleles between different Aboriginal 
Australian populations were found here, and by Ranford et al.
(1987). These results show heterogeneity exists between different 
regionally located Aboriginal Australian populations. Thus, it may be
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possible to distinguish between different geographically located 
Aboriginal Australian populations based on the frequency of 'A 3' 
and 'A 4' alleles, and in turn, distinguish these from other western 
Pacific indigenous populations. The difference in distribution of the 
most frequently occuring C4A alleles in Aboriginal populations is not 
unexpected, considering that many tribes have been isolated from 
each other by land distances similar to those sea distances separating 
the remote islands of the Pacific.
This study and the analysis of other western Pacific populations 
(Ranford, 1989), show that the C4B gene locus is dominated by 'Bl',
'B 2\  and 'B Q01 alleles, the frequencies of which vary between 
populations. However, it was difficult to group populations according 
to the distribution of the most frequently occuring C4B alleles. This 
is because this locus is more heterogeneous (with respect to variation 
of frequencies of the frequently occuring C4B alleles), than the C4A 
gene locus. Thus, analysis of the distribution of C4A allele 
frequencies appears to be a more reliable marker for studies of 
population origin and movement.
The estimated frequencies of C4A and C4B null alleles in Aboriginal 
populations in this study are relatively high in comparison to other 
C4 alleles in these populations, and similar to C4 null allele 
frequencies reported for many other western Pacific populations. The 
frequency of C4A null alleles in the West Cape York Aboriginal 
population was almost as high as that recorded by Ranford et al. 
(1987) for the northern Aboriginal Australian population. However, 
the lack of C4A 3,4 heterozygotes in the East and West Cape York 
Aboriginal populations could artificially inflate the expected number 
of C4A null alleles in these populations when tested for Hardy- 
Weinberg equilibrium. A technique based on optical density analysis 
may be used for the identification of C4 null alleles (Christiansen et 
al ., 1983). This technique could be used to test the number of 
heterozygous null alleles in these studies which was estimated by 
computer analysis.
In this study, C4A Q0 allele frequencies in populations from PNG 
were low in comparison to other western Pacific populations
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(Ranford, 1989). C4A QO alleles were not found in either the PNG 
highland or inland populations, whilst the coastal population had the 
lowest frequency of C4A QO alleles so far reported in the western 
Pacific. Bhatia et al. (1991), found a slightly higher frequency of 
C4A QO alleles in PNG populations which was nethertheless less than 
that detected in the Aboriginal Australians. At the C4B gene locus, 
the distribution of 'B QO' alleles was variable between the PNG 
populations. The inland PNG population was devoid of C4B QO alleles, 
whilst the highland population had a frequency of C4B QO alleles 
similar to that detected in Melanesians, Chinese and Thai (Ranford et 
al ., 1986). The coastal PNG population had a 'B QO’ frequency 
similar to that detected in Aboriginal Australians, Caucasians, and 
Japanese (summarised by Ranford, 1989). A Korean population is the 
only other indigenous population in the western Pacific where C4B  
null alleles were not detected, (Ranford et al., 1986). This finding 
suggests that, like other frequently occuring C4A alleles, the C4A  
QO rather than the C4B QO allele, is a more useful genetic marker 
for population studies.
A rare C4B allele, 'B 12', which might be considered as a genetic 
marker of Aboriginal Australian populations, was detected in low 
frequencies in both the East and West Cape York Aboriginal 
populations. This allele was also found in low frequencies in both the 
central and northern Aboriginal populations by Ranford et al.
(1987). There appears to be some confusion concerning the 
nomenclature for this allele as Ranford incorrectly cited this allele as 
'B IF  in her 1989 paper. To establish if this allele should be named 
'B IF  or 'B 12', two of the three Aboriginal donors having a 'B 12' 
allotype in this study were sent to the Western Australian C4 
standard reference typing laboratory (Department of Clinical 
Immunology, Royal Perth Hospital, Australia). Here, they were 
confirmed to be 'B 12' alleles. This allele has not been detected in 
other western Pacific populations which indicates that the 'B 12' 
allele might be a unique genetic marker for Aboriginal Australians. 
Bhatia et al. (1991), detected a rarely occurring C4B allele 'B 11' in 
PNG populations which migrates closely to the 'B 12' allele. These 
alleles could easily be misinterpreted as the same allele by protein 
gel electrophoresis, and so require confirmation by a standard
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reference typing laboratory, as was sought for the Aboriginal 'B 12' 
allele. It is possible that the 'B 11' allele found in PNG populations 
(Bhatia et al., 1991) and the 'B 12' allele found in Aboriginal 
Australian populations by Ranford et al. (1987), and in this study, 
are identical. If true, this would be important as it would suggest a 
genetic link exists between Aboriginal Australians and PNG 
populations. However, occasionally the same C4B mutations have 
arisen independently in different populations (Ranford, 1989), and 
therefore do not necessarily represent close genetic links between 
populations. It is also possible that the 'B 11' and 'B 12' alleles 
comprise of a different set of polymorphic amino acid residues but 
produce the same migration patterns by protein gel electrophoresis. 
Significant differences of frequently occuring C4 allele frequencies 
between Aboriginal Australians and PNG populations, as well as 
absence of the 'B 12' allele from populations of PNG studied here, 
suggest that the B 11' specific polymorphism may have arisen 
independently in the PNG populations studied by Bhatia et al.
(1991).
Other rare C4 alleles, thought to be unique to specific ethnic groups, 
have been found in other ethnic populations. The C4B 5 allele which 
is regarded as an Asian gene (Ranford, 1989), was detected here, for 
the first time, in the inland and coastal regions of PNG. The C4B 96 
allele was previously detected only in Chinese (Ranford et al., 1986), 
and always on a duplicated haplotype (Dunckley and Hawkins, 1986). 
However, this allele was detected also for the first time in this study 
in the inland PNG population occurring with a low frequency. In this 
study, a greater array of alleles, including eight different C4A alleles 
and eight different C4B alleles, were found at the respective C4A 
and C4B gene loci in the PNG populations compared to that found in 
Aboriginal Australian populations. Despite the polymorphism found 
here in PNG, the majority of alleles detected in the PNG populations 
(especially inland and highland regions), were 'A 3' and 'B 1' alleles. 
The highland PNG population is the most monomorphic indigenous 
population so far recorded in the western Pacific. The Aboriginal 
Australians showed less polymorphism of C4A and C4B alleles. 
However, the distribution of the frequency of C4A and C4B alleles
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was more varied having a number of frequently occurring alleles. By 
comparison to other western Pacific populations the distribution of 
frequency of the most frequently occuring C4 alleles in Aboriginal 
Australian populations is most varied. Studies here, detected the 
highest degree of polymorphism in the coastal region of PNG as did 
Bhatia et al. (1991). This high degree of polymorphism in the coastal 
region of PNG is probably a reflection of the interaction of these 
people with other visiting indigenous people. On the other hand, 
those situated in the inland and highland regions have been more 
isolated, and therefore less subjected to genetic admixture with other 
populations.
Linkage disequilibrium analysis of C4 allotypes in the Aboriginal 
Australian and PNG populations reflects the frequency of the most 
frequently occuring C4 alleles in each population. By comparison 
with the Aboriginal Australian populations, A 3' and B 1' alleles 
are in strong linkage disequilibrium in both the coastal and inland 
PNG populations. This linkage disequilibrium is weaker in the 
highland PNG populations, as many A 3' alleles are associated with 
other C4B alleles besides the B 1' allele. Bhatia et al. (1991), found 
linkage disequilibrium between ’A 3' and B 1' alleles, and 'A 4' 
and B 2' alleles in the lowland regions but not in the highland 
region of PNG. Linkage disequilibrium of A 4' and B 2' alleles was 
found here in each Aboriginal Australian population, which is 
stronger than that found between A 3' and B 1' alleles in these 
populations. This finding is in agreement with linkage disequilibrium 
analysis of central and northern Aboriginal Australians by Ranford 
et al. (1987). Results of linkage disequilibrium analysis conducted 
here support the hypothesis that different ethnic groups have 
linkage disequilibrium of different frequently occuring C4 alleles, 
which provides another means for population studies at the 
molecular level.
Comparisons of C4 gene frequencies and allotype distributions 
between different Aboriginal Australian and PNG populations 
indicate that the two Aboriginal populations are more closely related 
to each other, as are the three PNG populations. The coastal 
population of PNG is most different from the Aboriginal Australians.
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An important factor to consider is that analysis of gene frequency 
compares only one C4A or C4B gene at a time. The distribution of 
C4 allotypes between populations, on the other hand, compares C4  
allotypes carrying both C4A and C4B alleles, as well as comparing 
C4 allotypes carrying a specific C4A or C4B allele. Even though C4 
gene frequency analysis and C4 allotype frequency analysis analyse 
the distribution of C4 alleles between populations by a different 
approach, this study found the results from these two types of 
analyses were in agreement with each other. Gene frequency and 
allotype frequency analyses reflect differences in the number of C4  
alleles with relatively high 
frequencies.
Genetic distance analysis may provide the best indication of the 
genetic closeness between two or more populations as it pools 
together the C4A and C4B gene frequency data and determines the 
extent to which one population is different from another. However, to 
obtain the most accurate indication of the genetic distance between 
Aboriginal Australian and PNG populations other indigenous 
populations from surrounding countries would need to be included. 
Genetic distance analysis in these studies came to a different 
conclusion in comparison to those results obtained by gene frequency 
and allotype frequency analyses. Genetic distance analysis found the 
inland PNG population was most genetically distant to the Aboriginal 
populations, which is not surprising considering the inland PNG 
population is almost monomorphic at both the C4A and C4B gene 
loci.
Serological studies by Kirk (1972) and complement components C2 
and factor B studies by Ranford (1989), suggest that northern 
Aboriginal Australians are more similar to highland PNG populations. 
However, studies of the C4 gene locus in Aboriginal Australians and 
PNG populations here and by Ranford et al. (1987), and Bhatia et al. 
(1991), suggest that the Aboriginal Australians are distinctly 
different from PNG populations. The occurrence of two more 
frequently occuring alleles at the C4A and C4B gene loci indicates 
that the Aboriginal Australians may have originated from two 
different populations. One population would have a high frequency of
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the 'A 3 B 1' allotype, whilst the other would have a high frequency 
of the A 4 B 2' allotype. The Aboriginal Australian A 3 B 1' 
allotype may have originated from any of the surrounding Pacific 
island indigenous populations, as these alleles are common to all 
Pacific island populations. The Aboriginal Australian A 4 B 2' 
allotype would more likely to have arisen from one of the Asian 
populations which have relatively high frequencies of these alleles, 
rather than from a PNG population. In PNG the 'A 4' allele is 
virtually absent, and the 'B 2' allele only has a low frequency.
Western Pacific populations can be distinguished from each other 
according to the differences in frequency of the most frequently 
occuring C4A alleles 'A 3\ A 4\  and ’A Q0\ PNG is distinct from 
any other western Pacific population, as the A 3 allele is the most 
frequently occuring C4A allele, whilst all other C4A alleles have 
very low frequencies. Micronesians and Melanesians are similar to 
Papuans, except that they have slightly lower frequencies of 'A 3\  
and higher frequencies of A 4' and A Q0' alleles. Japanese, Chinese, 
Korean and Thai, on the other hand, are distinct from other 
populations mentioned above, by reason of their lower frequency of 
'A 3\ Also, the frequency of A 3' in Japanese, Chinese, Korean and 
Thai populations is three to four times higher than the frequencies of 
'A 4' and 'A Q0' in these populations. Aboriginal Australians are 
distinct from other indigenous western Pacific populations with 
respect to the most frequently occuring C4A alleles, A 3' and A 4', 
which occur with almost equally high frequencies. Caucasians can be 
distinguished from other populations, as their A 3' allele occurs four 
times more frequently than the A Q0' allele, which in turn occurs 
twice as frequently as the A 4' allele (Ranford et al., 1986).
This study has identified individuals with C4A and C4B null alleles, 
as well as rare C4A and C4B alleles, such as the 'B 12' allele, which 
will be useful for further studies at the molecular level. C4 allotypes 
identified here may also be useful for subsequent correlation with 
DNA analysis aimed at developing a molecular C4 allotyping 
protocol. The design of a molecular-based C4 allotyping protocol, and 
the application of this molecular approach are dealt with in the 
following chapters.
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Chapter 4
Molecular-based C4 allotyping protocol 
4.1 Introduct ion
Accurate and rapid identification of C4 allotypes is confined to a 
limited number of specialised laboratories. The currently used C4 
allotyping technique of protein gel electrophoresis has limitations in 
that it requires highly skilled interpretation of C4 allotypes and 
careful handling of C4 serum samples as this protein degrades 
rapidly.
Many techniques have been used to distinguish between C4A and 
C4B allotypes which are based on detecting differences of the 
polymorphic C4d gene region. These include, differential weight of 
C4A and C4B a-chains (Roos et al., 1982; Carroll et al., 1989;
Rittner and Stradmann-Bellinghausen, 1990); haemolytic activity of 
C4A and C4B protein (Kaufmann et al., 1990); immunoblotting of 
C4 using monoclonal and polyclonal antibodies (Doxiadis and Grosse- 
Wilde, 1990); pulse-field gel electrophoresis (Dunham et al., 1990); 
Rodgers and Chido typing (Yu et al., 1988; Giles, 1990); RFLP 
analysis (Schneider, 1990); C4 protein gel electrophoresis (Awdeh 
and Alper, 1980), and DNA sequencing (Belt et al., 1984 and 1985;
Yu et al., 1986; Anderson et al., 1992; Paz-Artal et al., 1993). As 
reported at the VI Complement Genetics Workshop in Germany 1989, 
researchers in the complement field used these protocols to re­
classify the majority of known C4 allotypes, and as a result the C4 
nomenclature was revised. Even though these methods have 
collectively demonstrated many features of C4 polymorphism, each 
technique is limited with respect to the amount of information it can 
provide about a particular C4 allele.
Of the techniques mentioned above, C4 protein gel electrophoresis 
followed by immunofixation has remained the major technique for 
C4 allotyping. This method separates proteins according to their size 
and overall net charge (described in detail in Chapter 2, section 2.5). 
The sensitivity of this technique has improved since its first 
application by Awdeh and Alper (1980). Introduction of
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Carboxypeptidase B enables slightly degraded C4 samples to be 
allotyped, and allows resolution of overlapping alleles (Sim and Cross, 
1986), and haemolytic overlays are used to identify co-migrating 
C4A and C4B alleles (Gaither et al., 1974; Kaufmann et al., 1990). 
Consequently, sub-types of the more frequently occurring C4 alleles 
have been identified such as the B 12 allele, which migrates closely 
to B 1 and B 2 alleles (refer to chapter 3 and Mauff et al., 1983).
Despite these improvements, some C4 allotypes remain difficult to 
identify by this procedure due to overlapping C4 alleles by protein 
gel electrophoresis (Sim and Cross, 1986). Gene duplication, which 
occurs frequently at the C4 gene locus, increases the difficulty of C4 
allotype interpretation, as even more protein bands are revealed by 
protein gel electrophoresis. Also, sequencing has revealed sub-types 
of C4 alleles identified by protein gel electrophoresis, indicating that 
not all C4 alleles can be detected by the latter (Belt et al., 1985; Yu, 
1991; Anderson et al., 1992).
Modern methods of molecular analysis have identified the molecular 
basis for much of the polymorphism which is characteristic of C4 
alleles by sequencing the polymorphic C4d gene region. An 
allotyping protocol based on known polymorphic nucleotide bases for 
each C4 allele would be the most accurate means of identification, 
and would obviate the problems that exist with conventional 
techniques. Accurate identification of C4 alleles is essential for the 
advancement of studies in associated diseases, and will facilitate 
reproducible results by researchers working in this region 
throughout the world. A molecular-based protocol has the advantage 
of being easily adopted by any molecular laboratory and routinely 
used in disease diagnosis without a high degree of difficulty. It also 
has the advantage of not being reliant on handling of C4 protein 
which is prone to degradation in transit and storage.
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4.2 Aim
The main aim of research reported in this chapter was to establish a 
molecular-based C4 typing protocol based on PCR-RFLP analysis by 
utilising known published sequences of C4 polymorphic alleles and 
new polymorphic nucleotide bases discovered in this study. This 
protocol was then used to identify C4 alleles which could not be 
identified by C4 protein gel electrophoresis (chapter 3), and to 
determine the molecular basis of other rarely occurring C4 alleles.
4.3 Materials and Methods
4.3.1 C4 nomenclature
C4 allotypes as determined by protein gel electrophoresis and 
allotypes as determined by DNA sequencing, are distinguished in this 
thesis by, for example, A 3 and A *3, respectively.
4.3.2 Samples for C4 PCR-RFLP allotyping
Nineteen Aboriginal Australian samples from Darwin (H) and East 
and West Cape York (ECY and WCY), two IDDM patients from 
Canberra (ASD) and Melbourne (RCH), three European workshop cell 
lines (EW), and three Caucasians from JCSMR (JC), were used in this 
study. Specific details of these samples are given in Chapter 2, section
2.3 and 2.4.
4.3.3 C4 protein gel electrophoresis and immunofixation
Plasma samples of Aboriginal Australians from Cape York, and 
Caucasians from JCSMR, were C4 allotyped by C4 protein gel 
electrophoresis followed by immunofixation, using the protocol 
outlined in section 2.5. Other samples from IDDM donors (RCH and 
ASD) were typed by Pam Ranford, JCSMR, and Darwin Aboriginal 
samples (H) were typed by Heather Dunckley, JCSMR, by using the 
same method of protein gel electrophoresis.
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4.3.4 Genomic DNA extraction
Genomic DNA extraction from buffy coats and cell lines was 
performed using the technique described in section 2.7.
4.3.5 Taq I restriction analysis of genomic DNA, and C4 specific 
hybridisation
Approximately 3 fig of genomic DNA was restricted in a total volume 
of 50 pi, with 30 units of Taq I restriction enzyme, and lx reaction 
buffer (provided by the enzyme manufacturer), at 65 °C for 2 hours. 
Reactions were stopped by adding 5 pi of 0.5 M EDTA, and heating to 
65 °C for 10 min. Restricted DNA products were precipitated by 
adding 25 pi of 7.5 M ammonium acetate and 160 pi of absolute 
ethanol. Samples were dried and resuspended in 10 pi of distilled 
water and 4 pi of electrophoresis buffer, and then electrophoresed as 
described in section 2.9. Samples were transferred to a nylon 
membrane following the protocol in section 2.11. C4 pAT-A, a full 
length C4-specific probe, was radioactively labelled and hybridised 
to Taq I restricted DNA fragments following the methods described 
in sections 2.12.1 and 2.12.2.
4.3.6 Primer design for PCR amplification of polymorphic C4 gene 
regions
Primers were designed to amplify nucleotide base regions which 
encode polymorphic amino acid residues within the ß-chain, a-cha in  
and C4d region. Where possible, entire exons were amplified to 
ensure sequencing of the complete coding region. Primers designed to 
amplify a region for sequencing, contained an enzyme site at the 5' 
end which was accompanied by a few additional nucleotide bases 
(3-5) to enable binding of the enzyme. Primers were tested for 
primer self-hybridisation, sense and antisense primer hybridisation, 
and nucleotide 'G and 'C base content by using an IBM computer 
programme called 'PCR'. All primers were synthesised by the 
biomolecular resource facility at JCSMR, ANU, Canberra. Primer pairs, 
and polymorphic amino acid residues encoded by nucleotide bases
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which were targeted for PCR amplification are listed in
Table 4.1, and there location within the a- and ß- regions of the C4
gene are shown in Figure 4.1.
4.3.7 PCR amplification of nucleotide bases encoding polymorphic 
amino acid residues
Polymorphic amino acid residues, their position within the C4 amino 
acid sequence, and PCR amplification specificity for C4A, C4B , and 
long or short C4 gene type, are listed in Table 4.2. PCR amplification 
of polymorphic gene regions followed the general description 
described in section 2.16. Nucleotide bases encoding amino acid 
residues #707 and #1267 were amplified using C4A and C4B  
isotypic primers (see primer pairs 4, 5, 12 and 13). However, the 
resulting PCR fragment sizes were too large (2703 bp for primer 
pairs 4 and 5, and 985 bp for primer pairs 12 and 13), and therefore 
contained too many restriction sites within the sequence to enable 
easy interpretation of PCR-RFLP banding patterns. As a result, 
samples were subjected to a second round of amplification using 
nested primers (pairs 6 and 14 for nucleotides encoding amino acid 
residue #707 and #1267 respectively), which were situated closer to 
the polymorphic nucleotide base of interest. This approach resulted 
in smaller PCR products (212 bp and 238 bp for amplification of 
nucleotide bases encoding residue #707 and #1267, respectively), 
containing less restriction sites. Specific PCR reaction conditions for 
each primer pair, and the resulting PCR product size, are given in 
Table 4.3. Detection of PCR amplification products was determined by 
gel electrophoresis as described in sections 2.9 and 2.10.
4.3.8 PCR-RFLP analysis of nucleotide bases encoding C4 
polymorphic amino acid residues
Restriction endonuclease digestion conditions for each PCR product 
(approximately 300 ng), were as described by the manufacturer of 
each enzyme, with the exception of Aci /. Digestion with this enzyme 
was optimised by the addition of Buffer #4 (provided by the 
manufacturer), 2 pi of 1 % gelatin, and 5 units of enzyme in a total
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Figure 4.1 Schematic representation of the molecular based C4  
typing protocol based on PCR-RFLP
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reaction volume of 15 pi. Restriction endonucleases, digestion 
conditions, and electrophoresis parameters are listed in Table 4.4. 
PCR-RFLP products were separated by agarose and polyacrylamide 
gel electrophoresis, and detected by gel staining as described in 
sections 2.9 and 2.10.
4.3.9 Cloning and sequencing of nucleotide bases encoding amino acid 
residues #286 to #330 in short C4 alleles
PCR products from amplification of nucleotide bases encoding amino 
acid residues #286 to #330 in short C4 genes, were sequenced for 
Aboriginal donors H14, ECY178, WCY1158, ECY028 and Caucasian 
RCH517. All samples were blunt-end cloned according to the method 
described in section 2.18.2. Recombinant clones were sequenced by 
automated sequencing as outlined in section 2.19. A minimum of 
three clones of the sense strand, and three clones of the antisense 
strand of DNA were sequenced for H14, WCY1158, ECY028 and 
RCH517. The short C4 gene PCR product of donor ECY178 
(approximately 1 pg), was subjected to restriction analysis with 
enzyme Pie I. The restricted fragments were separated on a 2.5 % 
agarose gel by electrophoresis as described in section 2.9. Restriction 
fragments encoding nucleotide bases for amino acid residue #286 to 
intron 9 nucleotide base #102 (total of 237 bp), were eluted from the 
gel and concentrated to a total volume of 10 pi, as described in 
section 2.17 Chapter 2, prior to cloning and sequencing.
4.3.10 Allele specific oligonucleotide (ASO) hybridisation to 
nucleotides encoding polymorphic amino acid residue #1182
4.3.10.1 Samples for ASO typing
C4A alleles were selectively amplified from 72 donors chosen at 
random, from the Cape York Aboriginal Australian populations used 
for analysis in Chapter 3. In addition, Caucasians having homozygous 
C4 allotypes A 3 (JC002), and A 4 (ASD97), as well as heterozygous 
allotypes A 3,4 (ASD49), as determined by C4 protein gel 
electrophoresis, were chosen as controls.
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4.3.10.2 PCR amplification of nucleotides encoding amino acid 
residue #1182 and Southern blotting
The C4 gene region encoding amino acid #1182 was amplified with 
the C4A isotypic primer pair 10 (Table 4.1), using PCR conditions set 
out in Table 4.3. PCR fragments were visualised by gel 
electrophoresis as described in sections 2.9, and 2.10, and transferred 
to a nylon membrane by Southern blotting, as described in section 
2 . 11 .
4.3.10.3 End-labelling of allele-specific oligonucleotides (ASO), and 
hybridisation to membranes
Two ASO's were used for analysis of nucleotide bases encoding the 
amino acid residue #1182; namely 5’-ATGCCCTGACACTGACCAA-3', 
which detects nucleotide bases encoding amino acid 'Thr', and 5'-ATG 
CCCTGTCACTGACCAA-3', which detects nucleotide bases encoding 
amino acid 'Serf Both ASO’s extend from nucleotide bases encoding 
amino acid residues #1180 to #1183. End-labelling and hybridisation 
of oligonucleotides to PCR products were as described in sections
2.12.3 and 2.12.4.
4.3.11 Sequencing of C4A *3 and C4A *4 alleles to confirm ASO 
hybridisation to nucleotides encoding amino acid residue #1182
4.3.11.1 Donor samples
Donor samples used for this study were Aboriginal Australian 
samples ECY743 (C4A 3 allele), and ECY519 (C4A 4 allele), whose 
C4 allotypes were detected by C4 protein gel electrophoresis, as 
described in section 2.5.
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4.3.11.2 PCR amplification of the gene region surrounding nucleotide 
bases which encode amino acid residue #1182
Primers used to amplify the C4 gene region encoding amino acid 
residues #1091 to #1206 of donors ECY743 and ECY519 were sense 
strand primer 5'-GACGGCCAGTGTCGACAGCAGCAGGCTGACGGCTCG-3', 
which has nucleotide bases encoding amino acid residues #1091 to 
#1097 (same as sense primer in pair 9. Table 4.1), and antisense 
primer 5'-AGCTATGACCGAATTCCCCCTCACCTCCAGTCTCCT-3,, which 
has nucleotide bases for amino acid residues #1203 to #1206 (same 
as antisense primer in pair 9, Table 4.1).
A second set of primers were used to amplify the C4 gene region 
encoding amino acid residues #1091 to #1189, of samples ECY743 
and ECY519. These primers were sense strand primer 5’-GACGGCC 
AGTGTCGACAGCAGCAGGCTGACGGCTCG-3' encoding amino acid 
residues #1091 to #1097 (same as sense primer in pair 9, Table 4.1), 
and antisense primer 5-GTCGAATTCGTCCGCAGGCGCCTTGGTC-3' 
encoding amino acid residues #1184 to #1189.
Samples were subjected to PCR as described in section 2.16, with 
specific conditions for each primer set as follows: The first set of 
primers which were designed to amplify nucleotide bases encoding 
amino acid residues #1091 to #1206, were amplified by 35 cycles of 
96 °C for 60 sec, 56 °C for 60 sec, and 72 °C for 120 sec. The second 
set of primers used to amplify nucleotide bases encoding amino acid 
residues from #1091 to #1189, were amplified using the same 
conditions as the first set of primers, however the annealing 
temperature was reduced to 49 °C. PCR products were visualised by 
gel electrophoresis and EtBr staining as described in section 2.9 and 
2 . 10 .
4.3.11.3 Cloning of PCR products and automated sequencing
PCR products having nucleotide bases which encode amino acid 
residues #1091 to #1206, were cloned into M13 using the blunt-end 
method outlined in section 2.18.2 to 2.18.7, whereas PCR products 
having nucleotides which encode residues #1091 to #1189, were
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cloned into M l3 using sticky-end cloning (see section 2.18.1, and 
2.18.3 to 2.18.7). Four M l3 blunt-end clones from ECY743, and two 
M l3 blunt-end clones from ECY 519, were chosen for sequencing. 
Three M l3 sticky-end clones from ECY 743, and three M l3 sticky- 
end clones from ECY 519, were chosen for sequencing. Samples were 
sequenced by automated sequencing as described in section 2.19.
4.3.12 Predicted Isoelectric Point (PI) of derived protein sequences 
for each C4 allele
Computer analysis of the derived protein sequence was used to 
determine the predicted isoelectric point (PI) of each C4 allele.
Details concerning this computer programme are given in section 
2.20 (Chapter 2).
4.4 Results
Results of this chapter are reported in three major sections. The first 
section deals with the approach taken to design a C4 m olecular 
allotyping protocol based on PCR-RFLP, using published information 
describing the molecular genetics of C4. The second section records 
the amino acid residues encoded by polymorphic nucleotide bases of 
C4 alleles within each donor. The final section details the molecular 
basis of each C4 allele including some alleles which were not 
accurately identified by C4 protein gel electrophoresis. This was 
carried out by combining and analysing the data from C4 protein gel 
electrophoresis (see Chapter 3), PCR-RFLP, Taq I RFLP analysis, and 
the predicted isoelectric points (PI), which were determined by using 
a protein analysis computer programme. An account of the approach 
taken, and consideration of results and those of other workers are 
necessary to relate here as an integral part of the development of the 
C4 allotyping protocol.
4.4.1 Design of the C4 PCR-RFLP molecular allotyping protocol
A major factor distinguishing C4A from C4B alleles is a set of 
closely situated polymorphic amino acid residues encoded by
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nucleotide bases in exon 26 of the C4d region. These amino acid 
residues, 'Pro,Cys-Leu,Asp' for C4A genes, and 'Leu,Ser-Ile,His' for 
C4B genes, have become known as the C4 isotypic or class-specific 
amino acid residues (Palsdottir et al., 1987a; Yu, 1991; Anderson et 
a l 1992). The C4, PCR-RFLP typing protocol was designed using 
C4A and C4B isotypic primers for the amplification of other 
nucleotide bases encoding polymorphic amino acid residues 
in each allele. This approach permitted C4A and C4B alleles to be 
typed individually.
Only polymorphic amino acid residues previously detected by 
nucleotide base sequencing were chosen for these studies, as they 
were thought to be more reliable than those detected by protein 
sequencing. Evidence elsewhere supported this approach. For 
example, the polymorphic amino acid residue #708 reported by 
Moon et al. (1981), may be a protein sequencing artifact as other 
more recent studies (Yu, 1991), did not detect such polymorphism.
A schematic representation of the molecular-based C4 typing 
protocol based on PCR-RFLP is shown in Figure 4.1. C4 polymorphic 
amino acid residues #306 (identified in these studies), and residue 
#328, located in exon 9 of the ß-chain. were situated too far from the 
C4 isotypic region (5 kb in short C4 genes and 12 kb in long C4 
genes), to implement the strategy of only C4A or C4B isotypic 
amplification. Knowing that the majority of C4A alleles reported are 
of the long (23 kb) type, whereas both long and short (16 kb) C4B  
alleles have been found (Schneider, 1990), an alternative approach to 
characterise amino acid residues #306 and #328, by utilising the 
differential size of intron 9 was designed. Two primer pairs were 
used, one which amplified only short C4 genes from the gene region 
encoding amino acid residues #286 to #330. The second primer pair 
amplified nucleotide bases encoding amino acid residues #286 to 
#329, such that both long and short C4 genes were amplified. Those 
amino acid residues detected in the short C4 gene were assigned to 
C4B alleles. Residues detected by the second set of primers were 
compared to those detected in the short C4 genes. Those which were 
different were assigned to either C4A or C4B alleles depending on:
(1). The allotype identified by C4 protein gel electrophoresis; (2).
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Other C4 alleles of the donor, and (3). PI values obtained using the 
protein analysis computer programme. It is important to note that 
even though C4 protein migration patterns are derived differently 
by isoelectric focusing and gel electrophoresis, they will ultimately 
result in the same pattern of migration, as both techniques separate 
the proteins according to their size and net charge. This thesis often 
refers to predicted isoelectric point (PI) (according to computer 
analysis, using the programme 'isoelectric'), and migration patterns 
resulting from C4 protein gel electrophoresis. It is the pattern 
resulting from migration of the subject protein in relation to other 
migrating C4 proteins which is important to this study, and not the 
technical procedures used to obtain these patterns of migration.
Polymorphic amino acid residue #458 was the only other residue 
situated too far from the C4 isotypic region to allow C4A and C4B 
specific amplification. As a result, PCR-RFLP analysis of nucleotide 
bases encoding amino acid residue #458 was performed on PCR 
product containing both C4A and C4B alleles.
4.4.2 Amino acid residues encoded by polymorphic nucleotide bases 
as determined by PCR-RFLP analysis
4.4.2.1 Amino acid residue #328
Nucleotide bases encoding amino acid residue #328 in both long 
(23 kb) and short (16 kb) C4 genes, were identified by PCR-RFLP 
analysis using the restriction enzyme 'Pie T. PCR-RFLP banding 
patterns resulting from restriction analysis of nucleotide bases 
encoding amino acid residue #328 are shown in Figure 4.2. 
Polymorphic amino acid residues for each Aboriginal and Caucasian 
donor, and their C4 allotypes, according to C4 protein gel 
electrophoresis, are listed in Tables 4.5 and 4.6, respectively.
PCR analysis showed that the majority of donors possessed both long 
and short C4 genes. Short C4 genes were detected by successful PCR 
amplification of DNA using PCR primers which were specific for short 
C4 genes. Long C4 genes were detected by
1 24
Figure 4.2 PCR-RFLP banding patterns of nucleotide bases encoding 
polymorphic amino acid residues #306 and #328 from short (16 kb) 
and long (23 kb)/short (16 kb) C4 PCR fragments. Examples of each 
banding pattern are listed as lane numbers for the respective amino 
acid residue. Where homozygote examples of each banding pattern 
could not be shown, a heterozygous example was referred to. 
Molecular weight markers consisted of pBR322  restricted with Msp  
1 in lane 10 and 13 for gels corresponding to amino acid reside 
#306, and lane 10 of the gel corresponding to amino acid residue 
#328. Resulting fragment sizes (bp) of pBR322 Msp I shown in each 
photograph include 67, 76, 90, 110, 123, 147, 160, 180, 190, 201,
217, 238, 242, 309, 404, 527, and 622 base pair fragments. 
Unrestricted PCR DNA fragments are shown in lanes 11 and 12 of gels 
corresponding to amino acid residue #306, and lane 11 for amino 
acid residue #328. Photographs of gels where PCR fragments are 
black represent gels stained with silver, and gels where fragments 
are white were stained with EtBr. Small PCR fragments 16 bp or less 
had migrated from the gel during electrophoresis and were therefore
not visible.
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heterozygosity of nucleotide bases encoding amino acid residue #328 
in the PCR product where primers had amplified all C4 genes both 
long and short. However, this approach was only possible if 
homozygosity was detected in the short C4 gene at residue #328.
Taq I RFLP studies of 13 Aboriginal donors (some of which were 
included in PCR-RFLP analysis), and two Caucasian donors, support 
the finding by PCR-RFLP analysis, that the majority of donors have 
both long and short C4 genes (Table 4.7). From PCR-RFLP analysis, 
donors WCY1179, WCY1204, EW-L0081785 and EW-Ducaf, have only 
long C4 genes, as short C4 genes could not be amplified (Tables 4.5 
and 4.6). Taq I RFLP analysis of donor WCY1204 confirmed the 
analysis by PCR-RFLP, that only long C4 genes were found at locus I 
and II in this donor (Table 4.7).
For the majority of alleles in this study, nucleotide bases encoding 
Tyr' for amino acid #328 were associated with long C4 genes, 
whereas nucleotide bases which encode 'Ser' for residue #328 were 
associated with short C4 genes (Tables 4.5 and 4.6). PCR-RFLP 
analysis of nucleotides encoding residue #328 in WCY1179 and 
WCY1204 (both donors only had long C4 genes), supported this 
finding, as each allele had residue 'Tyr'. Donors ECY 858, EW- 
L0081785, EW-Ducaf and ECY 178, on the other hand, were 
exceptions. Residue 'Ser' was encoded by nucleotides in both long and 
short C4 alleles of donor ECY 858, and in the long C4 alleles of 
donors EW-L0081785 and EW-Ducaf, whereas residues 'Ser' and 'Tyr' 
were detected in the short C4 alleles of donor ECY 178. Taq 1 RFLP 
analysis was necessary to establish these associations, as nucleotides 
encoding residue #328 in both long and short C4 alleles of these 
donors were homozygous. In the case of donor ECY 858, it should be 
noted that Taq I RFLP analysis data was not available to confirm 
that both long and short C4 genes were present.
A search was undertaken for nucleotide differences between long 
and short C4 genes which may identify these types of alleles. Yu 
(1991), reported the sequence for the large 7 kb intron 9 of a C4A 
*3a allele, where two copies of a mobile genetic element encoding 
nucleotide bases 5'-acagaca-3' at the beginning and end of the intron
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Table 4.7 Taq I RFLP analysis of the C4  gene region  
for Aborig inal  Austral ians ,  and Caucasians
Taq I RFLP (kb)
Donor C4
allo type#
Locus 1 
7 3.7
Locus 2
6.4 6 5.4 3.2
ECY006 A 3 B 1,Q0 * * * *
ECY218 A 3 B 2 * * * *
ECY277 A 4 B 1,Q0 * * * *
ECY720 A 4 B 1 * * * *
ECY740 A 3 B 1 * * * *
WCY1159 A 3,Q0 B 1 * * * *
ECY704 A 3,Q0 B 1 * * * * *
WCY1176 A 4 B 1,2 * * * *
WCY1199 A 4,Q0 B 2 * * * *
WCY1204 A 3 B 1,12 * * * *
ECY028 A 4 B 2 * * * * *
ECY248 A 4 B 1,2 * * * * *
ECY504 A 2,3 B 1 * * * * *
JC002 A 3 B 1 * * * * *
JC003 A 3,6 B 1 * * * * *
# allotype determined by protein gel electrophoresis. Taq I RFLP C4 locus I 
and II long (23 kb) genes are represented by 7 kb and 6 kb fragments, 
respectively. C4 locus II short (16 kb) genes are represented by 5.4 kb fragments. 
Locus I gene deletion and short (16 kb) locus II gene is represented by 6.4 kb 
fragments. RFLP fragments represent 21-hydroxylase A gene by 3.7 kb and 
21-hydroxylase B gene by 3.2 kb.
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9 sequence were detected. To establish if intron 9 of the short C4 
gene encoded one copy of the mobile genetic element, and to search 
for any other sequence differences which could be used to 
distinguish long from short C4 genes, the short C4 gene in the 
region of intron 9 was sequenced. If an association between specific 
nucleotide bases and the size of C4 alleles was found, this 
information could be used to analyse polymorphic residues 
separately in long and short alleles, and thereby be of use to the 
PCR-RFLP allotyping protocol.
Various donors which were found to have nucleotide bases encoding 
amino acid residues 'Ser' and/or Tyr' for residue #328, by PCR-RFLP 
analysis of the short C4 genes, were chosen for sequencing analysis. 
Sequencing results were compared with long C4 allele 'C4A *3ö' 
nucleotide base sequence reported by Yu, (1991), and are shown in 
Figure 4.3. Only nucleotide bases of the long C4A *3a allele which 
are also found in the short C4 alleles are shown. The remaining 
nucleotides of this allele, which comprise approximately 7 kb of 
intron 9 sequence, are not shown, and if included would appear at 
the site of the mobile genetic element.
The short C4B null allele of Aboriginal donor H14 (denoted as C4A 
*CAN1,  reported in Chapter 5), unlike the majority of other short C4 
alleles (Tables 4.5 and 4.6), had Tyr’ for residue #328. A Caucasian 
donor RCH517 (A *3 B *3), was heterozygous for residue #328 in the 
short C4 alleles (RCH517 a and b), having nucleotide bases encoding 
’Ser’ and ’Tyr’ (Table 4.6). Aboriginal donors WCY1158 and ECY 028 
were homozygous for short B *7 and B *2 alleles, respectively), 
both having residue 'Ser' for residue #328. Aboriginal donor ECY 178 
(heterozygous short B *2, *5 alleles) was heterozygous having 
residues 'Ser' and 'Tyr' encoded by nucleotides for residue #328. Only 
the short B *5 allele of donor ECY 178 having residue 'Tyr' was 
sequenced, as the two short alleles in this donor were digested using 
restriction enzyme 'Pie r  and then size fractionated by gel 
electrophoresis and electro-eluted prior to cloning and sequencing.
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Figure 4.3 Sequencing results of short C4 genes from nucleotide 
bases encoding residues #286 to #330, which extends across the 
variable sized intron 9. Each short C4 gene sequence is aligned with 
the corresponding long C4A *3a gene sequence reported by Yu 
(1991). C4 alleles are from the following donors, A *CAN1 from 
H14, B *5 from ECY178, B *1 from WCY1158, B *2 from ECY028, 
RCH517(a) and RCH517(b) are from donor RCH517. Upper-case 
sequence represent exon sequence, whereas lower-case represents 
intron 9 sequence. Numbers in bold print represent the position of a 
code of nucleotide bases for an amino acid residue. Intron 9 
nucleotide bases are numbered #1 to #420, and numbers denoted '#' 
represent a particular intron base. Nucleotides encoding residue #286 
to intron 9 base #107 were sequenced in C4 allele 'B *5', as 
sequencing was of a restricted PCR fragment, not a full length PCR 
fragment, as were the other sequences. The large 7 kb intron present 
in 23 kb C4 genes is not shown, however has been reported by Yu 
(1991), to be positioned between intron 9 base #280 and #287 
(mobile genetic element) in this figure.
am ino acid # 286 (exon 9)
A *3a cag CTG GTG AAT GGA CAG AGC CAC ATT TCC CTC TCA AAG GCA GAG TTC
A *CAN 1 cag CTG GTG AAT GGA CAG AGC CAC ATT TCC CTC TCA AAG GCA GAG TTC
B *5 cag CTG GTG AAT GGA CAG AGC CAC ATT TCC CTC TCA AAG GCA GAG TTC
B *1&B *2 cag CTG GTG AAT GGA CAG AGC CAC ATT TCC CTC TCA AAG GCA GAG TTC
R C H 517 ( a ) cag CTG GTG AAT GGA CAG AGC CAC ATT TCC CTC TCA AAG GCA GAG TTC 
R C H 517 (b ) cag CTG GTG AAT GGA CAG AGC CAC ATT TCC CTC TCA AAG GCA GAG TTC
amino acid # 306 309
A *3a CAG GAC GCC CTG GAG AAG CTG AAT ATG GGC ATT ACT GAC CTC CAG
A *CAN 1 CAG GAC GCC CTG GAG ATG CTG AAT ATA GGC ATT ACT GAC CTC CAG
B *5 CAG GAC GCC CTG GAG ATG CTG AAT ATA GGC ATT ACT GAC CTC CAG
B *1&B *2 CAG GAC GCC CTG GAG AAG CTG AAT ATG GGC ATT ACT GAC CTC CAG
R C H 517 ( a ) CAG GAC GCC CTG GAG ATG CTG AAT ATA GGC ATT ACT GAC CTC CAG 
R C H 517 ( b ) CAG GAC GCC CTG GAG AAG CTG AAT ATG GGC ATT ACT GAC CTC CAG
amino acid # 328 in tron 9
A *3a GGG CTG CGC CTC TAC GTT GCT GCA GCC ATC ATT GAG TAT CCA G gtgggtg
A *CAN l  GGG CTG CGC CTC TAC GTT GCT GCA GCC ATC ATT GAG TAT CCA G gtgggtg 
B *5 GGG CTG CGC CTC TAC GTT GCT GCA GCC ATC ATT GAG TAT CCA G gtgggtg
B *1&B *2 GGG CTG CGC CTC TAC GTT GCT GCA GCC ATC ATT GAG TCT CCA G gtgggtg 
R C H 517 ( a ) GGG CTG CGC CTC TAC GTT GCT GCA GCC ATC ATT GAG TAT CCA G gtgggtg 
R C H 5 17 (b ) GGG CTG CGC CTC TAC GTT GCT GCA GCC ATC ATT GAG TCT CCA G gtgggtg
intron 9 bp# ^ 0
A *3a actttcccttattgtaaccccagacccttgcctctgacctctgagctaaccctctgtcctccagcaccaacacca
A *CAN 1 actttcccttattgtaaccccagacccttgcctctgacctctgagctaaccctctgtcctccggcaccaacacca
B *5 actttcccttattgtaaccccagacccttgcctctgacctctgagctaaccctctgtcctccggcaccaacacca
B *1&B *2 actttcccttattgtaaccccagacccttgcctctgacctctgagctaaccctctgtcctccggcaccaacacca
R C H 5 1 7 (a )  actttcccttattgtaaccccagacccttgcctctgacctctgagctaaccctctgtcctccggcaccaacacca 
R C H 5 1 7 (b )  actttcccttattgtaaccccagacccttgcctctgacctctgagctaaccctctgtcctccggcaccaacacca
intron 9 bp# #87 #119
A *3a ccccc ac ttc tcacatc tcatctcagactcaaaaccc aggaaacaccccaggagacctggtttctctccaactc
A *CAN 1 cccc ac ttc tcacatc tcatctcagactcaaaacc aggaaacaccccaggagacctggtttctctccaactc
B *5 cccc ac ttc tcaca tc tca tc tca
B *1&B *2 cccc acttctcacatc tcatctcagactcaaaacc aggaaacaccccaggagacctggtttctctccaactc
R C H 5 1 7 (a )  cccc ac ttc tcacatc tcatctcagactcaaaacc aggaaacaccccaggagacctggtttctctccaactc 
R C H 5 1 7 (b )  cccc acttctcacatc tcatctcagactcaaaacc aggaaacaccccaggagacctggtttctctccaactc
A *3a tgtctctgtgactcggcccttttccctggctgagtttatttatttctttgctcgttctgctcattccttcactcctcca
A *CAN 1 tgtctctgtgactcggcccttttccctggctgagtttatttatttctttgctcgttctgctcattccttcactcctcca 
B *1&B *2 tgtctctgtgactcggcccttttccctggctgagtttatttatttctttgctcgttctgctcattccttcactcctcca 
R C H 5 1 7 (a )  tgtctctgtgactcggcccttttccctggctgagtttatttatttctttgctcgttctgctcattccttcactcctcca 
R C H 5 17(b) tgtctctgtgactcggcccttttccctggctgagtttatttatttctttgctcgttctgctcattccttcactcctcca
intron 9 bp# 238 #280 #287 #295 #304
A *3a gtggacatgtgttgttcaatgccccgtgctaggcctcagcatgcacagacaggaatacggcagcctgtgccctg
A *CAN 1 gtggacatgtgttgttcaatgccccgtgctaggcctcagcatg'lacagacaggaatacagcagcctgcgccctg 
B *1&B *2 glggacatgtgttgttcaatgccccgtgctaggcctcagcatgtacagacaggaatacagcagcctgcgccctg 
RCH5 17(a)  ggggacatgtgttgttcaatgccccgtgctaggcctcagcatgtacagacaggaatacagcagcctgcgccctg 
R C H 5 17(b)  ggggacatgtgttgttcaatgccccgtgctaggcctcagcatgiacagacaggaatacagcagcctgcgccctg
intron 9 bp# #354
A *3a ggagctcactgtcttgtgggagggaaccactcaagccactccccacttgtcctcctgtccctctcttcttgggctc
A *CAN 1 ggagctcactgtcttgtgggagggaaccactcaagccactccctacttgtcctcctgtccctctcttcttgggctc 
B *1&B *2 ggagctcactgtcttgtgggagggaaccactcaagccactccctacttgtcctcctgtccctctcttcttgggctc 
R C H 5 17(a)  ggagctcactgtcttgtgggagggaaccactcaagccactccctacttgtcctcctgtccctctcttcttgggctc 
R C H 5 1 7 ( b )  ggagctcactgtcttgtgggagggaaccactcaagccactccctacttgtcctcctgtccctctcttcttgggctc
intron 9 bp# #4 2 0
A *3a tgtcccccacctctctctgtcctttgtcttgcag
A *CAN 1 tgtcccccacctctctctgtcctttgtcttgcag 
B *1&B *2 tgtcccccacctctctctgtcctttgtcttgcag 
R C H 5 1 7 (a )  tgtcccccacctctctctgtcctttgtcttgcag 
R C H 5 1 7 ( b )  tgtcccccacctctctctgtcctttgtcttgcag
330 (exon 10)
GT GGG GAG ATG G 
GT GGG GAG ATG G 
GT GGG GAG ATG G 
GT GGG GAG ATG G 
GT GGG GAG ATG G
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Sequencing data (Figure 4.3) showed that the C4A *CAN1 allele from 
donor H I4, the B *5 allele from donor ECY 178, and one allele from 
donor RCH517(a), possessed nucleotide bases which encoded amino 
acid residue 'Met' for residue #306. On the other hand, published 
nucleotide base sequence from the long C4 allele 'C4A *3a' (Yu,
1991), and sequencing results of donors WCY1158 (B *7), ECY 028 
(B *2) and the other short C4 allele of donor RCH517(b), 
showed nucleotide bases encoding amino acid residue 'Lys' for 
residue #306. Sequencing revealed differences in nucleotide bases 
between the same alleles for residue #309 (Figure 4.3). The C4A 
*CAN1 and B *5 alleles, and donor RCH517(a) allele, had nucleotide 
bases for amino acid residue 'He', whereas the published long C4A 
*3a allele, as well as donors WCY1158 (B *7), ECY 028 (B *2) and 
RCH517(b) alleles, had nucleotides which encode residue 'Met'. In 
addition, heterogeneity was detected for nucleotide bases encoding 
residue #328. The C4A *CAN1 and B *5 alleles, and donor 
RCH517(a) allele, and the published A *3a alleles had nucleotide 
bases which encode residue 'Tyr'. Donors WCY1158 (B *7), ECY 028 
(B *2) and RCH517(b) alleles had nucleotides which encode residue 
'Ser'. These results were the same as those obtained by PCR-RFLP 
analysis of nucleotide bases encoding residue #328 (section 4.4.2.1).
Sequencing the short C4 genes of the above donors, found intron 9 
to be 420 bp compared with approximately 7 kb in the long type of 
C4 gene reported by Yu (1991). Polymorphism between the short 
C4 alleles sequenced in this study and the published sequence of 
A*3a'  (Yu, 1991) was detected of nucleotide bases in intron 9. For 
convenience, intron 9 has been numbered from 1 to 420 bp in this 
study. Yu (1991), detected two copies of the mobile genetic element 
5'-acagaca-3', at the beginning and end of the long C4 gene 'C4A 
*3a'. In these studies a single copy of the mobile genetic element 
was detected in the short C4 alleles which were sequenced from 
intron 9 base #281 to #287 (Figure 4.3). A polymorphic nucleotide 
base #280, which may distinguish long from short C4 alleles, was 
found closely situated to the mobile genetic element in intron 9. Yu, 
(1991), found this base was a 'cytosine' in the long C4 allele '*A3a'.
In these studies however, the base was found to be a 'thymine' in the 
short C4 alleles.
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Other polymorphic nucleotide bases of intron 9 in short C4 alleles 
were detected in this study (Figure 4.3), which are: (1) The 70th 
nucleotide base of intron 9 in each short C4 allele which encoded 
'guanine', whereas the long A *3a sequence (Yu, 1991) encoded 
'adenine'; (2) The short C4 alleles from this study had 'adenine' at 
nucleotide base #295 of intron 9, whereas Yu (1991) reported 
'guanine' for this nucleotide base in the long A *3a allele; (4) Intron 
9 nucleotide base #304 in the short C4 alleles was 'cytosine', 
whereas Yu (1991) reported 'thymine' for this base in the long A 
*3a allele; (5) Nucleotide base #354 of intron 9 in short C4 alleles of 
this study was 'thymine', whereas Yu (1991) reported 'cytosine' for 
this base in the long A *3a allele. Yu (1991), reported nucleotide 
base 'cytosine', at base positions #87 and #119 in intron 9 of the long 
C4A *3a allele. However, these nucleotide bases were deleted in the 
short C4 alleles of this study (Figure 4.3). One other polymorphism 
was detected in intron 9 at nucleotide base #238 (Figure 4.3). The 
long A *3a allele reported by Yu (1991), and short C4 alleles from 
donors H14 (C4A CAN*1) and WCY1158 (B *7) and ECY028 (B *2) 
in this study, had nucleotide base 'thymine', whereas both types of 
short C4 alleles of donor RCH517 in this study, had 'guanine'.
A number of these polymorphic sequences can be detected by 
restriction analysis, and therefore could potentially be useful in the 
PCR-RFLP protocol. Of those polymorphisms detected in intron 9, the 
following can be detected by various enzymes; nucleotide base #70 
by Hgi Cl and Nla 4; base #238 by Bsr I, Sec I, EcoR II, Bss KI,
Aea I, and Scr FI; #280 by Rsa I, Bsp 140, Csp 61, and Sph I; 
and #304 by Hin 61 and Hha 7. The deletion which was detected in 
intron 9 of base HI 19, can be detected by restriction enzyme Sec I. 
Polymorphic nucleotide bases encoding amino acid residues #306 and 
#328 can be detected by restriction enzymes Alu 1 and Pie I, 
respectively. Alu I restriction analysis of nucleotides encoding 
residue #306 has been included in the PCR-RFLP allotyping protocol. 
A number of polymorphic nucleotide bases including those which 
encode residue #309, nucleotide bases #295 and #354 in intron 9, 
and the deletion of base #87 in intron 9, are not recognised by 
restriction enzymes which are commercially available.
133
4.4.2.2 Amino acid residue #306
PCR-RFLP analysis of nucleotide bases encoding amino acid residue 
#306 for each donor, and resulting restriction fragment banding 
patterns are shown in Tables 4.5 and 4.6, and Figure 4.2. The 
majority of C4 alleles had nucleotide bases which encode amino acid 
residue 'Lys' for residue #306, in both long and short C4 genes. 
Nucleotides encoding amino acid residue 'Met' were mainly found in 
donors having rare alleles, and were not necessarily associated with 
either long or short C4 alleles.
4.4.2.3 Amino acid residue #458
PCR-RFLP banding patterns for polymorphic amino acid residues 
#458 are represented in Figure 4.4, and a summary of results for 
each donor is given in Tables 4.8 and 4.9. In this study, only a single 
Caucasian donor 'JC003' having the allotype C4A *3, *6 B *7, showed 
polymorphism of residue #458 encoding 'Trp' (see Table 4.9). It is 
possible the C4A *6 protein in this donor is haemolytically inactive, 
as the same polymorphism has been reported for the haemolytically 
inactive A *6 allele described by Anderson et al. (1992).
4.4.2.4 Amino acid residue #707
PCR-RFLP banding patterns from restriction of nucleotide bases 
encoding amino acid residue #707 are shown in Figure 4.4. 
Polymorphism of nucleotide bases encoding this amino acid residue 
was not detected amongst the C4 alleles represented in this study 
(see Tables 4.8 and 4.9). Amino acid residue 'Pro' was encoded by 
nucleotides in each allele. Nucleotides of C4A*3a allele described by 
Yu (1991), and Belt et al. (1984), however, were found to encode 
'Leu'. Yu (1991), reported that residue 'Leu' was not detected in a B 
*5 or B *3 allele, nor in ten other randomly chosen donors. This 
amino acid residue was therefore most probably the result of a rare 
m utation.
1 34
Figure 4.4 PCR-RFLP banding patterns of nucleotide bases encoding 
C4 allele polymorphic amino acid residues #458, #707, #1054 and 
#1101 -# 1106. Examples of each banding pattern are listed as lane 
numbers for the respective amino acids. Where homozygote 
examples of each banding pattern could not be shown, a 
heterozygous example was referred to. Molecular weight markers 
consisted of pBR322  restricted with either Msp I or Hae III, and 
resulting fragment sizes (bp) of each are listed in Figure 2.1, Chapter 
2. pBR322  restricted with Msp I resulting in 67, 76, 90, 110, 123,
147, 160, 180, 190, 201, 217, 238, 242, 309, 404, 527, and 622 base
pair fragments are shown in lane 9 in the gel for amino acid residue
#458 as well as the 34 bp fragment, lane 1 for residue #707, and 
lane 2 for the gel corresponding to residue #1101-#! 106. pBR322  
restricted with Hae III resulting in 18, 21, 51, 57, 64, 80, 89, 104,
123, 124, 184, 192, 213, 234, 267, 434, 458. 504, 540, and 587 base
pair fragments are shown in lane 2 for residue #1054. Unrestricted 
PCR DNA fragments are shown in lanes 2 and 1 of the gels 
corresponding to amino acid residues #707 and #1101 -# 1106, 
respectively. Unrestricted PCR fragments for PCR-RFLP analysis of 
residues #458 and #1054 are not shown in this figure. Small PCR 
fragments less than 19 bp were lost by gel electrophoresis for 
residue #1054, and fragments less than 40 bp for residues #1101- 
#1106.
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4.4.2.5 Amino acid residue #1054
PCR-RFLP banding patterns from restriction analysis with enzyme 
Fnu4Hl  are shown in Figure 4.4, and a summary of the results for 
each donor is given in Tables 4.8 and 4.9. Amino acid residue #1054 
is polymorphic, having nucleotide bases encoding either residue 'Gly' 
or 'Asp'. It is isotypic for the majority of C4A alleles, and allele- 
specific for C4B alleles (Tables 4.8 and 4.9). The A *2 alleles of 
donors ECY504 and ECY302 were found to be exceptions by having 
nucleotide bases which encode residue 'Gly' for residue #1054. This 
was also reported by Paz-Artal et al. (1993). Other researchers have 
found residue 'Gly' for residue #1054 in C4A *7 alleles and also in 
C4A *2 (Yu et al., 1986; Anderson et al., 1992). In this study, 
residue #1054 in C4B *7, B *72, B *22, B *3, B *4 and 
B *5 alleles was found to be 'Gly', whereas in C4B *2 and B*6 it 
was 'Asp', (Table 4.8 and 4.9). Others have found the same 
association of 'Gly' with C4B *7 and 'Asp' with C4B *2 (Belt et al., 
1984, and 1985; Yu et al., 1986; Yu., 1991; Anderson et al., 1992). 
Consistent with results here, Yu et al. (1986), found B *3 to have 
residue 'Gly' for residue #1054, whereas contrary to results found 
here, the C4B *5 allele was reported to have 'Asp'. Belt et al. (1985), 
detected another C4B *7 allele named C4B *lb, which had residue 
'Asp' encoded by nucleotides for residue #1054. A number of 
individuals found to be heterozygous for residue #1054 were 
homozygous by C4 protein gel electrophoresis. For example, C4A 
alleles of donor EW-Ducaf, and C4B alleles of donors ECY 178 and 
WCY1174.
4.4.2.6 Amino acid residues #1101 -# 1106
Amino acid residues #1101 -#1106 were isotypic in nature. This 
region of the C4 gene is conserved and distinguishes C4A from C4B  
alleles. In this study, individual's C4A alleles had residues 
'Pro,Cys,Pro,Val,Leu,Asp', whilst their C4B alleles had 'Leu,Ser,Pro, 
Val,Ile,His' (Figure 4.4 and Tables 4.8 and 4.9). Other researchers 
have reported the same finding with C4 alleles (Belt et al., 1984 
and 1985; Yu et al., 1986; Yu, 1991; Anderson et al., 1992; Paz- 
Artal et al., 1993). Both EW-L0081785 and EW-Ducaf are Caucasian
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donors with deleted C4B genes, and therefore only C4A isotypic 
residues were detected (Figure 4.4 and Table 4.9).
4.4.2.7 Amino acid residue #1157
PCR-RFLP banding patterns from restriction analysis using enzyme 
Alu /, and results for each donor are shown in Figure 4.5, and Tables
4.8 and 4.9. As with residue #1054, amino acid residue #1157 was 
generally isotypic, C4A alleles encoding 'Asn' and C4B alleles 
encoding 'Ser'. Exceptions were detected in donors WCY1174, ECY 178 
and JC003, where residue 'Asn' was found in the nucleotide sequence 
of the C4B alleles (Table 4.8 and 4.9). Similarly, other researchers 
have found 'Asn' in the nucleotide sequence of a C4B *la allele (Belt 
et al., 1985). Another exception was detected in C4A alleles of 
donors EW-L0081785 and EW-Ducaf, where residue 'Ser' was present 
instead of 'Asn'. The C4A *7 allele has also been reported to have 
'Ser' at this residue (Yu et al., 1986; Anderson et al., 1992).
4.4.2.8 Amino acid residue #1182
Polymorphism of residue #1182 has only been detected in a C4A *4 
allele, where nucleotide bases were found to encode amino acid 
residue 'Ser' by cDNA sequencing (Belt et al., 1984). All other 
reported nucleotide base sequence studies for both C4A and C4B  
alleles found amino acid residue 'Thr' encoded for residue #1182 
(Belt et al., 1985; Yu et al., 1986; Yu., 1991; Kawaguchi et al.,
1992b). To determine if residue #1182 was polymorphic in C4A 
alleles, allele specific oligonucleotide (ASO) hybridisation of C4A 
specifically amplified PCR products from Aboriginal Australians and 
three Caucasian controls (described in section 4.3.10.1), was carried 
out. This study detected nucleotide bases encoding amino acid 'Thr' 
for #1182. Sequencing the gene region encoding this residue in donor 
ECY743 having an A *3 allele, and another donor ECY519 having an 
A *4 allele, found only nucleotide bases encoding residue 'Thr'. The 
presence of nucleotide bases encoding amino acid residue 'Asn' for 
residue #1157 confirmed that only the C4A gene, and not the C4B
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Figure 4.5 PCR-RFLP banding patterns of nucleotide bases encoding 
polymorphic amino acid residues #1157, #1186, #1188, #1191, and 
#1267 in C4 PCR fragments. Examples of each banding pattern are 
listed as lane numbers for the respective amino acids. Restriction 
analysis by enzyme Aci I of the same PCR product identified which 
nucleotide bases encoded residues #1188 and #1191. Four 
photographs of gels representing the larger (429 and 510 bp) and 
smaller (73 and 51 bp) PCR fragment banding patterns of nucleotides 
encoding residues #1188 and #1191 surround the table showing the 
respective amino acid residues. Molecular weight marker pBR322  
restricted with Msp I was used for each gel and is represented by 
67, 76, 90, 110, 123, 147, 160, 180, 190, 201, 217, 238, 242, 309,
404, 527, and 622 base pair fragments in lane 2 and 8 for residue 
#1157, lanes 17, and 21 for residues #1188 and #1191, and lane 2 
for residue #1267. Molecular weight markers 622, 527, 404 and 309 
base pair fragments are shown in lane 1 for residue #1186 and lane 
7 for residues 1188 and 1191, and an additional fragment of 242 
base pairs is shown in lane 17 for residue 1186 and lane 14 for 
residues 1188 and 1191. Unrestricted PCR DNA fragments are shown 
in lane 1 and 7 for gels corresponding to residue #1157, lane 2 and 
18 for gels corresponding to residue #1186 table, lane 8, 15, 16, and 
22 for gels corresponding to residues #1188 and #1191 table, and 
lane 1 for the gel corresponding to residue #1267 table. Only the 
larger (396 and 481 bp) fragments are shown in the gels 
corresponding to residue #1186 table. Fragments less than 41 bp 
were lost during gel electrophoresis.
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gene, had been sequenced.
4.4.2.9 Amino acid residue #1186
Results of PCR-RFLP analysis of nucleotide bases encoding residue 
#1186 for each donor, and examples of the resulting restricted 
fragment banding patterns are shown in Tables 4.8 and 4.9, and 
Figure 4.5. Polymorphism of nucleotide bases encoding this amino 
acid residue was only detected at the nucleotide base level, 'gcg' for 
C4A alleles, and 'gcc' for C4B alleles. This study showed that these 
bases were isotypic in nature as were nucleotide bases encoding 
amino acid residues #1101 -# 1106, and therefore were useful for 
distinguishing C4A from C4B alleles. Kawaguchi et al. (1992b), 
found that the A *7 allele, unlike other C4A alleles, encoded 
nucleotide bases 'gcc' at this position. Studies here, found 
heterozygosity of the nucleotide bases encoding amino acid residue 
#1186 in C4B alleles of donors WCY1174, ECY 178 and ECY 302 
(Table 4.8).
4.4.2.10 Amino acid residues #1188 and #1191
Results of PCR-RFLP analysis of nucleotide bases encoding residues 
#1188 and #1191 for each donor, and examples of the resulting 
restricted fragment banding patterns, are shown in Tables 4.8 and 
4.9, and Figure 4.5. For the majority of donors, nucleotide bases 
encoding amino acid residue #1188 were isotypic in nature, encoding 
'Val' for C4A and 'Ala' for C4B alleles. Similarly, nucleotide bases 
encoding residue #1191 were isotypic in nature, encoding 'Leu' for 
C4A, and 'Arg' for C4B alleles (Table 4.8 and 4.9). C4B alleles of 
donors WCY1174, ECY 178, and ECY 302 were an exception, having a 
combination of residues encoded by nucleotides which are common 
to C4A and C4B isotypes, for residues #1188 and #1191. Anderson 
et al. (1992), similarly found the C4A *7 allele had nucleotide bases 
which encoded 'Ala' for residue #1188 and 'Arg' for residue #1191 , 
and in the case of the C4B *5 allele, Yu et al. (1986) found 'Val' and 
'Leu' were the respective amino acid residues. Of interest also here 
was the detection of heterozygosity for residue #1191 in donor JC003
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C4A alleles, whereas residue #1188 was homozygous in this donor. 
This combination of C4A and C4B residues for residues #1188 and 
#1191 in the same allele has not previously been reported. Usually a 
C4 allele will have either C4A- or C45-type amino acid residues 
for residues #1188 and #1191 and not a combination of C4A and 
C4B residues in the one haplotype.
4.4.2.11 Amino acid residue #1267
Results of PCR-RFLP analysis of nucleotide bases encoding residue 
#1267 for each donor are given in Tables 4.8 and 4.9, and examples 
of the resulting restricted fragment banding patterns are shown in 
Figure 4.5. Nucleotide bases encoding this amino acid residue were 
relatively non-polymorphic, encoding residue 'Ala' for both C4A and 
C4B alleles of most donors. Nucleotide bases encoding amino acid 
residue #1267 were polymorphic for the C4A *5 alleles of donors 
ECY 858 and A *3, *6 alleles of donor JC003 . The association of 
amino acid residue 'Ser' with A *3 alleles (Tables 4.8 and 4.9) is not 
surprising considering nucleotide bases encoding ’Ser’ have 
previously been detected in cDNA sequence of both A *3b and A *4 
alleles (Belt et al., 1984, and 1985). However, it is not certain if 
residue ’Ser' is associated with the A *3 or A *6 allele in donor 
JC003. The C4A alleles of donor EW-L0081785 remained 
unrestricted, suggesting there may be another sequence of nucleotide 
bases for residue #1267.
4.4.3 C4 allele-specific polymorphism
Identification of heterozygous C4A and C4B alleles by C4 protein 
gel electrophoresis was often difficult (Chapter 3). It was possible to 
assign polymorphic amino acid residues to specific C4A and C4B 
alleles by the analysis of: (1). Data from C4 protein gel 
electrophoresis (Figures 4.6, 4.7 and 4.8); (2). PCR-RFLP results from 
donors listed in Tables 4.8 and 4.9; (3). C4 nucleotide sequences, 
both from this study and that published by other researchers (Belt 
et al., 1984 and 1985; Yu et al., 1986; Yu, 1991; Anderson et al.,
1992; Paz-Artal et al., 1993); and (4). Computer protein analysis for 
predicting a proteins isoelectric point (PI) according to its derived
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Figure 4.6 C4B 12 and C4B 22 allotypes identified by protein gel 
electrophoresis. Schematic diagram showing the relative migration 
distances of C4  allotypes (VI complement genetics workshop 
reference typing), is reproduced with permission from W H O  
Bul l e t in ,70: 531-535, (1992). C4 allotypes for donor serum samples 
are as follows: Lanes 1 , A  3 B 1 standard; 2, A 3 B 1,12 WCY1204;
3,A  4 B 1,2 ECY024; 4 , A  3 B 1 standard; 5, A 2 B 1,12, WCY1204;
6, A 3,Q0 B 1 ECY851; 7, A 3 B 1 standard; 8, A 3 B 12 WCY1179;
9 , A  4 B 2 (A M B  *22,*2) JC001; 10, A 4 B 1,2 WCY1213. C4  
allotypes which were different by PCR-RFLP are enclosed in brackets 
after the allotypes detected by protein gel electrophoresis. Samples 
in lane 4, 5, 6, 9, and 10 had been treated with C a r b o x y p e p t i d a s e  
B prior to gel electrophoresis.
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Figure 4.7 C4 allotypes identified by protein gel electrophoresis. 
Schematic diagram showing the relative migration distances of C4  
allotypes (VI complement genetics workshop reference typing), is 
reproduced with permission from WHO Bulletin, 70: 531-535,
(1992). C4 allotypes for donor serum samples are as follows: 1,A 3 
B 1 standard; 2, A 3,Q0 B 1 WCY1159; 3, A 2,4 B 2 (A *4 B *2, *6) 
WCY1174; 4, A 3 B 1 standard; 5, A 2,4 B2 (A *4 B *2, *<5J 
WCY1174; 6 ,A  3 B 1 standard; 7, A 2,4 B 2,4 ECY302; 8, A 3,6 B 
1,2 ECY556; 9 , A 3 B 1  standard; 10, A 2,4 B2,4 ECY302. C4 
allotypes which were different by PCR-RFLP are enclosed in brackets 
after allotypes detected by protein gel electrophoresis. Samples in 
lane 4, 5, 8, and 10 had been treated with Carboxypeptidase B , 
and therefore only the most anodally travelling protein band of each 
C4 allele can be seen.
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Figure 4.8 C4 allotypes identified by protein gel electrophoresis. 
Schematic diagram showing the relative migration distances of C4  
allotypes (VI complement genetics workshop reference typing), is 
reproduced with permission from WHO Bulletin, 70: 531-535,
(1992). C4 allotypes for donor serum samples are as follows: 1,A  
4,6 B 2 (A *4, *58 B *2, *5) ECY178; 2 , A 4  B 1,2 ECY046; 3 , A 3  B 1 
standard; 4, A 2,4 B 1,2 (A *2, *4 B*2, *22) ECY432; 5, A 3 B 1 
standard; 6, A 3 B 1 standard; 7, A4 B 2 (A *4 B *22, *2) JC001; 8,
A 4 B 2,4 ECY168. C4 allotypes which were different by PCR-RFLP 
are enclosed in brackets after allotypes detected by protein gel 
electrophoresis. Samples in lane 6, 7, and 8 had been treated with 
Carboxypeptidase B prior to gel electrophoresis.
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amino acid sequence. Absence of C4A DNA contaminating the PCR 
reaction during C4B amplification, and C4B DNA contaminating the 
PCR reaction during C4A amplification, was shown by the lack of 
amplification of C4A and C4B isotypes DNA in homozygous C4B 
and C4A allele donors, respectively. PCR-RFLP results of donors with 
polymorphic nucleotide bases for a particular amino acid residue 
were repeated for confirmation. Results of these analyses are shown 
in Tables 4.10 and 4.11.
4.4.3.1 C4A alleles
Previous studies found the A *7 allele to be different from other 
C4A alleles by encoding amino acid residue 'Gly' for residue #1054, 
'Ser' for #1157, 'gcc' nucleotide bases for amino acid residue #1186, 
as well as residues 'Ala' and 'Arg' for residue #1188 and #1191, 
respectively (Yu et al., 1986). Studies here found the derived amino 
acid sequence for the A *7 allele to have a PI of 7.16 (Table 4.10). 
Amino acid residues #1054 and #1191 of the A *7 allele have a 
different charge to these residues in other C4A alleles, and therefore 
were thought to be responsible for the A *7 alleles unique migration 
pattern by C4 protein gel electrophoresis.
This study, and that of Paz-Artal et al. (1993), found the A *2~ 
allele to be different from all other C4A alleles by encoding residue 
'Gly' for residue #1054. Examples include C4A alleles of donors ECY 
504 and ECY 302 (Table 4.8). It should be noted that the A 2 
allotype identified by protein gel electrophoresis was confirmed by 
the C4 standard reference typing laboratory in Western Australia. 
Three other donors in this study, namely ECY 481 with A *2, *3, ECY 
581 with A *2, *4, and Caucasian 'JC004' with A *2, had amino acid 
residue 'Gly' for residue #1054, but these are not shown in Table 4.8. 
The A *2 allele's combination of amino acid residues results in a 
protein with a PI of 7.11, which corresponds with its migration 
pattern by C4 protein gel electrophoresis (Figure 4.7).
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Studies for this thesis, and other researchers, have identified a 
number of A *5 alleles, including A *3ci~, A *3b~, and A *5c~
(found here); A *3a (Yu et al., 1986), and A*3b (Belt et a l 1984 
and 1985). Published A *3a has amino acid residue 'Leu' for residue 
#707 (Yu, 1991), whereas A *3a~ in this study, has residue 'Pro' 
(Table 4.10). This study detected the published A *3b allele in donor 
ECY 858 (Table 4.8), which was denoted here as A *3b~. The C4A 3 
allotype, determined by protein gel electrophoresis for donor ECY 
858, was confirmed by the C4 standard reference typing laboratory 
in Western Australia. In this study the A *5c~ allele was detected in 
donors EW-Ducaf and EW-L0081785. This allele was different to 
other previously described A *3 alleles, encoding amino acid residue 
'Ser' for residue #1157. The combination of amino acid residues 
encoded by nucleotides for each C4A allele of donor EW-Ducaf were 
difficult to interpret as polymorphism of residue #1054 was 
detected. Polymorphism of residue #1157 was only detected in A *7 
and A *2 alleles. Neither of these alleles were detected by protein 
gel electrophoresis for these donors. Also, unrestricted DNA 
fragments resulting from PCR-RFLP analysis of nucleotide bases 
encoding residue #1267 in donor EW-L0018785, suggests other 
nucleotide bases encode this residue. These results suggest other 
types of A *5 alleles may exist.
The published A *4 allele sequence was essentially the same as 
published A *3b, except A *4 had amino acid residue 'Ser' instead 
of 'Thr' for residue #1182 (polymorphic amino acid residues of these 
alleles, with the exception of residue #1182, are shown in Table 
4.10). Alleles A *4~ (Donor ECY 028), and A *3a~ (Donor ECY 751), in 
these studies, had an identical composition of amino acid residues 
(Table 4.10), but different migration patterns were observed by 
protein gel electrophoresis. The C4 allotypes of these donors were 
confirmed by the C4 standard reference typing laboratory in 
Western Australia. Computer protein analysis of the derived amino 
acid sequence of each type of A and A *4 allele in this and other
studies, found the same PI of 7.05, despite their amino acid 
differences.
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An A *<5 allele, which was previously described by Anderson et al. 
(1992), was found in Caucasian donor JC003 in this study (Table 4.9). 
Another type of C4A allele was detected in Aboriginal Australian 
donors WCY1158 and ECY 178 (Table 4.8), which produced a similar 
migration pattern as the A *6 allele by protein gel electrophoresis. 
This novel C4A allele, unlike the A *6 allele, had amino acid residue 
'Arg' for residue #458, and 'Met' for residue #306, and was therefore 
denoted as an A *58- allele. The C4A allotype of donor ECY 178, as 
determined by protein gel electrophoresis, was confirmed by the C4 
standard reference typing laboratory in Western Australia, and was 
found to migrate between the A 5 and A 6 alleles. Unfortunately, 
the serum sample of donor WCY1158 upon arrival in Western 
Australia was degraded, and therefore could not be allotyped by 
protein gel electrophoresis. In this study, the derived amino acid 
sequence of A *<5~ and A *58- alleles produced the same PI value of 
7.0, which corresponded to the migration patterns of these alleles by 
protein gel electrophoresis (Figure 4.7 and 4.8).
4.4.3.2 C4B alleles
The B *7- allele in Aboriginal Australian and Caucasian donors 
(Table 4.11), was found here to have the same amino acid residues as 
the published B *lb allele (Belt et al., 1985). B *la, described by 
Belt et al. (1985), was different to the B *7- alleles studied here, as 
nucleotide bases from Belt's study encoded 'Asn' instead of 'Ser' for 
residue #1157. Computer protein analysis of the B *7- allele found a 
PI value of 7.23. Substituting amino acid residue 'Asn' for 'Ser' for 
residue #1157 did not alter the PI value of this allele. This result is 
not unexpected considering both types of amino acid residues #1157 
were neutral-polar, and therefore were not expected to result in a 
differently charged protein or to affect the migration of the protein 
by gel electrophoresis.
The B *2- allele in this study (Table 4.11), had an identical 
polymorphic amino acid residue composition as the published B *2 
allele (Belt et al., 1984, and 1985; Yu, 1991; Anderson et al., 1992). 
The B *2- allele was different to the B *7- allele by having 
nucleotide bases for amino acid residue 'Asp' instead of 'Gly' for
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residue #1054. This amino acid residue change, results in a charge 
change from an acidic to a neutral, non-polar residue, and therefore 
is thought to be responsible for the B *2- allele having a PI of 7.18, 
which corresponds to its migration pattern by protein gel 
electrophoresis. Examples of the electrophoresis migration pattern of 
the 'B 2' allele are shown in Figures 4.6, 4.7, and 4.8.
The rare C4B allele, B 12 (Chapter 3; Ranford et al., 1987), for 
which the molecular basis had not previously been described, was 
found to migrate between the B 1 and B 2 alleles by protein gel 
electrophoresis (Figure 4.6). This migration pattern for donors 
WCY1179 and WCY1204 was confirmed by the C4 standard 
reference typing laboratory, Western Australia. In these studies, this 
allele was found to have amino acid residue 'MET' for residue #306 in 
long C4 alleles, unlike B *1~ and B *2- alleles which have 'Lys' 
for this residue. The B *12- allele had amino acid residue 'Gly' for 
residue #1054 as did the B * l -  allele. The PI value for B *12- was 
found to be the same as the B *2- allele (7.18). Donor WCY1204, who 
was heterozygous at the C4B locus (B *1,*12), could be 
distinguished by gel electrophoresis. However, the resulting C4B  
protein bands merged into each other making interpretation of the 
C4 allotype by this method difficult (Figure 4.6).
Another C4 novel allele denoted as B *22-, was detected by PCR- 
RFLP analysis in donors ECY 248, ECY 432 and JC001. Donors ECY248 
and ECY432 were allotyped as B 1,2, and JC001 as B 2 by protein 
gel electrophoresis. Donor's ECY 248 and ECY 432 allotypes were 
confirmed by the C4 standard reference typing laboratory in 
Western Australia. The polymorphic amino acid residue composition 
of the B *22- allele was found to be similar to the B *12- allele. 
However, unlike the B *12- allele, B *22-, had 'Met' for residue 
#306 in the short C4 allele instead of the long C4 allele (Table 4.5).
All other residues in the B *22- allele were identical to those of the 
B *12- allele, except for residue #328 where B *12- had 'Tyr', and 
B *22- had 'Ser'. Polymorphic residues for #328 do not result in a 
differently charged C4 protein. However, amino acid 'Tyr' is larger 
than 'Ser', and may slightly affect the mobility of the B *22- protein 
migrating more closely to B 2 than B 12 by protein gel
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electrophoresis. The B *22- allele was identified by the detection of 
heterozygosity of nucleotides encoding residue #306 in the short C4 
genes PCR product. This indicated that two different short C4 alleles 
were present in donors ECY248 and ECY432. Both short C4B alleles 
have 'Ser' for residue #328, whereas the long alleles in these donors 
have Tyr'. Taq I RFLP analysis of donor ECY 248 (Table 4.7), found 
long C4 genes at locus I and II, as well as short C4 genes at locus II. 
Taq I RFLP analysis together with PCR-RFLP analysis of the same 
donor suggests there may be two types of short C4 genes, and a long 
C4 gene at locus II on the same haplotype. C4 protein gel 
electrophoresis of donor ECY 248 found A 4 B 1,2. It is possible that 
another C4B allele, such as B *1 or B *12-, is masked by the other 
C4B alleles by PCR-RFLP analysis. Unfortunately, Taq I RFLP 
analysis data is not available for donors ECY 432 and JC001 to 
determine if a similar gene organisation to ECY 248 is present. 
Allotypes A 2,4 B 1,2 of donor ECY432, A 4 B 1,2 of donor ECY248, 
and A 4 B 2 of donor JC001, as determined by protein gel 
electrophoresis, suggest that the B *22- allele is not visible by gel 
electrophoresis and co-migrates with B 2 (Figure 4.6 and 4.8, donor 
ECY 248 not shown).
Donor RCH517 was found by protein gel electrophoresis to have a B 
3 allele which had the same polymorphic residues (#1054 to #1186) 
as those of the published B *3 allele (Yu et al., 1986). Both PCR- 
RFLP and sequence analysis of B *3- from donor RCH517 found 'Met' 
and 'Tyr' were encoded by nucleotides for residues #306 and #328, 
respectively. By assuming the published B *3 allele and the B *3- 
allele described in this study were the same allele, the PI of this 
allele was estimated to be 7.18, which is the same as for the B *2- 
allele. However, there is evidence suggesting that these two types of 
B *3 alleles are not the same. The B *3- allele described in this 
study, has 'Tyr' for residue #328, and was found to be a short C4 
allele by PCR and sequence analysis. The published B *3 allele, 
however, was a long C4 allele (Yu et al., 1986), and nucleotide bases 
encoding residue #328 were not reported. Those nucleotide bases 
which have been analysed for the B *3- allele in this study, have the 
same composition as the B *12- allele. However, their migration
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patterns are different by protein gel electrophoresis. Also, PCR-RFLP 
analysis has identified two types of short C4B alleles in donor 
RCH517, whereas protein gel electrophoresis only detected one type 
of C4B allele.
Donor 'ECY 302', was found to be heterozygous at the C4B locus by 
protein gel electrophoresis, having both B 4 and B 2 alleles (Figure
4.7) . The B 4 allele was difficult to identify by having a similar 
migration pattern to the A 1 allele by protein gel electrophoresis.
The C4 standard reference typing laboratory, Western Australia, 
confirmed that donor ECY302 had a B 2 allele, however, the second 
C4B allele of this donor was reported to be haemolytically active 
(indicating a C4B allele and not C4A allele), and migrates more 
anodally than the B 3 allele by protein gel electrophoresis. PCR-RFLP 
analysis of C4A and C4B alleles separately, of donor ECY302, 
enabled the B *4~ and B *2~ alleles to be easily identified (Table
4.8) . Polymorphic residues, which were different to the well- 
described B *2 allele, were assumed to be possessed by the B *4~ 
allele. The polymorphic amino acid residue composition of the B *2~ 
and B *4~ alleles was different. However, the PI value from the 
derived protein sequence for each allele was the same. The same PI 
value for these two alleles was not consistent with their different 
migration patterns by gel electrophoresis (Figure 4.7).
Donor ECY 178 was found to have the allotype B 2 using the 
traditional method of protein gel electrophoresis (Figure 4.8). This 
was confirmed by the C4 standard reference typing laboratory in 
Western Australia. However, PCR-RFLP analysis, found 
heterozygosity of polymorphic residues at the C4B locus.
Polymorphic residues from the well-described B *2 allele were 
assigned as B *2 residues. The remainder were assigned to a second 
C4B allele, were collectively analysed, and found to have a PI value 
of 7.12 (Table 4.11). According to the PI of other C4 alleles, this 
allele with the PI value of 7.12 would migrate between an A 7 and 
an A 2 allele, and therefore was denoted as B *5~. In comparison 
with the B *5 allele described by Yu et al. (1986), the B *5~ allele 
from this study was different, encoding amino acid residues 'Gly' and 
'Asn' for residues #1054 and #1157, respectively (Table 4.11).
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Donor 'WCY1174', was thought to have the C4 allotype A 2,4 B 2, as 
determined by protein gel electrophoresis (Figure 4.7). However, 
PCR-RFLP allotyping detected heterozygosity of residues at the C4B 
locus (Table 4.8). Nucleotide bases encoding amino acid residues 
common to the B *2 allele were assigned as B *2~ residues, whilst 
the remaining residues were collectively analysed and found to have 
a PI of 7.07. This PI value corresponded to the migration pattern 
produced by a C4B allele migrating between an A 2 and an A 3 
allele, and was therefore denoted as a ß *<5~ allele. By re-analysing 
the allotype of donor WCY1174 as determined by protein gel 
electrophoresis (Figure 4.7), together with PCR-RFLP allotyping and 
the PI value, it was possible to determine the C4 allotype of this 
individual as A *4 B *2,*6.
4.4.3.3 Long and short C4 genes
For some alleles in this study, it was possible to identify whether 
they were of the long or short C4 gene type. Where possible, this 
information together with published data regarding C4 gene size of 
different alleles was used to establish the amino acid composition of 
some C4 alleles. Results of PCR-RFLP analysis in this study suggested 
there was an association between long C4 genes (23 kb) and 
nucleotide bases encoding the amino acid Tyr' for residue #328. For 
the majority of donors studied, those alleles amplified using the PCR 
primers which only amplified short C4 genes were found to have 
nucleotide bases for amino acid 'Ser' for residue #328. For those 
alleles amplified using the primers which amplify both long and 
short C4 genes, amino acid residues 'Tyr' and 'Ser' were usually 
encoded by nucleotides for residue #328. It was therefore not 
possible to determine if residue 'Ser' was also encoded by the long 
C4 genes.
Donor ECY 178 was found to have two short C4B alleles (B *2~, *5~) 
by PCR-RFLP analysis and one C4B allele (B 2) as determined by 
protein gel electrophoresis. Heterozygosity of residues #306 and 
#328 were detected in the short C4 gene PCR product (Table 4.5). 
Nucleotide bases encoding amino acid 'Tyr' were thought to be those 
of the B *5~ allele, as only nucleotides encoding amino acid 'Ser' had
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been detected in B *2~ alleles in this study and elsewhere (Belt et 
al., 1984 and 1985). The B *5 allele described by Yu et al. (1986), 
was a short allele. The short B *5~ allele in this study was different 
to other short C4 alleles by having amino acid 'Tyr' for residue #328. 
The only other short C4 allele encoding amino acid residue 'Tyr' was 
the C4A *CAN1~ allele described in Chapter 5. The C4 gene region 
encoding polymorphic amino acid residues #306 and #328 had not 
been sequenced for the majority of published C4B alleles (Belt et 
al., 1985; Yu et al., 1986), and therefore few comparisons could be 
made with the literature (see Table 4.11 as a summary).
Short C4A alleles have been reported for allotypes C4A *35 B *5 
(Schneider, 1990), and C4A *11,*6 B *Q0 (Giles et al., 1987), by 
RFLP analysis of the C4 gene region. Short C4A alleles were found 
to occur in only one of 103 donors (Schneider., 1990). Two published 
C4A alleles, namely A *3b and A *4 (Table 4.10), had amino acid 
'Ser' for residue #328. Whether these alleles were long or short has 
not been reported. The A *3b~ allele detected in donors ECY 858 and 
JC003 in these studies, was found to encode amino acid residue 'Ser' 
for residue #328 and 'Ser' for residue #1267. Taq I RFLP analysis 
would be required to determine if the A *3b~ allele is a long or short 
type of C4 gene. This hypothesis has not yet been tested due to a 
shortage of donor genomic DNA. It has been reported that the A *1 
and A *3a alleles are of the long C4 gene type (Yu et al., 1986).
Donors WCY1204 and WCY1179 had only long C4 genes, as 
amplification of the short C4 gene using primer pair 1 (Table 4.1), 
was unsuccessful, and Taq 1 RFLP analysis of donor WCY1204 
genomic DNA found only long C4 genes at both loci I and II (Table 
4.7). Each C4 allele in these donors had amino acid 'Tyr' for residue 
#328 (Table 4.5).
4.5 Discuss ion
C4 allotypes (defined in Chapter 3), as determined by C4 protein 
gel electrophoresis, provided a useful resource for the development 
of a C4 molecular allotyping protocol. This study found more 
polymorphism of C4 allotypes by PCR-RFLP analysis in comparison
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to protein gel electrophoresis. However, as a result of gene 
duplication, it is possible that some C4 alleles are overlooked by 
PCR-RFLP analysis, and therefore one must rely on either Taq I 
RFLP or PFGE to determine the gene organisation in these donors.
C4A alleles A *7, A *2~,A*5<3,A *3c~, A *58-, A *6, and C4B 
alleles B 7-, B *72~, B *22-, B *2, B *4~, B*5~ and B *6-, can now 
be allotyped individually using PCR amplification and restriction 
analysis by utilising the isotypic region of C4 genes and differential 
size of C4 intron 9. This procedure enables heterozygous alleles at 
loci I and II of the C4 gene region to be easily identified, which had 
previously been misinterpreted or undetected by the traditional 
method of protein gel electrophoresis. Although this new molecular 
C4 allotyping protocol cannot distinguish between all C4 alleles, it 
has proven to be useful in the identification of a number of rare and 
common C4 alleles whose molecular basis has not previously been 
established. These include, B *72-, B *22-, B *4~, B *5-, B *6-, and 
A *58-.
A number of notable results were found by sequence analysis of the 
short C4 alleles, including: (1). The identification of two additional 
polymorphic nucleotide bases encoding residues #306 and #309; (2). 
Identification of polymorphic nucleotide bases in intron 9 which 
were unique to short C4 alleles; and (3). Location of a single copy of 
the mobile genetic element previously reported by Yu, (1991), which 
borders the long intron 9.
Of particular significance from sequencing analysis was the 
association of the polymorphic residue #306 with the C4A *CAN1 
allele of donor H14 and the rare B *5 (RCH517a) and B *5 alleles. As 
a result, this residue which could be identified by restriction analysis 
with enzyme Alu /, was included in the PCR-RFLP C4 allotyping 
protocol. Polymorphism of residue #306 proved to be very important 
in the identification of other rare C4 alleles including A *58- and B 
*6~. Alleles which had nucleotide bases encoding the residue 'Met' 
for residue #306, migrated more anodally than those alleles with a 
similar composition of amino acid residues but had 'Lys' for this 
residue, for example, B *7- and B *72- alleles. This observation is 
not unexpected, as nucleotide base differences of residue #306
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resulted in a charge change from a basic 'Lys' residue to a non-polar 
'Met' residue, thereby altering the overall charge of the C4 allele and 
therefore its migration pattern by protein gel electrophoresis.
Polymorphism of nucleotide bases encoding amino acid residue #309 
resulted in a silent alteration of the amino acid residue, and therefore 
was not expected to greatly affect the migration pattern of each C 4 
allele. Unfortunately this polymorphic residue could not be 
recognised by restriction enzymes which are available. Residue #309 
is closely situated to the polymorphic residue #306, and sequencing 
results indicate that the two residues are linked. As a consequence, 
the polymorphic residue #309 was not included in the PCR-RFLP 
allotyping protocol.
Of significance also, sequence analysis of the short C4 alleles, 
identified a number of polymorphic nucleotide bases in intron 9 
which distinguished between short and long C4 alleles. One of these 
polymorphic bases is situated alongside the mobile genetic element 
in intron 9, namely base #280. Short C4 alleles in this study had 
nucleotide base 'cysteine' for base #280, compared to the long C4A 
*3a allele described by Yu, (1991), which had 'thymine' for base 
#280. Studies for this thesis have shown that the polymorphic intron 
9 base #280 is not universally linked with nucleotide bases encoding 
polymorphic amino acid residue #328. This is because short C4 
genes (with nucleotide base 'cysteine' for base #280), which were 
sequenced here, encoded both amino acid residues 'Ser' and 'Tyr' for 
residue #328. However, intron 9 base #280 may be specifically 
associated with the size of a C4 allele, as nucleotide base 'thymine' 
was consistently found at base #280 in each short C4 gene.
PCR-RFLP, Taq I RFLP and sequencing analysis of short and long C4 
genes described above, suggest that the mutation creating 
polymorphism of nucleotide base #280 predated the mutation 
creating polymorphism of nucleotides encoding residue #328 in short 
C4 genes. The polymorphic base #280 could potentially be used for 
specific amplification of either long or short C4 alleles. In turn, it 
could be used for linkage analysis of polymorphic nucleotide bases 
encoding amino acid residues #328 and #306 to either long or short
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C4 alleles. Nucleotide base #280 would be the least likely 
polymorphic nucleotide base, situated in intron 9, to undergo 
recombination with a long C4 allele. This is because other 
polymorphic nucleotide bases are located further from the mobile 
genetic element in which the large 7 kb intron inserts. Therefore, 
intron 9 base #280 would be the most reliable marker for long and 
short C4 alleles. A study to substantiate these findings should be 
given high priority in further development of this molecular C4 
allotyping protocol based on PCR-RFLP.
From this study it can be seen that each allele is a composition of 
polymorphic nucleotide bases encoding amino acid residues which 
have been derived from ancestral C4 alleles. It is this combination of 
residues which is responsible for each allele's net charge, and unique 
migration pattern produced by protein gel electrophoresis.
A number of C4 alleles having the same predicted PI but a different 
combination of polymorphic amino acid residues were identified.
C4A alleles, A *3a, A*3a~, A *3b, A *3c~, and A *4, all had the 
same predicted PI of 7.05, and produced indistinguishable migration 
patterns by protein gel electrophoresis, with the exception of A *4 
which migrated slightly more anodally than did the A 3 allele. C4B  
alleles B *12-, B *2, B *22-, B *3-, and B *4, on the other hand, 
had predicted PI values of 7.18 but migrated to different positions 
by protein gel electrophoresis, except for B *2 and B *22- which co­
migrated. These results suggest additional, undetected 
polymorphisms exist in C4 alleles with the same PI. Also, it is 
possible that the unique combination of polymorphic amino acid 
residues, in the C4 alleles having the same PI, result in different 
structural conformations of the protein. In turn, the different 
conformation may affect the migration patterns of these alleles. A 
number of researchers have found that different alleles with the 
same net charge can be resolved by isoelectric focusing. For example, 
different mouse haemoglobins for which the a-chain composition is 
well known, were resolved with a high-voltage isoelectric focusing 
system, even though their proteins had the same isoelectric point 
(Whitney III et al., 1979). It is quite possible that proteins with the
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same net charge but different size may be resolved by protein gel 
electrophoresis as this system, like isoelectric focusing, resolves 
proteins according to their net charge and size.
In the case of the C4A group of alleles mentioned above, each allele 
had a different combination of polymorphic amino acid residues. 
However, these differences were only between small, neutral, non­
polar amino acid residues which do not alter the overall structure 
and charge of a protein, and therefore would not cause a large shift 
in the migration of a protein. The only factor which may alter the 
migration of these proteins by protein gel electrophoresis is if 
additional polymorphic amino acid residues were identified which 
were different in size and/or charge. This could affect the overall 
conformational structure and migration of these proteins. For 
example, amino acid 'Arg' has a side chain consisting of three 
hydroxyl groups terminating in a basic group, compared to amino 
acid 'Gly' which is the smallest and simplest neutral, non-polar amino 
acid residue (Watson et al., 1987).
The structure and net charge of amino acid residues #306, #1054 and 
#1191 were different for each C4B allele described above. However, 
despite these differences the predicted PI (7.18) of each allele was 
the same although the proteins from these alleles were found to have 
different migration patterns by protein gel electrophoresis. It is 
possible that the different structure of some polymorphic amino acid 
residues encoded by nucleotides of these alleles are solely 
responsible for the unique migration pattern of these alleles despite 
their similar PI. However, as the entire sequence of each allele has 
not been determined, it is also possible that other polymorphic amino 
acid residues which will alter the PI of these alleles have not as yet 
been identified.
Summarising the above results and observations, there are two 
groups of C4 alleles which have the same predicted PI. The first 
group has a PI of 7.05, and different polymorphic amino acid 
residues which are similar in size and charge, and migrate to the 
same or similar position by protein gel electrophoresis. The second 
group of alleles has the same PI which is 'basic' in charge, and
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different amino acid compositions which are different in size and 
charge, and can be resolved by protein gel electrophoresis. It is most 
likely, that the different electrophoretic mobility patterns of these 
alleles with the same PI is probably a reflection of the different sizes 
of amino acid residues which they have.
Considering there are other C4 alleles which have not been studied 
at the molecular level and that other polymorphic amino acid 
residues may exist, in this study, a close association was often found 
between C4 allotypes identified by protein gel electrophoresis and 
C4 allotypes identified by PCR-RFLP. In addition, a close association 
was found between the PI of many C4 alleles compared to these 
alleles migration patterns produced by protein gel electrophoresis. 
These close associations suggest that the majority of polymorphic 
amino acid residues which are responsible for the unique migration 
patterns of the different C4 alleles have most probably been 
analysed in these studies.
A number of C4 allotypes such as C4A 51, 14, 13, 11 and 
C4B 51, 31, 29, 21, 91, which were identified by protein gel 
electrophoresis, and described in the 1983 nomenclature statement 
(Mauff et al., 1983), are being reviewed. Some of these C4A and 
C4B alleles are thought to be one and the same. For example,
C4B 31 is now considered to be identical to C4A 91. Also, some 
alleles such as B 29 and B 3 are now recognised as the same C4B 
allele (WHO-IUIS Nomenclature Sub-Committee, 1993). Application of 
the C4 molecular typing protocol based on PCR-RFLP will help 
overcome these inconsistencies.
Development of the C4 molecular allotyping protocol described in 
this thesis is at an early stage, where polymorphism between C4 
alleles has been detected, and some new alleles have been identified. 
However, additional sequencing is required to reveal other 
polymorphic nucleotide bases which will distinguish between those 
C4 alleles which have the same combination of polymorphic 
residues.
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The C4 PCR-RFLP allotyping protocol has been designed in this study 
to type the C4A and C4B alleles separately, and thereby decrease 
the probability of misinterpreting heterozygous alleles. However, 
gene duplication causes problems with the interpretation of 
heterozygotes at a particular C4A or C4B locus. The use of 
Taq I RFLP analysis and pulsed-field gel electrophoresis (PFGE), may 
be used to determine the number of C4 genes present in a donor, 
prior to PCR-RFLP analysis.
Another problem which will need to be resolved with the PCR-RFLP 
typing protocol is the masking effect of multiple alleles having the 
same amino acid residues for residues #306 and #328. These 
residues are situated too far from the isotypic region to enable 
analysis of C4A and C4B alleles separately. Therefore, it appears in 
these cases that in addition to PCR-RFLP analysis, protein gel 
electrophoresis allotyping is required to ensure all C4 alleles are 
identified. For example, in donor ECY 178, the A *58 allele is masked 
by the B *5 allele for residue #306. However, for future use of the 
PCR-RFLP typing protocol it would be more appropriate to link the 
polymorphic residues #306 and #328 to the C4 isotypic region and 
intron nucleotide base 280 which determines the different size of C 4 
alleles.
Other techniques such as allele specific oligonucleotide (ASO) 
hybridisation (ASO), and single stranded conformational 
polymorphisms (SSCP), may have been used to develop a C4 
molecular allotyping protocol. However, for the majority of C4 alleles 
described in Tables 4.10 and 4.11, only A *<5, and A *3a could be 
identified by hybridisation of a single ASO. For other C4 alleles 
described in Tables 4.10 and 4.11, multiple ASO's would need to be 
used to enable the C4 allotype of an individual to be determined.
It would be possible to develop a protocol similar to the PCR-RFLP 
protocol described here, which is based on polymorphism of 
nucleotide bases found in introns of the C4 gene. This study has 
identified a number of nucleotide base differences within intron 9. 
However, many of these base differences distinguish between the 
long and short form of this intron in C4 genes, and are not C4
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allele-specific. The majority of published C4 nucleotide base 
sequences have been obtained by sequencing cDNA, which excludes 
intron sequence, and therefore little information concerning the 
polymorphism of nucleotide bases in C4 introns is known.
Sequencing of introns from different C4 alleles is required to 
identify polymorphic nucleotide bases which could then be used to 
develop a molecular-based C4 allotyping protocol based on intron 
polymorphic nucleotide bases. However, as the C4 gene is very large 
(either 23 kb or 16 kb), it is highly likely that many researchers will 
continue to sequence cDNA in preference to genomic DNA (containing 
both intron and exon sequence) where the entire C4 gene is encoded 
by 5.2 kb of DNA sequence.
An alternative to ASO and PCR-RFLP analysis would be the use of 
SSCP for a C4 molecular typing technique. Amplified PCR fragments 
which are heterogeneous have different nucleotide base sequence, 
and would therefore migrate differently in their single stranded 
forms. The main disadvantage of this technique is that it does not 
determine which particular nucleotide base is polymorphic as does 
the PCR-RFLP typing protocol. However, new polymorphic nucleotide 
bases can be detected by SSCP which may not be detected by PCR- 
RFLP analysis. PCR-RFLP is directed at identification of a specific 
sequence of nucleotide bases. However, it is possible for PCR-RFLP to 
identify other polymorphic bases by heteroduplex formation 
between restricted fragments having different nucleotide base 
sequence.
A number of other known nucleotide base sequences encoding 
polymorphic amino acid residues (Yu., 1991), were not included for 
PCR-RFLP analysis in this study. Belt et al. (1984), found that amino 
acid residue #1478 was polymorphic in the C4A *4 allele. Each 
residue encoded by nucleotides for residue #1478 was differently 
charged and could therefore play an important role in establishing 
different migration patterns between the A *4 and A *3 alleles. 
Amino acid residue #1478 was not included in this study due to the 
unavailability of a restriction enzyme which could identify the 
nucleotide base sequence encoding this polymorphic residue. Also, 
C4 isotypic amplification of the nucleotide base sequence encoding
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this residue would be difficult as it is situated 3.36 kb from the 
isotypic region. An oligonucleotide, specific for nucleotide bases 
encoding this residue, would be required for hybridisation to 
different C4 alleles to establish if this residue is polymorphic.
Nucleotide bases encoding amino acid residue #399, could potentially 
be useful in the identification of the A *4 allele by PCR-RFLP 
analysis. Nucleotide bases encoding this residue were found by Yu 
(1991), to be polymorphic in the C4A *4 allele, encoding 'Ala' 
instead of 'Val' which is seen in other C4 alleles. Both of these amino 
acid residues are non-polar. They would therefore not be expected to 
cause a large shift in the migration pattern of this allele by protein 
gel electrophoresis, but rather may be responsible for a smaller shift 
similar to that observed between A 3 and A 4 alleles.
PCR-RFLP analysis, using primers specific for the sequence region 
surrounding intron 9, enabled identification of the size (either 23 kb 
or 16 kb) of some C4 alleles where the alleles were homozygous. For 
example, the length of the C4B *12 allele, and C4A and C4B alleles 
of donor ECY858, was determined by the presence or absence of PCR 
amplification using primer pairs 1 and 2. When alleles were in a 
heterozygous form, the length of each C4 allele could not be 
determined with any degree of certainty. Sequencing from 
polymorphic nucleotide bases of exon 9, through intron 9, and to the 
isotypic nucleotide bases of the C4d region, would be the most 
accurate way to determine the length of each specific allele. If intron 
9 nucleotide base #280 is specifically associated with the length of a 
C4 allele, polymorphism of this nucleotide base may be useful for 
establishing the association of other polymorphic amino acid residues 
in this region, with specific C4 alleles.
The C4 PCR-RFLP allotyping protocol is advantageous as resulting 
DNA fragments are clearly interpreted, and the protocol may be 
easily implemented in any laboratory environment avoiding the 
problems associated with plasma samples containing unstable C4 
protein.
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In conclusion, development of the molecular C4 allotyping protocol 
based on PCR-RFLP analysis has proven to be valuable by facilitating 
the determination of the molecular basis of a number of rare C4 
alleles (B *12-, B *22-, B *4-, B *5-, B *6- and A *58~). These 
alleles together with more commonly occurring C4 alleles can be 
detected by PCR-RFLP analysis without the more technically difficult 
methods of C4 protein gel electrophoresis and haemolytic overlays. 
Alleles which are in a heterozygous state at a single C4 gene locus, 
can be easily and accurately identified. In time, when other 
polymorphic nucleotides are identified, other C4 alleles may be 
allotyped without the need for traditional protein typing techniques.
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Chapter 5
Molecular basis of C4 null alleles in Aboriginal Australians 
5.1 Introduct ion
Characterisation of C4 null alleles at the molecular level will advance 
the understanding of their association with disease susceptibility. 
Their identification will also assist in providing a more rapid and 
accurate method of C4 allotyping these alleles at the molecular level 
compared to the traditional method of protein gel electrophoresis and 
immunofixation. Earlier in this thesis (Chapter 4), it was found that 
the traditional method of protein gel electrophoresis does not always 
accurately identify the C4 allotype of an individual. However, 
polymorphism within the C4 gene has enabled the identification of 
many of these C4 alleles at the molecular level by PCR-RFLP analysis 
(Chapter 4). It is important that C4 null alleles be included in the 
PCR-RFLP typing protocol due to their association with disease and 
their high allelic frequency within the general population.
There is a high frequency of the C4 null allotypes C4A QO (5-15 %) 
and C4B QO (10-20 %), in the Caucasian population (Schendel et al., 
1984; Partanen and Koskimies, 1986a and b). Frequencies of C4 null 
alleles vary between different ethnic populations, with the highest 
frequency being detected in an Aboriginal Australian population, 
where C4A QO alleles approached 30 % and C4B QO alleles 
approached 25 % (Ranford et al., 1987). These unusually high 
frequencies of C4 null alleles suggest that either partial C4 
deficiency is not a major health risk, or that C4 null alleles detected 
by protein gel electrophoresis and immunofixation are incorrectly 
defined. The second hypothesis proposes that a number of alleles 
designated as C4 null alleles, are functional alleles but their true 
identity has been misinterpreted by C4 protein typing.
As previously described in Chapter 1, C4 null alleles have been 
found to eventuate from: (1) Deletion of a C4 locus which usually 
occurs together with a 21-hydroxylase gene (Carroll et al., 1985a, c); 
(2) Non-expression of a defective C4A mutant gene, resulting from a 
2 bp insertion into exon 29 (Barba et al., 1993); and
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(3) Isoexpression (Raum et al., 1984; Rittner et al., 1984; Uring- 
Lambert et al., 1984), or homoexpression of identical C4 isotypes on 
the same haplotype (Yu and Campbell, 1987).
There appears to be a common type of C4 null allele in the Caucasian 
population, where approximately 60% of null alleles were found to 
result from deletion of a C4 gene together with an adjacent 21- 
hydroxylase gene (Schneider et al., 1986). C4A null alleles in 
Caucasian populations have been found to be strongly associated with 
SLE (Ng and Walport, 1988). A worthwhile study would be to 
establish if C4A Q0 alleles in Aboriginal Australians, (who have the 
highest recorded frequency of this allele), result from large deletions 
of the C4 gene region, and whether these alleles are associated with 
SLE or other disease states.
Where C4 null allele allotypes result from homoexpression and/or 
isoexpression, protein gel electrophoresis detects C4 protein in 
either the anodal or cathode region of the gel, as these alleles migrate 
to the same region. As a result of the common migration pattern 
produced by each allele, this type of C4 allotype simultaneously 
results in a C4 null allotype at the adjoining region of a gel, even 
though both C4 gene loci contain functional alleles. Examples of this 
phenomenon have been reported, such as, isoexpression of the C4 
allotype C4 A *2, *3 B *Q0, found in Norway and Germany 
(Fredrikson et al., 1991). This allotype was found to be most 
commonly a part of the extended haplotype HLA-A 3, Cw 4, B 35,
C4A 3, C4B Q0, Bf F, C2 C, DR 1. Isoexpression and homoexpression 
have only been detected with C4A alleles, where a single haplotype 
has two long C4A alleles but no C4B allele (Partanen and Campbell, 
1989; Welch et al., 1989; Braun et al., 1990).
C4 alleles which have a combination of C4A and C4B type 
polymorphisms have been associated with the C4 null allotype 
(Rittner et al., 1984; Raum et al., 1984; Uring-Lambert et al., 1984; 
Partanen and Campbell, 1989). One individual for example, had 
the allotype A 3 B Q0, and had long C4 genes at both loci I and II 
(Partanen and Campbell, 1989). At the molecular level, this 
individual was found to have a gene at locus II which had a C4A
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isotype but antigenic determinants more typical of C4B genes. This 
unusual allele was associated with one of the following haplotypes 
HLA-ß 44, Bf S, C4A 3, C4B QO, DR 4, or HLA-5 62, Bf S, C4A 3, C4B 
QO, DR 4. The specific haplotype having this allele could not be 
determined as other family members were not informative for 
determining the inheritance of each allele. Thomson et al. (1988), 
detected the same haplotype HLA-B 44, C4A 3, C4B QO, DR 4 in 
association with Felty's syndrome. The C4 gene region of this 
individual was found to have a duplicated set of C4A alleles which 
was shown to produce functional C4A protein. The C4A alleles were 
only detected using monoclonal antibodies specific for the isotypic 
region of the gene. Therefore, whether the antigenic determinants, of 
each of these C4A alleles, were C4A- or C4B-like were unknown.
Both haplotypes described by Partanen and Campbell (1989), and 
Thomson et al. (1988), may have the same unusual C4A/C4B 
hybrid-type allele, which was shown to be functional by Thomson et 
al. (1988). This unusual type of C4-hybrid allele is associated with 
the C4 null allotype as determined by protein gel electrophoresis, 
however, the molecular basis of this association has not been 
resolved and requires further investigation.
Barba et al. (1993), found three types of nondeleted C4A null 
alleles which were described in Chapter 1 (Section 1.11.2). In 
summary, the first type of C4A null allele had a 2 bp insertion into 
exon 29 which leads to a termination codon during transcription. This 
type of C4A null allele was found to be associated with the 
haplotype HLA-Z? 60, DR 6. Barba et al. (1993) found evidence for 
gene conversion to the C4B isotype in the second type of C4A null 
allele. The molecular basis for the third type of nondeleted C4A null 
allotype has not yet been determined.
Summarising some of the more significant findings of these earlier 
studies described above; (1) The C4 null allotype is quite common in 
the general population, and occurs with relatively high frequencies in 
some specific ethnic groups such as Aboriginal Australians; (2) The 
molecular basis for a number of C4 null allotypes has been 
determined, and other types of C4 null alleles have been identified 
which require further investigation; (3) These earlier studies have
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provided evidence which questions the association of certain types of 
C4 null alleles with the C4 null allotype as determined by protein 
gel electrophoresis; these null alleles possibly being functional alleles 
with a C4 null allele allotype.
5.2 Aim
To determine the molecular basis of C4 null allele allotypes in 
Aboriginal Australians, and to use this knowledge for identification of 
C4 null alleles which can be incorporated into the molecular-based 
C4 allotyping protocol.
5.3 Materials and Methods
5.3.1 C4 null allele donors for genetic analysis
Aboriginal Australian C4 null allele donors were used in this study 
due to the high frequency of this allotype, as well as the high 
prevelance and severity of SLE in Aboriginal Australian populations. 
Also, the molecular-basis of C4 null alleles in this ethnic group is 
unknown. Peripheral blood samples from donors Hl l ,  H14 and H19 
were collected from Darwin, Northern Territory; donors denoted 'ECY' 
and 'WCY' were Aboriginal samples from the East and West Cape 
York region of Australia, respectively. Sample numbers 30017 to 
40045 were Aboriginal samples from Groote Island. A series of 50 
SLE Caucasian patients numbered SLE502 to SLE686 were from 
Canberra. IDDM patient cell lines were provided by the Royal 
Childrens Hospital (RCH) in Melbourne, and Woden Valley Hospital 
(ASD), Canberra. 10th International Histocompatibility Workshop cell 
line samples were denoted as 'EW'.
5.3.2 C4 protein gel electrophoresis and immunofixation
Samples from Aboriginal Australians denoted as 'ECY' and 'WCY' were 
C4 allotyped as described in section 2.5. RCH and ASD patient 
samples were C4 allotyped using the same technique by Pam 
Ranford, John Curtin School of Medical Research (JCSMR). Darwin 
Aboriginal samples and Groote Island Aboriginal Australians having
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C4 null allele allotypes were C4 allotyped by Heather Dunckley, 
JCSMR. SLE samples were C4 allotyped by Heather Dunkley and 
Elizabeth Jazwinska, JCSMR.
5.3.3 Genomic DNA extraction
Genomic DNA from donor buffy coats or cell lines were extracted 
according to the method described in section 2.7.
5.3.4 Taq I restriction analysis of genomic DNA, and C4-specific 
hybridisation
Approximately 3 pg of genomic DNA was restricted with 30 units of 
Taq I restriction enzyme as previously described in Chapter 4, 
section 4.3.4.
5.3.5 Gel electrophoresis, Southern blotting and hybridisation of PCR 
amplified products containing C4 isotypic nucleotide bases
Nucleotide bases encoding the C4 isotypic amino acid residues 
#1101 -# 1106 were amplified by primer pair number nine (see 
Chapter 4, Table 4.1), then visualised by electrophoresis, using the 
method described in section 2.9, and EtBr stained as outlined in 
section 2.10. Samples were transferred to nylon membrane by 
Southern blotting following the protocol in section 2.11.
The following C4 oligonucleotides were designed for hybridisation to 
nucleotide bases encoding the C4 isotypic amino acid residues 
#1101 -# 1106. The C4A-specific oligonucleotide for nucleotide bases 
encoding amino acid residues #1100 to #1107 was 5'-ACCCCTGTCCA 
GTGTTAGACAGG-3'. The C4B-specific oligonucleotide for nucleotide 
bases encoding amino acid residues #1100 to #1107 was 5'-ACCTCTC 
TCCAGTGATACATAGG-3'. End-labelling and hybridisation of 
oligonucleotides to PCR products were as described in sections 2.12.3 
and 2.12.4.
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5.3.6 C4A- and C4B-specific PCR, and PCR-RFLP analysis of C4 
polymorphic regions
PCR primer pairs 10 and 11 were used for C4A- and C45-specific 
amplification, respectively. PCR primers used for analysing nucleotide 
bases which encode amino acid residues #306, #328, #1054, #1101- 
#1106, #1157, #1186, #1188, #1191, and #1267 are listed in Chapter 
4, Table 4.1, and their position within the C4 gene sequence is 
shown in Figure 4.1. PCR conditions for each set of primers can be 
found in Table 4.3. Polymorphic amino acid residues encoded by 
nucleotide bases from the C4 gene region are listed in Table 4.2. 
Restriction enzymes, reaction conditions, and gel electrophoresis 
parameters for each PCR-RFLP are given in 
Table 4.4.
5.3.7 Screening by PCR-RFLP analysis, for a 2 bp insertion in exon 29 
which creates a C4A Q0 allele
PCR-RFLP analysis was used to screen for a 2 bp insertion into the 
nucleotide sequence of exon 29 in C4A Q0 allele Aboriginal donors. 
Sense primer 5-GACGGCCAGTGTCGACGATAACCTGTACTGGGGCTC-3', 
and antisense primer 5'CTACTTGGGTACTGCGGAATC-3', were used to 
amplify a 254 bp C4 nucleotide sequence encoding amino acid 
residues #1207 to #1284, in exon 29. PCR reaction conditions were
35 cycles of 60 sec at 96 °C denaturation, 60 sec at 58 °C annealing,
and 90 sec at 72 °C extension. The resulting PCR product was 
restricted with Fok I enzyme, using conditions recommended by the 
manufacturer, as outlined in section 2.8. Samples were prepared for 
gel electrophoresis as described in section 2.9. PCR-RFLP products 
were separated by gel electrophoresis in an 8 % polyacrylamide gel, 
at 35 mA, for 2 hours. Separated PCR-RFLP products were visualised 
by staining with silver as described in section 2.10.
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5.3.8 Total RNA extraction from Aboriginal donors Hl l ,  H14, and 
H I9. Preparation of cDNA, and C4 null allele specific PCR analysis
Total RNA was extracted from cell lines of Aboriginal donors carrying 
C4 null alleles as described in section 2.13. RNA was transferred to a 
nylon membrane by Northern blotting, and hybridised with a C4 
specific probe following the protocol in section 2.14. Total cDNA was 
prepared from total RNA for each donor by using a Poly T ' tail non­
specific 3' primer which adheres to all 3' nucleotide coding region of 
genes. C4-specific cDNA was prepared by using a C4-specific 3' 
primer which adheres to exon 30 of the C4 gene region. This 
technique has been described in detail in section 2.15.
PCR primers for C4 cDNA analysis of donors Hl l ,  H14, H19 and 
genomic controls are listed in Table 5.1, and PCR reaction conditions 
for each primer pair are given in Table 5.2. Primer pairs T  and '2',
'3' and '4', '5' and '6', were used to amplify C4A and C4B cDNA 
separately, whereas primer pair '7' amplified each C4 allele from the 
C4 gene region. Primer pairs T  and '2' amplified nucleotide bases 
encoding amino acid residues #1091 to #1097, '3' and '4' amplified 
nucleotide bases encoding amino acid residues #1033 to #1106, '5' 
and '6' amino acid residues #1101 to #1284, and amplified 
nucleotides encoding residues #1091 to #1284.
5.3.9 Predicted Isoelectric Point (PI) of derived protein sequences for 
each C4 allele
Computer analysis of the derived protein sequence was used to 
determine the predicted isoelectric point (PI) of each C4 allele.
Details concerning this computer programme are given in section 
2.20 (Chapter 2).
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5.4 Results
Comparisons with certain results from other workers and a brief 
discussion is necessary here to show the relevance of these results in 
an applied context and the rationale behind the step-wise 
progression of research conducted to achieve the stated aim.
5.4.1 Detection of C4 null alleles by protein gel electrophoresis and 
im m unofixation
C4 null allele allotypes were detected by the absence of C4 protein 
in the acidic and/or basic region of the gel for a given donor's serum 
sample. C4A null alleles were detected in homozygous form in 
Aboriginal donors H19, ECY509 and Caucasian EW-Vavy. Homozygous 
C4B null alleles were detected in Aboriginal donor's Hl l ,  H I4, 
ECY519, ECY743 and Caucasian EW-L0081785. C4A and C4B null 
alleles in a heterozygous state with a functional C4 allele were also 
detected, but were not included in this analysis. Examples of 
homozygous C4B null allele and heterozygous C4A and C4B null 
alleles are shown in Figure 5.1.
5.4.2 Taq I RFLP analysis of the C4 gene region
To establish the molecular basis of Aboriginal C4 null allotypes, it 
was first necessary to determine if the C4 genes of each donor were 
intact and of the expected C4 gene size (23 kb for long and 16 kb for 
short C4 genes), or whether they resulted from a large deletion, as 
previously detected in C4 null alleles from Caucasian populations.
Taq I RFLP analysis of the C4 gene region for C4 QO allele 
Aboriginal Australian donors are shown in Figure 5.2. A summary of 
these results, the C4 allotypes, and their HLA- DRB1,DQB1,  and 
DQA1 extended haplotypes are given in Table 5.3. Even though Taq 
I RFLP fragments are not directly associated with C4A and C4B 
genes (Tokunaga et al., 1991), it is possible to establish if donors 
carrying C4 null alleles have C4 genes at both C4 gene loci I and
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Figure 5.1 C4 allotypes of C4 QO Aboriginal donors determined by 
protein gel electrophoresis and immunofixation. Schematic diagram 
showing the relative migration distances of C4 allotypes (VI 
complement genetics workshop reference typing), is reproduced with 
permission from WHO Bulletin, 70: 531-535, (1992). C4 allotypes 
for donor serum samples are as follows: Lanes #1,A  3 B 1,Q0, 
ECY006; #2 ,A  3 B 1 standard; #3, A 3,Q0 B 1, WCY1159; #4, A 3 B 
1, standard; #5, A 3 B QO, ECY743; and #6, A 3,Q0 B 1, ECY704. 
Samples from lane #4, 5, and 6 had been treated with 
Carboxypeptidase B prior to protein gel electrophoresis.
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Figure 5.2 Taq I RFLP and C4-specific probe hybridisation 
analysis of the C4 gene region for C4 QO Aboriginal Australian 
donors. Taq 1 RFLP of C4 loci I and II long (23 kb) genes are 
represented by 7 kb and 6 kb fragments, respectively. C4 locus II 
short (16 kb) genes is represented by 5.4 kb fragments. Locus I gene 
deletion together with a short (16 kb) locus II gene are represented 
by 6.4 kb fragments. 21 -hydroxylase A and 21-hydroxylase B 
genes are represented by RFLP fragments 3.7 kb and 3.2 kb, 
respectively. Aboriginal donors are represented in the following 
figures: A. lane #2 ECY509 (A QO B 1); #7 ECY525 (A 4 B QO)B. 
lane #1 ECY743 (A 3 B QO); #2 H19 {A QO B 7); #3 H14 (A3 B QO);
#4 Hl 1 (A 3 B QO); #5 ECY519 (A 4 B QO); C. lane #2 ECY704 (A 
3,Q0 B 1). Taq 1 RFLP results for each of the C4 QO allele donors is 
shown in Table 5.3. Molecular weight marker X restricted with Hind  
111 and Hind 111/Eco R1 is represented in A, lane #5 and #10, and 
in C, lane #1.
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II. C4A genes are usually present at locus I and C4B genes at locus 
II (Schneider, 1990).
Each donor with a C4B Q0 allotype had long C4 genes at locus I. 
Aboriginal donor H ll had short C4 genes at locus II, whereas 
Aboriginal donors ECY743 and ECY519 had long C4 genes at locus II. 
Aboriginal donor H14 was a heterozygote at locus II, with both long 
and short C4 genes. Each donor had a CYP21A and CYP21B gene 
which were represented by 3.7 kb and 3.2 kb fragments, 
respectively.
It was hypothesised that two types of C4B *Q0 alleles were present 
in this population of Aboriginals as both long and short C4 genes 
were found in association with the C4B null allotype by Taq I RFLP 
analysis. This hypothesis was supported by analysis of each donor's 
HLA-extended haplotype, results of which are given in Table 5.3. 
Donor H ll was thought to be a homozygote for the short type of 
C4B *Q0 allele which had the HLA-extended haplotype DRB *04,
DQB *0402, DQA *0301, whereas donor ECY519 appeared to be a 
homozygote for the long type of C4B *Q0 allele having the HLA- 
extended haplotype DRB *0803, DQB *0503, DQA *0103. Donor H14 
appeared to be heterozygous for each type of C4B *Q0 allele, having 
one of each of the HLA-extended haplotypes found in H ll and 
ECY519. Donor ECY743 had a different HLA-extended haplotype more 
typical of that seen in Caucasian populations (Dawkins et al., 1983), 
and therefore was expected to have different C4B Q0 alleles.
Taq I RFLP analysis of Aboriginal donors H19 and ECY509 having a 
C4A Q0 allotype, found long (7 kb) C4 genes at locus I, and both 
long (6 kb) and short (5.4 kb) C4 genes at locus II, ( Figure 5.2 and 
Table 5.3). The HLA-extended haplotype for donor H I9 was not 
resolved, and therefore requires further investigation. The HLA- 
extended haplotype for donor ECY509 indicated heterozygosity of 
C4A null alleles.
Only one Aboriginal donor in this study, namely, 'ECY704' with the 
allotype A 3,Q0 B 1, was found to have C4A deficiency resulting 
from a large deletion of the C4 gene at locus I, which was
178
represented by a 6.4 kb Taq I RFLP fragment (Figure 5.2 and Table 
5.3). This donor had foreign ethnic admixture of a DRB1 *0301 allele 
(Table 5.3), which has been found in linkage disequilibrium with 
C4A null alleles resulting from a large deletion in Caucasian 
populations (Schur et al., 1990; Kumar et al,  1991).
Aboriginal donor ECY525, which has the C4 allotype A 4 B Q0, 
showed unusual results of Taq I RFLP and HLA-extended haplotype 
analysis. Only a long (7 kb) C4 fragment was detected at locus I by 
Taq 1 RFLP analysis. The HLA-extended haplotype for this donor 
showed the same alleles on one haplotype as that of donor ECY704, 
(having partial C4A deficiency resulting from a large deletion of the 
C4A gene at locus I). The second haplotype of donor ECY525 had the 
same alleles as the HLA-extended haplotype found in donor ECY519, 
(having C4B deficiency of the long (6 kb) C4 gene type). Donor 
ECY525 may have gene duplication at the C4 gene region, as Taq I 
RFLP analysis resulted in a strong 7 kb DNA fragment and weaker 
6.4 kb, 6 kb and 5.4 kb DNA fragments. The 6.4 kb fragment 
corresponds to a deletion of a long (7 kb) gene at locus I and the 
presence of a short C4 gene at locus II on one chromosome, however 
the strong 7 kb fragment suggests two long loci I C4 genes. C4 gene 
copy number of this donor could be clarified by PFGE analysis with 
Bss HII or Sac II restriction enzymes and a C4 gene specific probe.
These results show that the molecular-basis of C4 null allotypes in 
Aboriginal Australian donors do not result from large C4 gene 
deletions. The next important question is whether these non-deleted 
C4 null alleles are functional and can produce messenger RNA 
(mRNA), which will result in C4 protein. The C4 gene locus is a 
duplicated gene region having a minimum of two highly homologous 
alleles on each haplotype. Therefore, prior to RNA analysis it was 
first necessary to find a means of identifying the C4 null alleles as 
distinct from other C4 alleles on each haplotype. Donors ECY525 and 
ECY704 were not included in any further molecular analysis as donor 
ECY525 was suspected of having a duplicated C4 gene loci and 
ECY704 was heterozygous for the C4A alleles. Both of these 
features may interfere with the interpretation of molecular results 
for the C4 null alleles in these donors.
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5.4.3 C4A-, and C4B- specific oligonucleotide hybridisation analysis 
of Aboriginal donors' having C4 null alleles
C4-specific PCR primers were used to amplify the C4 gene region 
encoding nucleotide bases for the C4A and C4B isotypic amino acid 
residues, and was followed by C4A- and C4Z?-specific 
oligonucleotide hybridisation analysis (see Figure 5.3). The C4A- 
specific oligonucleotide hybridised to each donor including those with 
C4A null allele allotypes, namely H19 and ECY509, whereas the 
C4B-specific oligonucleotide hybridised to each donor, except those 
with C4B null allele allotypes, namely Hl l ,  H14, ECY743 and ECY519. 
This result indicated that nucleotide bases encoding the C4A isotypic 
amino acid residues were present in all C4 null allele donors 
including those with a C4A null allele allotype. On the other hand, 
nucleotide bases encoding the C4B isotypic amino acid residues were 
absent and/or different in donors with C4B null allele allotypes.
5.4.4 C4A and C4B isotypic PCR amplification of C4 *Q0 alleles
The absence and/or alteration of nucleotide bases encoding C4B  
isotypic amino acid residues for C4B null alleles was confirmed by 
lack of PCR amplification using the C4ß-specific oligonucleotide 
(Figure 5.4). Donors H ll and ECY743 produced the same results but 
are not shown in this figure. The presence of nucleotide bases 
encoding C4A isotypic amino acid residues for C4A null alleles was 
confirmed by PCR-RFLP analysis of C4A-specifically amplified PCR, 
DNA fragments (Figure 5.5, 5.6 and Table 5.4).
5.4.5 PCR-RFLP analysis of nucleotide bases encoding C4A and C4B 
isotypic amino acid residues in C4B null allele donors
Restriction analysis of the C4 isotypic region in Aboriginal donors 
having either C4A or C4B null alleles was performed by PCR-RFLP 
with enzyme Mnl /  (Figure 5.5 and Table 5.4). This analysis showed
180
Figure 5.3 Hybridisation of C4A- and C4B-specific oligonucleotides 
to Aboriginal donors with C4 Q0 alleles. PCR products were obtained 
using primers which would amplify both C4A and C4B alleles. 
Hybridisation in A was with a C4A-specific oligonucleotide probe, 
whereas in B the same PCR products were probed with a C4B- 
specific oligonucleotide. Lane numbers in A and B represent the 
following Aboriginal donors; #1 ECY519 (A 4 B Q0)\ #2 ECY743 (A 3 
B Q0); #3 Hl 1 (A 3 B Q0); #4 H14 (A 3 B Q0)\ #5 H19 (A Q0 B 7);
#6 WCY1164 (A 4 B 2); #7 ECY504 (A 2,3 B 7).
B
1 2 3 4 5 6 7
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Figure 5.4 C4B isotypic PCR amplification of Aboriginal donors with 
C4B QO alleles. Samples include; lane #1 Molecular weight marker 
pBR322 restricted with Hae III; #2 H14 (A 3 B QO)-, #3 ECY519 (A 
4 B QO); #4 ECY873 (A 3 B 1,12); #5 WCY1204 (A 3 B 1,12); #6 
PCR negative control (PCR reaction with no DNA template added).
1 2 3 4 5 6
Figure 5.5 PCR-RFLP banding patterns of nucleotide bases encoding 
polymorphic amino acid residues #1054 and #1101-#1106 in C4 Q0 
alleles. Lanes for nucleotide bases encoding amino acid residue 
#1054 are; #3. 'GLY'; #9. ’ASP'; #7. heterozygote ’GLY’ and 'ASP'. 
PCR-RFLP banding patterns for nucleotide bases encoding amino acid 
residues #1101 -#1106 are; lane #19. PCR-RFLP patterns for C4B Q0 
donors which have C4A isotypic nucleotide bases, #18. PCR-RFLP 
pattern for C4A Q0 donors with both C4A and C4B isotypic 
nucleotides. Restricted fragments less than 19 bp for residue #1054, 
and fragments less than 53 bp for residues #1101 -#1106, were lost 
during electrophoresis. Unrestricted PCR fragments are shown in lane 
#1 and #13 for residues #1054 and #1101 -# 1106, respectively. 
Molecular weight marker pBR322  restricted with Hae III resulting 
in 18, 21, 51, 57, 64, 80, 89, 104, 123, 124, 184, 192, 213, 234, 267, 
434, 458, 504, 540, and 587 base pair fragments are shown in lane 
#2 for residue #1054. pBR322  restricted with Msp I represented 
by 67, 76, 90, 110, 123, 147, 160, 180, 190, 201, 217, 238, 242, 309, 
404, 527, and 622 base pair fragments are shown in lane #14 for 
residues #1101 -# 1106.
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Figure 5.6 PCR-RFLP banding patterns of nucleotide bases encoding 
polymorphic amino acid residues #1157, #1186, #1188, #1191 and 
#1267, in C4 QO alleles. For gels corresponding to residue #1157, 
lanes of each PCR-RFLP banding pattern are; lane #2 'ASN'; #11 'SER'; 
#5 heterozygote for 'ASN' and 'SER', unrestricted fragments are 
shown in lanes #1 and #7. For gels corresponding to residue #1186, 
example PCR-RFLP banding patterns for this residue are; lane #9 
nucleotide bases 'gcg' for residue 'ALA'; #10 heterozygous for bases 
'gcg' and 'gcc', both encoding residue 'ALA', unrestricted fragments 
are shown in lane #2. PCR-RFLP analysis of nucleotides encoding 
residues #1188 and #1191 are from digestion of the same PCR 
product and with the same restriction enzyme. Lanes of PCR-RFLP 
analysis of residues #1188 and #1191 are; lane #3 'ALA' for residue 
#1188; #10 heterozygous for 'ALA' and 'VAL' for residue #1188;
#18 'ARC for residue #1191; #23 'LEU' for residue #1191, 
unrestricted fragments are shown in lane #2, #16 and #22. PCR- 
RFLP banding patterns for nucleotides encoding residue #1267 are; 
lane #3 'ALA'; #9 heterozygote for 'ALA' and 'SER', unrestricted 
fragments are shown in lane #1. Each gel shows molecular weight 
marker pBR322  resticted with Msp I represented by 67, 76, 90,
110, 123, 147, 160, 180, 190, 201, 217, 238, 242, 309, 404, 527, and 
622 base pair fragments in lanes #5 and #8 for residue 1157, lanes 
#17 and #21 for residues 1188 and 1191, and lane #2 for residue 
1267. Only molecular weight fragments of 622, 527, 404, and 309 bp 
are shown in lane #1 for residue 1186, and 622, 527, and 404 bp are 
shown in lane #1 for residues 1188 and 1191.

184
-s
>
'ü
- z
t  £
o -
c a 
o c 
-3 a
a Cu 
a J  
— 0-
>2 Ö
<  £ .
3 >»
= -
a
3  2
ü o
3 a
u
o S 
s c
S _
a o
. 2  ’««
— ü?
0 Ä 2 = 
S 3
>>
1  £
-  3
£
>
ro
Tf
IO
ja
a
H
=a
> < <
r*
SO
<N 00 C/0
<$s 48
Cj
< < < < < <
— c^ C8
C\ O
~ J J
J J - 4 - 4
aa
00 > < <2
00
*“ < <
U > > > > > >
cq
sC > X2oc O
__ XD
4fc >l-
O 3 3 3 3 3 3
2Qr~ > 00 m
oo o
3$:
a: 00 ty:
=>J
o z Z z z Z Z
ÜC hU
O op > >
C cu cu
_ o
i n
- 4
oo
«tfe
i Q Q Q Q Q Q
o _2 - 4 _J - 4 - 3 - 4
> > > > > >
_ o
Q C4 cu cu Ch Cm
u CJ u U U o
a. Cu Cu CU Ch cu
2Q
> Ü O3 " o
IT',
c
Q
a:
>
o
Q Q Q Q o Q
*
■—.
*
"D
aq aq
-q -q
3 a:
0
01 
*
o
0 3
*
7 u* *
3 -
*
°o
* qf q
s
f'n
*
<'n
*
3 -'
* *
o
0 3
*
o
0 3
*
a:
3
D
Ch
O o O oJ
Ol Ol Ol Ol =q as3 =Q =q «3 C5 o
> rn 0 3 0 3
C
4 a: <
Cs m GS•_. —* 3" O
o r-' uo
3 — 3 " >- >- >- CN
O — — u U o —•
O “T*■—t — LÜ 04 04 X
5  ICj ju
J= •- 3w c
i  *>
ä o
o
V3
<u
< 2  _ 3
C/5
U
ZJ
"O
c/i
UC/5
1 o
■ S l 'S .
■§ 5 ü
ca ü
-  « J 1  
•2 £  o
o °
=  . a ?  
_2 0  
■O § <4-
1  ®
D «fl
1 I  1
r  ca ca 
a c
<  ^  «
. >
2 O o
c/3 ~u“
Z “ O "3
^ d>
C c/j
a "oß 3
<  .M 3 
2  . £
G £
> .  H 
-a u
!
aß
£
3
-3
p
cu1 15 
J  2  *
£ a U
22 3  ^
Z3 ^ -O c3
g. O I
. 3  CU
£ S £
z: ^ 3^
CS
* - I  £
—-
. -  aß 
c/5 c  —
ü o '- T3 üo o q-U '-o
53 ^
8  2  
3
Äcu
O
8
u _g Z '
_  3
« u O 
aß -3  w
c o Io 
' 3  « ‘
2 a £cu a 
>% H 3
-O  —  aß
'Sc 
£ S 
8 2 
äj
~  Ji
3
s .«
Z  15 _o
« ;  
=* ro
8 ü  
> «
>%.o
1
-o
1)
C .
en
co
di
ng
 
am
in
o 
ac
id
 
re
si
du
es
 
#1
05
4,
 
#1
15
7,
 
#1
18
6,
 
#1
18
8,
 
#1
19
1,
 
an
d 
#1
26
7,
 
as
 
an
al
ys
is
 
o
f 
nu
cl
eo
tid
es
 
en
co
di
n 
#1
10
1-
#!
 1
06
 
in
 
th
es
e 
do
no
rs
 
sh
ow
ed
 
o
n
ly
C
4
4
 
ba
se
s 
w
er
e 
pr
es
en
t.
185
C4A null allele donors had both C4A and C4B isotypic nucleotides, 
whereas C4B null allele donors possessed only C4A nucleotide bases 
in this region. These results confirmed those detected by C4 isotypic 
hybridisation and by C4A and C4B isotypic PCR amplification 
studies described above.
5.4.6 PCR-RFLP analysis of nucleotide bases encoding C4 allelic 
polymorphic amino acid residues in C4B *Q0 alleles of Aboriginal 
donors
The studies described above suggest that C4B null alleles of 
Aboriginal donors Hl l ,  H14, ECY519 and ECY743, may have two C4A 
alleles on the one haplotype but no C4B allele. To test this 
hypothesis, and identify nucleotides which are unique to the C4B  
null allele, PCR-RFLP analysis of nucleotide bases encoding known 
polymorphic amino acid residues (Yu, 1991), was performed. Only 
C4A specifically amplified PCR fragments from C4B *Q0 allele 
donors were used for PCR-RFLP analysis, as these donors did not 
have C4B isotypic nucleotide bases. PCR-RFLP banding patterns are 
shown in Figures 5.5, 5.6, and 5.7, and a summary for each donor is 
presented in Tables 5.4 and 5.5.
PCR-RFLP analysis of nucleotide bases encoding residues #306 and 
#328 for short (16 kb) C4 genes of donors H ll and H14, detected 
nucleotides which encoded amino acid residues 'Met' and 'Tyr', 
respectively. Analysis of PCR fragments, containing both long (23 kb) 
and short (16 kb) C4 genes, in donors H ll and H14, found both 
residues 'Met' and 'Lys' were encoded by nucleotides for residue 
#306 in each donor. Amino acid residue 'Tyr' was encoded by 
nucleotides for residue #328 in donor Hl l ,  whereas residues 'Tyr' 
and 'Ser' were encoded by nucleotides for residue #328 in donor H14. 
These results indicate that nucleotides encoding 'Tyr' are present in 
both long and short C4 genes of donor Hl l .  However, nucleotides of 
donor H14 encode 'Tyr' in the short and 'Ser' in one or both of the 
long C4 genes for residue #328.
Figure 5.7 PCR-RFLP banding patterns from the analysis of 
nucleotide bases encoding polymorphic amino acid residues #306 and 
#328 in C4 Q0 allele donors. Lanes representing the analysis of 
residue #306 are; #1. 'MET' in short C4 genes; #7. 'LYS' in short C4 
genes, #3. 'LYS' in long and short C4 genes, #15. heterozygous for 
'LYS' and 'MET' in long and short C4 genes. Lanes representing the 
analysis of nucleotides encoding residue #328 are; lane #12. 'TYR' in 
short C4 genes; #19. 'SER' in short C4 genes; #14. 'TYR' in long and 
short C4 genes; #28. 'SER' in long and short C4 genes; #15. 
heterozygous for 'TYR' and 'SER' in long and short C4 genes. 
Unrestricted PCR fragment controls for the analysis of residue #306 
are shown in lane #11 and #12, and lane #11 and #25 for residue 
#328. PCR-RFLP fragment sizes less than 57 bp were lost from each 
gel during gel electrophoresis. Molecular weight marker pBR322  
restricted with Msp I represented by 67, 76, 90, 110, 123, 147, 160, 
180, 190, 201, 217, 238, 242, 309, 404, 527, and 622 base pair 
fragments are shown in lane #10 and #13 for residue #306, and 
lane #10 and #26 for residue #328.
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These results indicate that the short C4B *Q0 alleles of donors H ll 
and H14 are unique by comparison to the majority of other donors as 
'Tyr' instead of 'Ser' is encoded by nucleotides for residue #328 of 
the short C4 genes (Chapter 4, Tables 4.5 and 4.6). Also, similar to 
the amino acid composition of rare C4 alleles described in Chapter 4 
(such as A *58-, B *12-, B *22-, B *5-, and B *6~), amino acid 
residue 'Met' is encoded by nucleotides for residue #306 in the C4B  
*Q0 alleles of donors H ll and H14. C4B *Q0 alleles of donors 
ECY519 and ECY743 were different to those of donors H ll and H I4, 
and similar to those of other long C4 genes described in Chapter 4, 
(Tables 4.5 and 4.6). Donor ECY519 had amino acid residues 'Tyr' and 
'Lys' encoded by nucleotides for residues #328 and #306, 
respectively, whilst donor ECY743 had amino acid residues 'Tyr' and 
'Ser' encoded by nucleotides for residue #328, and 'Lys' for residue 
#306. Heterozygosity of nucleotide bases encoding amino acid 
residues #1157, #1186, #1188, and #1191, and homozygosity of 
nucleotides encoding amino acid residues #1054 and #1267 were 
found in donors H ll and H14 (Table 5.4). These results indicate that 
more than one type of C4A allele is present in Aboriginal donors 
H ll and H14. Also, heterozygosity of nucleotides encoding amino acid 
residue #328 of donor ECY743 suggests more than one type of C4A 
allele exists for this donor, whereas donor ECY519 had only one type 
of C4A allele according to PCR-RFLP analysis.
5.4.7 PCR-RFLP analysis of nucleotide bases encoding polymorphic 
amino acid residues of C4A null alleles of Aboriginal donors
Results of PCR-RFLP analysis of nucleotide bases encoding amino acid 
residues #306 and #328 of C4A *Q0 alleles of donors H19 and 
ECY509, are given in Table 5.5. PCR-RFLP banding patterns for each 
of these donors are shown in Figure 5.7. Both long and short C4 
genes of donors H19 and ECY509 had 'Lys' for residue #306. Short 
C4 genes of these donors had 'Ser' for residue #328, whereas both 
'Ser' and 'Tyr' amino acid residues were detected in PCR fragments 
amplified from the long and short C4 genes. These results indicate 
that 'Ser' is encoded by nucleotides of the short C4 genes of these 
donors, whereas 'Tyr' and/or 'Ser' are encoded by the long C4 genes.
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Results of PCR-RFLP analysis of nucleotide bases encoding amino acid 
residues #1054, #1157, #1186, #1188, #1191, and #1267 for C4A  
*Q0 alleles of donors H19 and ECY509 are given in Table 5.4, and the 
resulting PCR-RFLP banding patterns are shown in Figures 5.5 and 
5.6. Each type of C4A allele of these donors had the same nucleotide 
bases, encoding amino acid residues #1157, #1186, #1188, and 
#1191. However, heterozygosity was detected for residue #1267, 
where both donors had amino acid residues 'Ala' and 'Ser'. Donor 
H19's nucleotide bases encoded 'Asp' for residue #1054, whereas 
donor ECY509's nucleotide bases showed heterozygosity for this 
residue encoding 'Asp' and 'Gly'.
5.4.8 Aboriginal C4B *Q0 alleles identified by PCR-RFLP analysis and 
their predicted isoelectric points (PI)
The amino acid residues derived from PCR-RFLP analysis of 
nucleotide bases from Aboriginal C4 null alleles were compared with 
those residues derived for other C4 alleles nucleotide bases 
described in Chapter 4 (Tables 4.10 and 4.11). PCR-RFLP analysis of 
C4 null alleles and comparison with other defined C4 alleles 
enabled nucleotides encoding amino acid residues specific for C4 *Q0 
alleles to be identified. A summary of these results and the predicted 
isoelectric point (PI) of each C4 *Q0 allele is given in Table 5.6.
From these results it can be seen that a new C4B *Q0 allele has been 
identified in donors H ll and H14. This allele is a short C4 gene 
which consists of a unique hybrid combination of both C4A- and 
C4B-specific amino acid residues. This C4B *Q0 allele has not 
previously been detected, and as it has C4A isotypic residues, was 
named C4A *CAN1. Nucleotide bases of the C4A *CAN1 allele 
encoded 'Met' for residue #306, whereas nucleotide bases of the A 
*3 allele, of donors H ll and H14, encoded 'Lys'. Sequencing of the 
C4A *CAN1 allele revealed nucleotide bases which encode 'Met' for 
residue #309, whereas other C4 alleles nucleotide bases encoded 
'lie' (Chapter 4, Figure 4.3). However, this polymorphism could not be 
detected by PCR-RFLP analysis, and was therefore excluded from this 
analysis. As with the C4A *3 allele, nucleotide bases of the
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C4A *CAN1 allele encoded 'Tyr' for residue #328, whereas 
nucleotides for residues #1157, #1186, #1188, and #1191, from the 
C4A *CAN1 allele encoded the same residues as detected in other 
C4B alleles (Table 5.6). Similar to the C4A *3, B *7, and B *2 
alleles, nucleotide bases of the C4A *CAN1 allele encoded 'Ala' for 
residue #1267. This combination of amino acid residues together 
with the known conserved amino acid residues of the C4 gene, 
produced a PI value of 7.05, which is the same as that predicted for 
the C4A *3 allele. Therefore, C4A *3 and C4A *CAN1 alleles would 
be indistinguishable by protein gel electrophoresis.
PCR-RFLP analysis (Table 5.6), and Taq I RFLP analysis (Table 5.3), 
of the second type of C4B *Q0 allele found in Aborigines ECY743, 
ECY519, and the long C4B *Q0 allele of donor H I4, found nucleotides 
which were identical to those of the C4A *3 and A *4 alleles at 
locus I of these donors. Therefore, C4 alleles of these donors would 
be indistinguishable by protein gel electrophoresis.
5.4.9 Aboriginal C4A *Q0 alleles identified by PCR-RFLP analysis, 
and their predicted isoelectric points (PI)
There appeared to be three types of C4A *Q0 non-deleted alleles in 
the Aboriginal population (Table 5.6), as heterozygosity of residues 
#1267 and #1054 in donor ECY509 was found (Table 5.4). Nucleotide 
bases of one type of C4A *Q0 allele, which was denoted 'C4A 
*Q0Aba', encoded amino acid residue 'Gly' for residue #1054 which 
is the same as the A *2~ allele (Table 4.10). Nucleotide bases of 
another type of C4A *Q0 allele, which was denoted 'C4A *Q0Abb', 
were similar to those of the A *3a~ allele (Table 4.10), encoding 'Ala' 
for residue #1267. Nucleotide bases of the the third type of C4A *Q0 
allele, which was denoted 'C4A *Q0Abc', encoded 'Ser' for residue 
#1267 (Table 5.6), as was found for alleles C4A *3b~ and C4A *4, 
(Table 4.10).
In summary, more than one type of non-deleted C4A *Q0 allele is 
present in the Aboriginal population. Donor ECY509 is heterozygous 
for C4A *Q0Aba, and C4A *Q0Abc alleles, and donor H I9 is
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heterozygous for the C4A *QOAbb, and C4A *Q0Abc alleles 
(Table 5.6).
5.4.10 PCR-RFLP analysis of Aboriginal donors having C4A Q0 alleles 
to screen for a 2 bp insertion into exon 29
It was necessary to determine if non-deleted C4A *Q0 alleles of 
donors H19 and ECY509 resulted from the same mutation as a 
Caucasian non-deleted C4A *Q0 allele described by Barba et al.
(1993). Nucleotide bases encoding amino acid residues #1207 to 
#1284 were amplified from each C4 allele of Caucasian donors 
RCH555 (A Q0 B 1,2), ASD22 (A Q0 B 1) and ASD37 (A Q0 B 1), and 
Aboriginal donors H19 (A Q0 B 1), ECY509 (A Q0 B 1) and WCY1204 
(A 3 B 1,12). PCR-RFLP analysis of this PCR product (254 bp), with 
the restriction enzyme Fok I, was undertaken to identify the 
presence of a 2 bp insertion into exon 29. Restriction analysis of C 4 
alleles with Fok 1 produces two fragments of 76 bp and 178 bp in 
length. If the 2 bp insertion is present, it will be found in the 76 bp 
fragment. During electrophoresis, this results in two additional bands 
migrating slower than the 76 bp band. One of these bands contains 
the 2 bp insertion (mutant allele), whilst the second, slower 
migrating band results from a combination of the wild and mutant 
type alleles. This type of pattern was detected for Caucasian donor 
RCH555 (Figure 5.8). Other C4A Q0 allele donors did not result in 
this pattern, and therefore did not have the 2 bp insertion in this 
gene region, nor did donor WCY1204, used as a control, who had 
functional C4A and C4B alleles. Donor ECY509 appears to have an 
additional PCR-RFLP banding pattern apart from the expected 
pattern. The origin of this additional pattern is unknown and 
requires further investigation by sequence analysis.
Barba et al. (1993), found that the C4A *Q0 alleles which resulted 
from a 2 bp insertion were in linkage disequilibrium with the HLA- 
DR 6 allele. Donor RCH555 was chosen to investigate the presence of 
the 2 bp insertion, as this donor had a C4A *Q0 allele and a DR 6 
allele. Aboriginal donor ECY509 was heterozygous at the DR locus, 
having DR *0404, and DR *1402 alleles, which are DR 4 and DR 6
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Figure 5.8 PCR-RFLP analysis of C4A QO allele donors, in search of 
a 2 bp insertion in exon 29. PCR fragments include nucleotide bases 
encoding residues #1207 to #1284 for each C4 allele. Restriction 
analysis resulted in PCR fragment sizes of 178 bp and 76 bp for each 
sample. Lane #3 represented donor WCY1204 (A 3 B 1,12), #4  
donor ASD37 (A QO B 1), #5 donor ECY509 (A QO B 7), #6 donor 
H19 (A QO B 1), #7 donor ASD22 (A QO B 7), and #8 donor RCH555 
(A QO B 1,2). Lane #1 is unrestricted PCR fragments, and lane #2 
represents molecular weight marker pBR322  restricted with Msp 1.
1 2 3 4 5 6 7 8
67
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allotypes, respectively (Table 5.3). However, this donor did not have 
a 2 bp insertion in exon 29 of it's C4 alleles. Donor ASD22 was 
heterozygous at the DR locus having DR 3,4 alleles, and ASD37 was 
homozygous for DR 3 alleles. The DR haplotype of donor H19 is 
unknown.
5.4.11 Transcription analysis of C4 *Q0 alleles in Aboriginal donors 
HI 1, H14, and H19
Now that it was possible to identify the short, non-deleted C4B *Q0 
allele of donors H ll and H14, and the C4A *Q0 alleles of donor H19, 
RNA studies were performed to determine if these alleles were 
transcribed. Extraction of total RNA from cell lines of donors Hl l ,
H14 and H19, was used for both C4-specific cDNA and total cDNA 
analysis. This revealed that these donors could produce full length 
mRNA for the C4 QO allele which they possessed. PCR and PCR-RFLP 
analysis of cDNA from donors Hl l ,  H14 and H19, are shown in 
Figures 5.9, 5.10 and 5.11. A C47?-specific primer which detected 
nucleotide bases encoding 'Arg' for residue #1191, was used to 
amplify the C4A *CAA7 allele from cDNA of donors H ll and H14, 
(Figure 5.9). The same primer amplified the C4B alleles from cDNA 
of donor H19, (Figure 5.9). There was some genomic DNA 
contamination in each cDNA sample, but was easily distinguished 
from the cDNA-PCR product due to the different size of each product 
(542 bp for genomic DNA, and 342 bp for cDNA). These same results 
were obtained from both total, and C4-specific, cDNA preparations.
PCR-RFLP analysis, of cDNA containing all C4 alleles of donors Hl l ,  
H14 and H I9, using restriction enzyme Aci 7, was carried out to 
identify nucleotides encoding residues #1188 and #1191. This 
analysis detected both C4A and C4B types of nucleotides thereby 
indicating that both C4A *3 and C4A *CAN1 alleles were fully 
transcribed (Figure 5.10A and B). Restriction analysis produced 544 
bp, 41 bp, and 16 bp fragment sizes for the A *3 allele, indicating 
that amino acid residues 'Val' and 'Leu' were encoded by nucleotides 
for residues #1188 and #1191, respectively. Fragment sizes 306 bp, 
230 bp, 41 bp, 16 bp, and 8 bp were detected for the C4A *CAA7 
allele, indicating that amino acid residues 'Ala' and 'Arg' were
Figure 5.9 C4£-specific PCR amplification of nucleotides encoding 
amino acid residues #1091 to #1191 from cDNA samples of 
Aboriginal donors Hl l ,  H14 and H19. The cDNA PCR fragment size 
was 342 bp, whereas the genomic PCR fragment size was 542 bp.
Lane #1 Hl l ,  #2 H14, #3 H19, #4 WCY1204 genomic positive control 
(primer pair 2, Table 5.1), #5 ECY743 (A 3 B Q0) genomic negative 
control (primer pair 2, Table 5.1), #6 ECY743 genomic positive 
control using different primers which are not C4B-specific, and 
amplified bases encoding residue #1091 to #1206 (primer pair 9, 
Table 4.1, Chapter 4), #7 molecular weight marker pBR322  
restricted with Msp /, #8 PCR negative control, without a DNA 
template. Each cDNA PCR result showed some genomic contamination 
which resulted from cDNA preparation, whereas contamination was 
absent in the other negative controls.
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Figure 5.10 PCR-RFLP analysis of nucleotide bases encoding 
residues #1188 and #1191, in cDNA samples from Hl l ,  H14 and H19. 
PCR fragments represented all C4 alleles. Figures 'A' and 'B’ 
represent polymorphism of nucleotides encoding residues #1188 and 
#1191. PCR-RFLP fragments shown in Figure A were separated on 2.5 
% agarose gel and EtBr stained, whereas those in Figure B were 
separated on 8 % polyacrylamide and silver stained. Lanes #3, #4  
and #5, represent donors Hl l ,  H14 and H19, respectively, in Figures 
'A', whereas lanes #3, #4 and #5 represent donors H19, H14 and 
Hl l ,  respectively, in Figure 'B'. Lane #2 in Figure 'A', and #1 in 
Figure 'B' are unrestricted PCR cDNA samples. pBR322 restricted 
with Msp 1 is the molecular weight marker shown in each figure.
A1 2 3 4  5
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Figure 5.11 C4A-specific amplification of cDNA samples from C4A 
QO allele donor H19. Figure 'A' shows C4A amplification of 
nucleotide bases encoding C4A isotypic residues #1101-#1106 to 
nucleotides encoding residue #1284 (primer pair 5, Table 5.1), where 
lane #1 represents donor Hl l ,  #2 is H14, #3 is H19, #4 is a genomic 
negative control (using primer pair 5, Table 5.1) donor 'EW-Vavy'
(C4A QO resulting from deletion of the C4A gene), #5 is a cDNA 
positive control of donor H I9 (using C4B-isotypic primer pair 6,
Table 5.1), #8 is a PCR negative control without a DNA template. 
Figure 'B' shows C4A amplification including nucleotide bases for 
C4A isotypic residues #1101-#1106 to #1033 (primer pair #3, Table 
5.1), where lane #1 represents cDNA PCR fragments of donor Hl l ,  #2 
is H14, #3 is H19, #4 is a positive genomic control donor 'WCY1204' 
(primer pair #3, Table 5.1), #6 is a PCR negative control without a 
DNA template. Lane #1, #2 and #3 in 'B' have some genomic 
contamination of the cDNA preparation, whereas contamination was 
absent in the negative control. pBR322  restricted with Msp I is the 
molecular weight marker shown in each figure.
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encoded by nucleotides for residues #1188 and #1191 (Figure 5.10A 
and B). The larger 544 bp fragment was clearly visible on a 2.5 % 
agarose gel stained with EtBr, whereas the 306 bp and 230 bp 
fragments were more readily detected by separation on an 8 % 
polyacrylamide gel which was silver stained (Figures 5.10A and B). 
Fragment sizes less than 60 bp could not be seen as they were lost 
during gel electrophoresis.
The molecular basis for the C4A Q0 allotype of Aboriginal donors 
has not been determined. However, PCR and PCR-RFLP analysis of 
cDNA from donor H19, identified C4A-specific nucleotides, thereby 
indicating that the C4A alleles are completely transcribed, (Figure 
5.10A and B, and 5.11 A and B). PCR-RFLP analysis of cDNA encoding 
residues #1188 and #1191 in donor H19, found nucleotides common 
to both C4A and C4B alleles, indicating that both C4A and C4B 
genes were completely transcribed (Figure 5.10A and B). In this 
analysis the C4A alleles were represented by 544 bp, 41 bp, and 16 
bp fragments, whereas the C4B alleles were represented by 306 bp, 
230 bp, 41 bp, 16 bp and 8 bp fragments, (Figure 5.10A and B).
C4A alleles were successfully amplified by two different pairs of 
C4A -specific primers (Figure 5.11 A and B). The first pair of primers 
amplified a sequence region having nucleotide bases encoding C4A 
isotypic residues #1101 -# 1106 to nucleotide bases encoding residue 
#1284. This PCR amplification resulted in a fragment size of 574 bp 
(Figure 5.11 A). The second pair of primers amplified the nucleotide 
base sequence region of C4A alleles encoding amino acid residue 
#1033 to nucleotides encoding the C4A isotypic residues #1101- 
#1106. The resulting PCR fragment size from this amplification was 
262 bp (Figure 5.1 IB). Even though C4A-specific PCR-RFLP patterns 
were obtained by analysis of cDNA from donor H19 (A *Q0 B *7), it 
was not certain whether each C4A Q0 allele of the homozygous 
allotype was transcribed. Further PCR-RFLP analysis of nucleotide 
bases encoding residue #1267 is required to resolve this question as 
the C4A alleles of donor H19 were heterogeneous for nucleotides 
encoding this residue.
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5.4.12 Association of the C4A *CAN1 allele with the C4B QO allotype 
in ten related Groote Island Aboriginal donors, and 50 non-related 
SLE Caucasian patients by PCR-RFLP analysis
A summary of PCR-RFLP analysis of each Groote Island Aboriginal 
donor is given in Table 5.7. PCR-RFLP banding patterns are the same 
as those shown in Figures 5.5 and 5.6. PCR-RFLP analysis of 
nucleotide bases encoding amino acid residues #1101 -#1106, #1157 
and #1191 of ten C4B QO Groote Island Aboriginal donors, found 
that six of these donors carried the C4A *CAN1 allele. The remaining 
four Groote Island Aboriginals had similar PCR-RFLP patterns (Table 
5.7) as C4B *Q0 allele donors ECY743 and ECY519 (Table 5.6). Each 
C4A *CAN1 allele donor had a DR 8 allele, while C4B *Q0 allele 
donors, with similar PCR-RFLP patterns to donors ECY743 and 
ECY519, had both DR 4 and DR 8 alleles. Unfortunately the 
inheritance of both types of C4B *Q0 alleles could not be shown as 
some family members were suspected to be unrelated.
A Caucasian SLE patient group of 50 donors (28 having a C4B QO 
allotype), were screened for the C4A *CAN1 allele by PCR-RFLP 
analysis of nucleotide bases which encoded amino acid residue 
#1188. Twenty three patients carried a C4B QO allele in a 
heterozygous state with either a B 1 or B 3 allele, four patients 
were homozygous C4B QO, and the remaining patients had B 1 
and/or B 2 alleles. Only one donor, 'SLE612', was found to have 
amino acid residue 'Ala' encoded by nucleotides for residue #1188, 
which was also detected in the C4A *CAN1 allele. This patient's 
ethnic background was English and New Zealand, and was the only 
donor with a DR 8 allele which was found also in Aboriginal donors 
from Groote Island having the C4A *CAN1 allele. These results 
suggest that the C4B QO allotype in Caucasians is not associated with 
the C4A *CAN1 allele, with the exception of donors who have DR 
alleles common to those found in Aboriginals.
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Table 5.7 PCR-RFLP results for nucleotides encoding  
C 4  polymorphic amino acids of Groote Island Aborigines
D o n o r C4  allotype# # 1 1 0 1 - # 1 1 0 6 #1 157 # 1 1 9 1
C4A C4B C4A C4A
30017 A 3  B Q0 PCPVLD LSPV IH N&S L&R
30019 A 3  B 00 PCPVLD - N&S L&R
30618 A 3 B 1,Q0 PCPVLD LSPV IH N L
30620 A 4  B LQ0 PCPVLD LSPVIH N L
40033 A 4  B OO PCPVLD - N L
40034 A 3 B Q0 PCPVLD - N&S L&R
40036 A 4  B Q0 PCPVLD - N&S L&R
40041 A 4  B OO PCPVLD - N L
40042 A 3 B 1,Q0 PCPVLD LSPV IH N&S L&R
40045 A 3 B 1,Q0 PCPVLD LSPV IH N&S L&R
# allotype determined by protein gel electrophoresis.'- ' indicates absence of
nucleotides which code for the respective C4 isotypic amino acid residues.
PCR product encoding each 1C4 allele of a donor was used for analysis of
nucleotides encoding residues #1101 to #1106. C4A specifically amplified 
PCR product was used for analysis of nucleotide basesencoding amino acid
residues #1157 and #1191.
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5.4.13 Frequency of the C4A *CAN1 allele in Aboriginal Australians 
from Cape York
To establish the frequency of the C4A *CAN1 allele in Aboriginal 
Australians,50 donors from Cape York were screened by PCR-RFLP 
analysis using the restriction enzyme Aci /. This enzyme 
distinguished between nucleotide bases encoding either amino acid 
residue 'Ala' or 'Val' for residue #1188 in the C4A alleles of each 
donor. Examples of the resulting PCR-RFLP banding pattern can be 
seen in Figure 5.6. Only two Aboriginal donors had a C4B Q0 allele in 
a heterozygous form with either a B 1 or a B 2 allele. Both of these 
donors had DR 4 and DR 5 alleles, which are common HLA class II 
alleles in Caucasian populations (personnel communication with Prof. 
Serjeantson, JCSMR). The remaining donors carried other functional 
C4B alleles which were detected by protein gel electrophoresis. From 
PCR-RFLP analysis of these donors, not one carried the C4A *CAN1 
allele, indicating that very few A 3 or A 4 alleles are masking the 
C4A *CAN1 allele. The C4A *CAN1 allele is therefore more 
commonly associated with the B Q0 allotype.
5.5 Discuss ion
Association of the C4 null allotype with disease emphasises the need 
to elucidate its molecular basis. Studies here and elsewhere, show 
that C4 null alleles can result from large deletions or a small 2 bp 
insertion, as well as from C4 isotypic gene duplication. It is possible 
that other undefined C4 null alleles may be generated at the post- 
transcriptional level as has been demonstrated for C4-low protein 
producing strains of mice (Nakayama et al., 1990b; Pattanakitsakul 
et al., 1992a and b; Zheng et al., 1993), but such a phenomenon has 
not been demonstrated in man.
One type of C4B Q0 allele in this study was shown to comprise of a 
mixture of both C4A- and C4B-type polymorphic amino acid 
residues. The newly identified polymorphic residue, #306, together 
with PCR-RFLP analysis of other known polymorphic amino acid 
residues, enabled the molecular basis for the association of this 
C4A/C4B hybrid type of allele with the C4B Q0 allotype to be
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determined. These results indicate that this unique combination of 
residues may enable the resultant protein to migrate into the anodal 
region by C4 protein gel electrophoresis, thus appearing as a C4B  
Q0 allotype. This novel C4A/C4B hybrid allele was thus denoted as 
C4A *CAN1.
Functional assays of the C4A *CAN1 and other C4 alleles with mixed 
C4A and C4B polymorphic amino acid residues are required. This 
analysis would determine if proteins from C4 alleles with mixed 
residue properties are functionally different from other more typical 
C4A and C4B alleles. Also, functional assays would determine the 
association of hybrid C4A and C4B alleles with different disease 
states.
As previously mentioned, C4 alleles with mixed C4A/C4B amino 
acid residues have been reported which are associated with the C4B  
null allotype. However, until now, the molecular basis for this type of 
association was unknown. Previous efforts were made to establish if 
these alleles were a part of a particular HLA-extended haplotype. 
However, the evidence was inconclusive. Partanen and Campbell 
(1989), detected a C4A *3, B *Q0 allotype having long C4 genes at 
both loci I and II, which is the same C4 gene organisation as 
detected for Aboriginal donors H ll and H14 from this study. They 
found that, as with donors H ll and H14, the C4 locus II gene had an 
allele with C4A isotypic nucleotide bases, and Chido and Rodgers 
antigenic determinants which were common to C4B alleles. Also, as 
with donors H ll and H14, this individual's C4B *Q0 allele was 
associated with the HLA class II DR 4 allele. However, as other 
family members were not informative, it could not be determined 
which haplotype this unusual allele was associated with, (either 
HLA-Z? 44, BfS, C4A 3, C4B Q0, DR 4, or HLA-Z? 62, Bf S, C4A 3, C4B 
Q0, DR 4). RFLP analysis together with PFGE, in a study by Dunham 
et al. (1989), found that a C4B Q0 allele in the extended haplotype 
HLA-Z? 44, C4A 3, C4B Q0, DR 4, was associated with the presence of 
a duplicated C4A gene at locus II. Studies here, and by Hammond 
et al. (1992), and Braun et al. (1990), found duplicated C4 genes 
which were functional by producing C4 protein. These studies 
indicate that the haplotype HLA-Z? 44, Bf S, C4A 3, C4B Q0, DR 4
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{detected by Partanen and Campbell (1989)}, may have a duplicated 
C4A allele as detected by Hammond et al. (1992). The other 
haplotype, HLA-B 62, Bf S, C4A 3, C4B Q0, DR 4, however, could be 
the one which is associated with the hybrid type C4A allele.
In addition to these studies described above, the extended haplotype 
HLA- B 44, DR 4, Bf S, C2 C, C4A 3, C4B Q0 was detected in 12 of 17 
patients with non-deleted C4B Q0 (Schneider et al., 1986). However, 
whether or not this C4B Q0 allele was a duplicated C4A gene had 
not been investigated.
Of significance, is that a DR4 allele which is part of the extended 
haplotype HLA-5 44, C4A 3, C4B Q0, DR 4, associated with the C4B 
Q0 allotype, has been found with increased prevalence amongst 
patients with Felty's syndrome (Thomson et al., 1988). The 
molecular basis for the C4B Q0 allotype however, has not been 
investigated. Using advances made in the molecular basis of C4 null 
alleles, here, and by Hammond et al. (1992), and Braun et al.
(1990), it would be possible to establish if this haplotype has 
duplicated C4A genes. This may represent the first case of disease 
association with this type of C4 gene organisation. The mechanism 
underlying this association was thought to be reduced efficiency of 
the classical-pathway-mediated immune complex clearance 
mechanisms (Morgan and Walport, 1991a). However, as Hammond 
et al. (1992) and Braun et al. (1990), have shown, the haplotype 
HLA-Z? 44, C4A 3, C4B Q0, DR 4 has a duplicated C4A gene, where 
both genes were functional, producing C4 protein. If the haplotype 
associated with Felty's patients contains the same C4 gene 
organisation as described by Hammond et al. (1992) and Braun et 
al. (1990), there may be an overproduction of C4A protein in 
patients with Felty's syndrome. In this case a breakdown of the 
classical-pathway-mediated immune complex clearance mechanism 
is highly unlikely, as the C4A protein has been shown to be more 
efficient than C4B in mediating binding of immune complexes in 
vitro to erythrocyte CR1 (Schifferli et al., 1987).
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Results here show that both C4B Q0 allotypes, resulting from C4A 
gene duplication or having C4A *CAN1 alleles, have functional alleles 
at each C4 gene locus. Therefore, these C4 allotypes are not strictly 
C4 deficient. However, homozygosity for C4A alleles still results in 
deficiency of C4B protein. C4A and C4B alleles have isotypic amino 
acid residues which are important for the differential binding of C 4 
protein to immune complexes or to hydroxyl-containing 
carbohydrate surfaces, such as those which occur on the surface of 
encapsulated microorganisms. However, there are no known 
functions which are exclusive for either C4A or C4B isotypes. In the 
case of those individuals with C4A alleles at both loci I and II, this 
would result in higher concentrations of circulating C4A, and would 
be expected to partially compensate for C4B deficiency. It is likely 
that deficiency of C4 protein in patients caused by deletions or 
mutation of alleles encoding these proteins, are the types of C4 null 
allotypes which are associated with different disease states. Further 
functional studies of different C4 alleles are necessary to confirm 
these hypotheses.
Just as other previously identified C4 null alleles are associated with 
particular HLA-extended haplotypes, so too are the C4 null alleles 
described here. The new C4A *CAN1 allele is associated with two 
HLA alleles, including either DR 4 and DR 8 alleles. The C4B Q0 
allotype resulting from duplication of C4A alleles is also associated 
with both DR 4 and DR 8 HLA alleles in the Groote Island 
Aborigines and with DR 8 alleles in donor ECY519. Donor ECY743, in 
addition to the DR 4 allele, had a DR 6 allele. Of the SLE patients, 
only one had the C4A *CAN1 allele, and this allele was associated 
with the DR 8 allele, which is comparatively rare in the Caucasian 
population.
Studies here suggest that the molecular basis of nondeleted C4B null 
alleles in Caucasian SLE patients is different from that of Aboriginal 
C4B *Q0 alleles, and these C4B null alleles are associated with 
different DR haplotypes more typical of those found in Caucasian 
populations. The non-deleted type of C4B Q0 alleles in Caucasians 
require further investigation.
205
Of the 50 Aboriginal donors from Cape York which had functional 
alleles at both C4 gene loci as determined by protein gel 
electrophoresis, not one had the C4A *CAN1 allele. This supports the 
hypothesis that the C4A *CAN1 allele is only associated with the 
C4B Q0 allotype. It is possible however, with gene duplication in the 
C4 gene region, that the C4A *CAN1 allele would be undetected by 
protein gel electrophoresis. For example, an individual with C4A *3, 
*CAN1, B *1,*2 alleles could be interpreted as C4A 3, B 1,2 by 
protein gel electrophoresis. This stresses the need for molecular 
analysis with PCR-RFLP to accurately determine the C4 allotype of 
some individuals.
In Caucasian population studies, only non-deleted C4B *Q0 alleles of 
the long type have been detected (Jenhani et al., 1992). Further 
analysis of these alleles by using the PCR-RFLP C4 allotyping 
protocol is necessary to establish if C4A alleles are present at both 
loci I and II as in the cases of Aboriginal donors ECY519 and ECY743 
in this study.
It was not possible to establish if the C4 genes representing the B 
Q0 allotype in donors ECY743 and ECY519 were capable of producing 
RNA, as there was no way of distinguishing between the alleles at 
both C4 gene loci. It may be possible in future studies to test if both 
C4A genes at loci I and II are functional by a two-site 
immunoradiometric assay (Hammond et al., 1992). This assay 
measures C4A, C4B and total C4 protein concentration in sera. If 
each donor had a total of four C4A alleles (two on each haplotype), 
this assay would show a higher concentration of circulating C4A 
than an individual with two C4A alleles. However, there has been 
some criticism of this approach, as it is difficult to establish the base 
level for circulating C4A and C4B protein due to the variation of 
this level among individuals (Milis et al., 1992).
Molecular analysis of non-deleted C4A null alleles in this study, did 
not detect any unusual molecular properties which may result in a 
dysfunctional allele, nor did it provide an explanation for this allele's 
association with the C4A null allotype. However, this study has 
indicated that the defect may lie at the post-transcriptional level as
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RNA studies of donor H I9 found the C4A *Q0 allele to be fully 
transcribed. Further studies are required to establish if these alleles 
can produce the correct sized RNA transcript where all introns are 
successfully removed by splicing. Also, PCR-RFLP analysis of cDNA is 
necessary to determine if both C4A alleles of donor H19 are 
transcribed. The same RNA and cDNA studies are required for C4A 
Q0 allele donor ECY509.
It is uncertain as to where to begin searching for defects of these 
undefined C4 null alleles in the latter genetic processing stages. 
Knowledge of these types of defects in other human alleles or animal 
models may be useful in directing this research. Nakayama et al. 
(1990b), compared the transcriptional activity of C4 genes between 
high and low C4-protein-producing strains of mice and found no 
difference in transcriptional activity between high and low C4- 
protein-producing genes. However, they found that the steady state 
levels of C4 mRNA were ten times lower in low C4 protein strains 
than in high C4 protein strains. This suggested that the major 
regulation of C4 plasma levels occurred at the post-transcriptional 
level. Later studies by Pattanakitsakul et al. (1992a and b), 
discovered that the C4 mRNA of low C4 protein-producing strains 
was abnormally processed, resulting from a 200 bp insertion derived 
from a B2 sequence (short repetitive genetic element in rodents). 
Zheng et al. (1993), found a difference in the regulation of 
transcription of this C4 gene between two main sources of C 4 
biosynthesis including the liver and peritoneal macrophages. These 
animal model studies suggest it is possible that C4 Q0 alleles in 
humans which are able to transcribe mRNA, may be affected by 
other regulatory mechanisms at the post-transcriptional level, like 
those described in low C4 protein-producing strains of mice.
Determination of the molecular basis of C4B *Q0 alleles here, and for 
other C4 *Q0 alleles by other workers has been important for the 
development of the PCR-RFLP allotyping protocol. Each of these C4 
*Q0 alleles can now be identified by either Taq I RFLP and/or by 
PCR-RFLP analysis. The potential use of PCR-RFLP as a molecular
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C4 allotyping protocol is thus enhanced, and heterozygous carriers of 
these C4 'null' alleles can now be identified.
The genetic mechanisms involved with evolution of C4 *Q0 alleles 
are complicated, involving gene duplication and genetic 
recombination or gene conversion. The unusual C4A/C4B hybrid 
type of C4 allele has shown that C4 alleles can potentially be 
incorrectly ascribed by protein gel electrophoresis. Detection of this 
allele, associated with the C4B null allotype in the Aboriginal 
Australian donors from Darwin, suggests that the high frequency of 
C4B null alleles in the Darwin population could be accounted for, in 
part, by this hybrid type of allele.
In conclusion, studies reported in this chapter have increased the 
understanding of the molecular basis of C4 null alleles in Aboriginal 
populations, and have provided a means of identifying these alleles 
at the molecular level. Areas of further research have been identified 
and include the function of C4 proteins which are associated with 
the C4 Q0 allotypes described in this thesis, especially in relation to 
their association with different disease states.
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Chapter 6 
General Discussion
Studies reported here have investigated the distribution of C4  
alleles between two northern located Aboriginal Australian 
populations and three PNG populations from coastal, inland and 
highland regions. The distribution of C4 alleles was found to be 
distinctly different between the Aboriginal and PNG populations, and 
between each PNG population. A molecular-based C4 typing protocol 
was developed and its application has identified a number of novel 
and rare alleles. The molecular basis of the C4B null allele in 
Aboriginal Australians has been established and found to result from 
either C4A gene duplication or possession of a novel C4A/C4B  
hybrid type of allele. The finding that the C4A null allele can 
produce cDNA indicates the C4A null allotype may result from a 
defect in the post-transcriptional processing of the allele.
Prior to this research, limited information was available concerning 
the distribution of C4 allotypes within Aboriginal Australian and 
PNG populations. The Aboriginal Australian populations were found 
here to be quite different to many of the other western Pacific 
indigenous populations having two frequently occurring C4A alleles 
and two frequently occurring C4B alleles. By comparison with the 
Aboriginal Australian populations each PNG population, especially 
from inland and highland regions, was almost monomorphic at the 
C4 gene locus by having one frequently occurring C4A and one 
frequently occurring C4B allele. Results here, and those by Ranford 
(1989), indicate that the distribution of the most frequently 
occurring C4 alleles in a population can contribute to understanding 
the origin of Aboriginal populations and their movement within 
Australia.
C4A null alleles were found to be rare in PNG populations, they were 
absent in highland and inland populations and only a low frequency 
was detected in the coastal population. By contrast C4A null alleles 
were found to be common in Aboriginal Australians. The frequency 
of C4B null alleles in PNG populations was higher than that detected 
for the C4A null alleles except for the inland population where C4B
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null alleles were absent. The frequencies of C4B null alleles for the 
highland and coastal PNG populations were slightly lower than those 
detected for the Aboriginal Australians.
The high frequencies of C4A null alleles detected in Aboriginal 
Australian populations both here and by Ranford et al. (1987), 
suggest that this allele is common to these populations. Frequencies 
of C4B null alleles in the Aboriginal Australian populations were 
similar to those found in the Caucasian population. However, 
molecular analysis indicated that these C4B null allotypes identified 
in Aboriginal Australians were not true null alleles, but were instead, 
either duplicated C4A alleles or a C4A/C4B hybrid type of allele 
which has a similar PI value to a C4A allele. Molecular analysis thus 
provides strong evidence for the conclusion that C4 protein 
allotyping by gel electrophoresis does not always give an accurate 
description of the C4 allotype.
A number of rarely occurring C4 alleles were identified in the 
Aboriginal Australians and PNG populations, some of which, were 
previously thought to be unique to other indigenous populations, for 
example, 'B 5' in Asians and 'B 96' in Chinese. The presence of these 
rare alleles could indicate a genetic link between different ethnic 
populations. This study has shown however, at the genetic level that 
it is not unusual for C4 alleles with different combinations of 
polymorphic amino acid residues to have the same or similar 
migration patterns by protein gel electrophoresis, thereby appearing 
as the same allotype. It is quite possible therefore that rare C 4 
alleles recorded in different ethnic populations may have different 
amino acid residue compositions, but the same or similar PI value. 
Consequently, it is important to establish the molecular basis of these 
rarely occurring C4 alleles, in order to define whether they have 
evolved independently, or if they have a genetic link. PCR-RFLP 
analysis would help to establish if the rare alleles identified in 
different ethnic groups have the same composition of polymorphic 
nucleotide bases and therefore verify any such genetic links between 
these ethnic groups.
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A lack of Hardy-Weinberg equilibrium was detected for the 
distribution of C4 alleles in the East Cape York Aboriginal 
population, which is a population sample previously found to be in 
Hardy-Weinberg equilibrium at HLA-DR and HLA-DQ loci by Gao 
et al. (1992a). This demonstrates that the C4 protein gel 
electrophoresis technique does not always provide an accurate 
description of the distribution of C4 alleles in a population. In this 
particular study it's most likely that the inability to resolve C4 A3,4 
heterozygous alleles has led to an overestimate of the number of C 4 
A3 alleles in this population. This provided further evidence of the 
need for a molecular-based C4 allotyping protocol.
Existing C4 sequence information used in conjunction with additional 
DNA sequencing results obtained here, enabled the development of a 
molecular-based protocol for C4 typing involving PCR-RFLP. This 
new protocol involved analysis of C4A and C4B alleles 
independently by amplification using primers which anneal to the 
C4A and C4B specific isotypic nucleotide bases. This strategy 
allowed ready identification of heterozygote and homozygote 
allotypes at the C4A and C4B gene loci that otherwise could be 
misinterpreted by protein gel electrophoresis.
The discovery of the polymorphic amino acid residue #306 was 
crucial to understanding the unique migration patterns of some of 
the rarely occurring C4 allotypes as polymorphism of this residue 
results in a charge change of the overall protein. Detection of 
polymorphic intron 9 nucleotide bases in this study provided a 
means for the identification of long and short C4 genes at the 
molecular level by PCR-RFLP. Sequencing of C4 alleles from intron 9 
nucleotide base 280 to nucleotide bases encoding polymorphic 
residues #306 and #328 will determine which polymorphic residues 
are associated with short or long C4 alleles. To establish if the 
polymorphic residues #306 and #328 are associated with either C4A  
or C4B specific residues it is necessary to sequence from the C4 
isotypic nucleotide bases to nucleotide bases encoding these residues. 
These additional studies would confirm the association of
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polymorphic residues #306 and #328 with specific C4 alleles as 
reported in this thesis.
These studies have shown that each C4 allele consists of an array of 
polymorphic amino acid residues which appear to have come from 
ancestral C4 alleles by genetic recombination and thereby creating 
C4 allelic diversity. It is possible that the presence of the large 7 kb 
intron 9 in some C4 alleles and absence in others has contributed to 
instability in the C4 gene region, as this difference in length may 
cause misalignment and unequal cross-over of different, yet highly 
homologous C4 genes. The high 'G' and 'C  nucleotide base content in 
the C4d gene region may also contribute to the process of unequal 
cross-over between C4 alleles as these bases bind more strongly 
than 'A' and 'T' nucleotide bases (Yu et al., 1986).
PCR-RFLP typing of a number of C4 alleles (A 58~, B 12~, B 22~,
B 4~, B 5~, and B 6~), for which the molecular basis was previously 
unknown, characterised the combination of polymorphic amino acid 
residues encoded by nucleotide bases of these alleles. These findings 
suggest that PCR-RFLP typing may provide a rapid method for 
identification of the genetic composition of other novel C4 alleles.
C4 allotyping results obtained by protein gel electrophoresis 
compared with those obtained later by PCR-RFLP analysis, were in 
some cases found to be conflicting. For example, alleles typed as A 6 
were found to be A *58 by PCR-RFLP analysis. This finding 
highlights problems in the interpretation of C4 allotypes determined 
by protein gel electrophoresis. A typing protocol based on the unique 
sequence of each C4 allele cannot be easily misinterpreted and thus 
enables accurate C4 allele typing.
False interpretation of C4A or C4B allotype homozygosity will not 
result in deviation from Hardy-Weinberg equilibrium so long as the 
number of heterozygotes is double that of homozygous alleles. 
Deviation from Hardy-Weinberg equilibrium could, however, arise 
when heterozygous alleles, for example C4A 3,4, are interpreted as 
homozygous C4A 3 alleles. This would result in an increased number 
of homozygous C4A 3 alleles.
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Molecular analysis has found heterogeneity for the C4A 3 allele, 
including the 'A *5a' allele (Yu, 1991), and the 'A *3b' allele 
(Anderson et ai,  1992). In addition the molecular C4 typing protocol 
developed here, identified other polymorphisms of the C4A 3 allele, 
these were the A *3c~' allele, and the C4A *CAN1 allele which co­
migrates with C4A 3 alleles during C4 protein gel electrophoresis. 
Clearly, C4 protein gel electrophoresis is unable to resolve some 
alleles with different amino acid sequences but with similar PI 
values. Further complications can arise in interpretation of C4 
protein gel electrophoresis patterns due to known duplication and 
deletion of C4A and C4B alleles.
It is highly likely that other polymorphic nucleotide bases remain 
undetected within the C4 gene. Only a single large (23 kb) C4A *3 
allele has been completely sequenced (Yu, 1991), and as such, no 
other sequence is available for comparison which might allow 
detection of other polymorphic nucleotide bases. All other C4 allelic 
sequence information has been provided from analysis of the 
polymorphic C4d region, and the region immediately flanking this 
site. It is clear that the C4d region is most important for the function 
of antibody/antigen binding of the C4 protein and therefore is the 
region of the gene most likely to have the majority of the C4 genes 
polymorphic residues encoded. As a result of these observations it 
can be hypothesised that by comparison with the polymorphic C4d  
region, fewer polymorphic residues will be identified outside of this 
region and are more likely to be allelic polymorphisms.
Detection of novel polymorphic nucleotide bases by sequencing 
presents a difficult task due to the length of the coding C4 gene (5.2 
kb). However, molecular techniques for identifying nucleotide 
mismatches between a known and unknown sequence are available 
(Anderson et ai,  1992), and may be applied to search the C4 gene 
for novel polymorphic nucleotides.
In future studies, if polymorphic nucleotide bases are found to be 
located too far from the isotypic region of the C4 gene for 
amplification with C4 isotypic primers, it may be necessary to use 
cDNA for the PCR-RFLP typing protocol. Analysis of cDNA may enable
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amplification of distant polymorphic nucleotides as the introns are 
absent in this form of DNA. However, genomic DNA is preferred for 
PCR-RFLP typing as it is easily extracted from peripheral blood, and 
requires less preparation time in comparison to cDNA. An alternative 
method, compared to the use of cDNA for the analysis of distant 
polymorphic nucleotide bases, could be the use of allele-specific 
oligonucleotides which would specifically hybridise to the 
polymorphic nucleotide base of interest.
A molecular-based C4 allotyping protocol will prove to be very 
useful in future C4 population studies, as a more accurate account of 
the distribution of C4 alleles will be obtained, compared to the 
traditional method of C4 protein gel electrophoresis. A molecular- 
based protocol can identify alleles which appear to be the same by 
protein gel electrophoresis, and is able to determine which particular 
type of C4 null allele is present. In addition, the molecular-based 
protocol can identify hybrid types of C4 alleles which protein gel 
electrophoresis cannot.
Until these studies little was known of the molecular basis of C4 null 
alleles in ethnic groups apart from Caucasians. Only three types of 
C4 null alleles have previously been characterised: (1) Those 
representing approximately 60 % of Caucasian C4 null alleles which 
result from large deletions of the entire C4 gene and usually an 
accompanying 21-hydroxylase gene; (2) Duplicated C4 genes 
associated with a C4 null allele at the alternative C4 locus and; (3) 
C4A null alleles with a 2 bp insertion resulting in a truncated 
message during transcription. Other studies have suggested another 
type of non-deleted hybrid C4 null allele consisting of amino acid 
residues common to both C4A and C4B alleles (Partanen and 
Campbell, 1989). The molecular basis of the hybrid type of C4 null 
allele and its association with the C4 null allotype according to 
protein gel electrophoresis, was determined in studies for this thesis.
Of the Aboriginal Australian C4 null alleles characterised in these 
studies, only those with extended HLA haplotypes having DR and 
DQ alleles commonly found in Europeans were found to have null 
alleles resulting from large deletions. Those individuals with
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haplotypes more commonly found amongst Aborigines have non- 
deleted types of C4 null alleles. Some C4B null alleles are associated 
with duplicated C4A genes, as determined by RFLP and PCR-RFLP 
analysis. Other C4B null alleles were found to be associated with a 
hybrid type of C4A allele (C4A *CAN1) which co-migrates with the 
C4A 3 protein. Both types of non-deleted C4B null alleles were 
found to be associated with HLA-DR 4 and DR 8 alleles.
It is possible that the C4A *CAN1 hybrid type of C4 allele identified 
here, is the same or similar to the hybrid C4 allele reported by 
Hammond et al. (1992) and Braun et al. (1990), which was also 
associated with the DR 4 allele. Studies for this thesis provide a valid 
explanation for the C4A *CAN1 alleles' association with the C4B null 
allele. The evidence was provided by identification of the unique 
combination of polymorphic amino acid residues of C4A *CAN1. This 
included identification of the polymorphic amino acid residue #306 
(not previously known to be polymorphic), which was important in 
establishing that C4A *CAN1 has a PI value the same as an C4A *3 
allele. The C4A *CAN1 allele can now be identified by the C4 
molecular allotyping protocol without the requirement for family 
studies which were necessary for Hammond et al. (1992), and Braun 
et al. (1990) to detect this type of hybrid C4A/C4B allele. Detection 
of hybrid allele-specific transcripts in this study proves that this 
novel type of allele is capable of producing an RNA transcript. 
However, further Northern analysis is required to determine whether 
the RNA transcript is of the predicted size. Rodgers and Chido 
antigenic determinant serological analysis would determine whether 
this protein is present in serum.
A number of studies in vitro have indicated selective roles for the 
protein products of C4A and C4B alleles under pathological 
conditions. Law, Dodds and Porter (1984) have demonstrated 
variations in binding specificity of C4A and C4B products, despite 
their high degree of amino acid homology (discussed in Chapter 1). 
C4A 3 is also known to be more efficient than C4B 1 in the 
inhibition of immune complex precipitation (Schifferli et al., 1986). 
However, only one functional study investigating the metabolic 
differences of C4A and C4B alleles in vivo has been performed
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(Peake et aL, 1989). Peake concluded that C4B 1 was catabolised 
more rapidly than C4A 3 in patients with pathological complement 
activation but not in control subjects. This difference, reported by 
Peake, was said to reflect the relatively greater extravascular 
distribution of C4B at sites of immune complex deposition or, 
alternatively, different rates of catabolism of inactive C4 isotypes.
There are no reported cases which have compared the metabolic 
differences of different C4A alleles and different C4B alleles. These 
types of studies are necessary as they will also determine whether 
an individual with hybrid alleles, or duplicated C4A or C4B alleles, 
is more or less at an advantage with regard to elimination of immune 
complexes or microorganisms during an immune response. These 
types of studies may also resolve the uncertainty as to the role of C 4 
null alleles in the clinical situation. That is, whether C4 null alleles 
are directly associated with disease pathogenesis or whether they are 
associated with another gene causing the susceptibility. Analysis of 
C4 alleles in different indigenous populations have shown their are 
two common C4A alleles (A 3 and A 4) and two common C4B 
alleles (B 1 and B 2) in each population. It is possible that 
evolutionary forces have sort to maintain these alleles in each 
population as they may have a selective advantage in processing 
infectious agents during an immune response. Only functional studies 
comparing the metabolic differences of C4 alleles will resolve these 
questions described above. As few studies have investigated C4 
allele products in vivo there is little experience with the 
complications which arise from working with this protein. In vitro 
studies of C4 protein can be difficult due to the instability of this 
protein. Possibly the instability of C4 protein reflects the lack of 
functional studies performed in vivo on this protein. However,
Peake's study is encouraging as results indicated no variable loss of 
functional activity during purification between different C4 protein 
preparations.
A worthwhile study would be to determine whether the hybrid type 
of C4A *CAN1 allele or duplicated C4A alleles are associated with 
the C4B QO allotype in Felty's Syndrome patients. This is because
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previous studies have shown that the C4B QO allotype which is 
associated with this disorder, like that of the C4 hybrid allele and 
C4A duplicated gene haplotype described here, is associated with 
the DR4 allele. Such a study would also seek to establish whether 
particular types of C4 null alleles are associated with different 
disease states.
Messenger RNA was identified for the C4A type of non-deleted null 
allele by PCR analysis of cDNA which suggests that the C4A null 
allele results from a post-transcriptional defect. This analysis 
indicated that the complete RNA transcript was produced. However, 
as the complete size of the transcript could not be detected by 
Northern analysis due to insufficient quantities of RNA in peripheral 
blood, it could not be shown that all introns were successfully 
removed by splicing. Therefore, the ability of this RNA transcript to 
translate protein is uncertain. Northern analysis of RNA isolated from 
liver, (the major producer of C4 protein), could be used to overcome 
this problem, however, liver samples from human donors with this 
type of C4 defect are not readily available. Therefore, it may be 
necessary to amplify, by allele-specific PCR, sections of the entire 
gene to ensure all introns have been removed.
Guinea-pig and murine models of C4 protein defects at the post- 
transcriptional level, as described by (Whitehead et al., 1983; 
Nakayama et al., 1990b, respectively), could be used as a guide for 
designing studies on genetic mechanisms responsible for C 4 
defective alleles in humans. Chido and Rodgers determinants have 
been detected on red blood cells of C4 deficient patients by Ballow 
et al. (1979), and O'Neill et al. (1979), however, these determinants 
were absent in plasma. These authors postulated there was an 
additional regulator locus for C4 deficiency. It is possible that this 
type of C4 deficiency may result from rapid consumption of C4 
protein by a later acting component of the classical pathway.
The work described in this thesis has involved design and 
assessment of a molecular-based protocol for C4 allotyping which in 
conjunction with RFLP or PFGE analysis, can provide more 
information than any of the existing serological typing protocols. This
217
molecular protocol can now be expanded to cover other rarely- 
occurring C4 allotypes. The molecular basis of the Aboriginal 
Australian C4B null allele has been determined, and results from 
two types of C4A alleles including the novel C4A *CAN1 allele. This 
thesis has contributed to knowledge of the complex genetics of C4 , 
and of some evolutionary mechanisms underlying that complexity, 
and has indicated direction for future research in this field.
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